{"id": "BioInfer.d669.s0_BioInfer.d669.s0.p0", "text": "The product of UL38 has been shown to be essential for capsid assembly, but no role has previously been assigned to the product of UL18.", "text_with_entity_marker": "The product of [E1]UL38[/E1] has been shown to be essential for capsid assembly, but no role has previously been assigned to the product of [E2]UL18[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL38", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL18", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p20", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, [E1]ERCC2[/E1] (XPD), mouse RAD51, and the HHR23B/[E2]p58[/E2] and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC2", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p58", "entity_2_idx": [[141, 144]], "entity_2_idx_in_text_with_entity_marker": [154, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p21", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse [E1]RAD51[/E1], and the HHR23B/[E2]p58[/E2] and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[119, 124]], "entity_1_idx_in_text_with_entity_marker": [123, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p58", "entity_2_idx": [[141, 144]], "entity_2_idx_in_text_with_entity_marker": [154, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p22", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include [E1]ERCC1[/E1], ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and [E2]HHR23A[/E2] subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC1", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HHR23A", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p23", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, [E1]ERCC2[/E1] (XPD), mouse RAD51, and the HHR23B/p58 and [E2]HHR23A[/E2] subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC2", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HHR23A", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p24", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse [E1]RAD51[/E1], and the HHR23B/p58 and [E2]HHR23A[/E2] subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[119, 124]], "entity_1_idx_in_text_with_entity_marker": [123, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HHR23A", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p25", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include [E1]ERCC1[/E1], [E2]ERCC2[/E2] (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC1", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ERCC2", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p26", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include [E1]ERCC1[/E1], ERCC2 (XPD), mouse [E2]RAD51[/E2], and the HHR23B/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC1", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p27", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, [E1]ERCC2[/E1] (XPD), mouse [E2]RAD51[/E2], and the HHR23B/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC2", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s1_BioInfer.d267.s1.p0", "text": "NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.", "text_with_entity_marker": "NLS-less S.cerevisiae proteins include both RAD51 and [E1]RAD52[/E1] that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and [E2]HRR25[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HRR25", "entity_2_idx": [[162, 167]], "entity_2_idx_in_text_with_entity_marker": [175, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s1_BioInfer.d267.s1.p1", "text": "NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.", "text_with_entity_marker": "NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the [E1]RAD23[/E1] and [E2]HRR25[/E2] molecules.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD23", "entity_1_idx": [[152, 157]], "entity_1_idx_in_text_with_entity_marker": [156, 161], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HRR25", "entity_2_idx": [[162, 167]], "entity_2_idx_in_text_with_entity_marker": [175, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d26.s0_BioInfer.d26.s0.p0", "text": "A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1.", "text_with_entity_marker": "A distinct modulating domain in [E1]glucocorticoid receptor[/E1] monomers in the repression of activity of the transcription factor [E2]AP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "glucocorticoid receptor", "entity_1_idx": [[32, 55]], "entity_1_idx_in_text_with_entity_marker": [36, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[123, 127]], "entity_2_idx_in_text_with_entity_marker": [136, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d607.s0_BioInfer.d607.s0.p0", "text": "The drastic effects of the exogenous cofilin on actin assembly were suppressed by phosphatidylinositol 4,5-bisphosphate (PIP2).", "text_with_entity_marker": "The drastic effects of the exogenous [E1]cofilin[/E1] on [E2]actin[/E2] assembly were suppressed by phosphatidylinositol 4,5-bisphosphate (PIP2).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[37, 44]], "entity_1_idx_in_text_with_entity_marker": [41, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[48, 53]], "entity_2_idx_in_text_with_entity_marker": [61, 66], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d607.s1_BioInfer.d607.s1.p0", "text": "The previous investigation (Abe et al. (1989) J. Biochem. 106, 696-702) suggested that cofilin is deeply involved in the regulation of actin assembly in developing skeletal muscle.", "text_with_entity_marker": "The previous investigation (Abe et al. (1989) J. Biochem. 106, 696-702) suggested that [E1]cofilin[/E1] is deeply involved in the regulation of [E2]actin[/E2] assembly in developing skeletal muscle.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[87, 94]], "entity_1_idx_in_text_with_entity_marker": [91, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[135, 140]], "entity_2_idx_in_text_with_entity_marker": [148, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s0_BioInfer.d246.s0.p0", "text": "Here we identify a pathway for the regulation of cofilin, a ubiquitous actin-binding protein that is essential for effective depolymerization of actin filaments.", "text_with_entity_marker": "Here we identify a pathway for the regulation of [E1]cofilin[/E1], a ubiquitous [E2]actin-binding protein[/E2] that is essential for effective depolymerization of actin filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[71, 92]], "entity_2_idx_in_text_with_entity_marker": [84, 105], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s0_BioInfer.d246.s0.p1", "text": "Here we identify a pathway for the regulation of cofilin, a ubiquitous actin-binding protein that is essential for effective depolymerization of actin filaments.", "text_with_entity_marker": "Here we identify a pathway for the regulation of [E1]cofilin[/E1], a ubiquitous actin-binding protein that is essential for effective depolymerization of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s0_BioInfer.d246.s0.p2", "text": "Here we identify a pathway for the regulation of cofilin, a ubiquitous actin-binding protein that is essential for effective depolymerization of actin filaments.", "text_with_entity_marker": "Here we identify a pathway for the regulation of cofilin, a ubiquitous [E1]actin-binding protein[/E1] that is essential for effective depolymerization of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[71, 92]], "entity_1_idx_in_text_with_entity_marker": [75, 96], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s1_BioInfer.d246.s1.p0", "text": "Our results define a mechanism for the regulation of cofilin and hence of actin dynamics in vivo.", "text_with_entity_marker": "Our results define a mechanism for the regulation of [E1]cofilin[/E1] and hence of [E2]actin[/E2] dynamics in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[53, 60]], "entity_1_idx_in_text_with_entity_marker": [57, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s2_BioInfer.d246.s2.p0", "text": "Phosphorylation by LIM-kinase 1 inactivates cofilin, leading to accumulation of actin filaments.", "text_with_entity_marker": "Phosphorylation by LIM-kinase 1 inactivates [E1]cofilin[/E1], leading to accumulation of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[44, 51]], "entity_1_idx_in_text_with_entity_marker": [48, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s2_BioInfer.d246.s2.p1", "text": "Phosphorylation by LIM-kinase 1 inactivates cofilin, leading to accumulation of actin filaments.", "text_with_entity_marker": "Phosphorylation by [E1]LIM-kinase 1[/E1] inactivates cofilin, leading to accumulation of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinase 1", "entity_1_idx": [[19, 31]], "entity_1_idx_in_text_with_entity_marker": [23, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s2_BioInfer.d246.s2.p2", "text": "Phosphorylation by LIM-kinase 1 inactivates cofilin, leading to accumulation of actin filaments.", "text_with_entity_marker": "Phosphorylation by [E1]LIM-kinase 1[/E1] inactivates [E2]cofilin[/E2], leading to accumulation of actin filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinase 1", "entity_1_idx": [[19, 31]], "entity_1_idx_in_text_with_entity_marker": [23, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[44, 51]], "entity_2_idx_in_text_with_entity_marker": [57, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s3_BioInfer.d246.s3.p0", "text": "Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase.", "text_with_entity_marker": "Regulation of [E1]actin[/E1] dynamics through phosphorylation of [E2]cofilin[/E2] by LIM-kinase.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s3_BioInfer.d246.s3.p1", "text": "Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase.", "text_with_entity_marker": "Regulation of [E1]actin[/E1] dynamics through phosphorylation of cofilin by [E2]LIM-kinase[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIM-kinase", "entity_2_idx": [[67, 77]], "entity_2_idx_in_text_with_entity_marker": [80, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d246.s3_BioInfer.d246.s3.p2", "text": "Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase.", "text_with_entity_marker": "Regulation of actin dynamics through phosphorylation of [E1]cofilin[/E1] by [E2]LIM-kinase[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIM-kinase", "entity_2_idx": [[67, 77]], "entity_2_idx_in_text_with_entity_marker": [80, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d542.s0_BioInfer.d542.s0.p0", "text": "Since RAD54 is a recombinational protein associated with RAD51, this is the first genetic evidence that cancer arises from a defect in repair processes involving homologous recombination.", "text_with_entity_marker": "Since [E1]RAD54[/E1] is a recombinational protein associated with [E2]RAD51[/E2], this is the first genetic evidence that cancer arises from a defect in repair processes involving homologous recombination.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD54", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD51", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p20", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E2]AP-1[/E2] and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p21", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E2]p38[/E2] MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p38", "entity_2_idx": [[325, 328]], "entity_2_idx_in_text_with_entity_marker": [338, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p22", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E2]mitogen-activated protein kinase[/E2] (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[198, 230]], "entity_2_idx_in_text_with_entity_marker": [211, 243], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p23", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 [E1]muscarinic receptors[/E1] are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and [E2]c-Jun N-terminal kinase[/E2], but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptors", "entity_1_idx": [[29, 49]], "entity_1_idx_in_text_with_entity_marker": [33, 53], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "c-Jun N-terminal kinase", "entity_2_idx": [[288, 311]], "entity_2_idx_in_text_with_entity_marker": [301, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p24", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 [E1]muscarinic receptors[/E1] are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptors", "entity_1_idx": [[29, 49]], "entity_1_idx_in_text_with_entity_marker": [33, 53], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p25", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 [E1]muscarinic receptors[/E1] are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptors", "entity_1_idx": [[29, 49]], "entity_1_idx_in_text_with_entity_marker": [33, 53], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "muscarinic receptor", "entity_2_idx": [[358, 377]], "entity_2_idx_in_text_with_entity_marker": [371, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p26", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 [E1]muscarinic receptors[/E1] are involved in [E2]muscarinic receptor[/E2]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptors", "entity_1_idx": [[29, 49]], "entity_1_idx_in_text_with_entity_marker": [33, 53], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "muscarinic receptor", "entity_2_idx": [[66, 85]], "entity_2_idx_in_text_with_entity_marker": [79, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p27", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 [E1]muscarinic receptors[/E1] are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 [E2]MAPK[/E2], may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptors", "entity_1_idx": [[29, 49]], "entity_1_idx_in_text_with_entity_marker": [33, 53], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "MAPK", "entity_2_idx": [[329, 333]], "entity_2_idx_in_text_with_entity_marker": [342, 346], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p28", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 [E1]muscarinic receptors[/E1] are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/[E2]extracellular signal regulated protein kinase[/E2] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptors", "entity_1_idx": [[29, 49]], "entity_1_idx_in_text_with_entity_marker": [33, 53], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "extracellular signal regulated protein kinase", "entity_2_idx": [[238, 283]], "entity_2_idx_in_text_with_entity_marker": [251, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p29", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 [E1]muscarinic receptors[/E1] are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E2]MAPK[/E2])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptors", "entity_1_idx": [[29, 49]], "entity_1_idx_in_text_with_entity_marker": [33, 53], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "MAPK", "entity_2_idx": [[232, 236]], "entity_2_idx_in_text_with_entity_marker": [245, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p40", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and [E1]c-Jun N-terminal kinase[/E1], but not via [E2]p38[/E2] MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-Jun N-terminal kinase", "entity_1_idx": [[288, 311]], "entity_1_idx_in_text_with_entity_marker": [292, 315], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p38", "entity_2_idx": [[325, 328]], "entity_2_idx_in_text_with_entity_marker": [338, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p41", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E1]mitogen-activated protein kinase[/E1] (MAPK)/extracellular signal regulated protein kinase and [E2]c-Jun N-terminal kinase[/E2], but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[198, 230]], "entity_1_idx_in_text_with_entity_marker": [202, 234], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-Jun N-terminal kinase", "entity_2_idx": [[288, 311]], "entity_2_idx_in_text_with_entity_marker": [301, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p42", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E1]muscarinic receptor[/E1]-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "muscarinic receptor", "entity_1_idx": [[358, 377]], "entity_1_idx_in_text_with_entity_marker": [362, 381], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p43", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p44", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 [E1]MAPK[/E1], may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAPK", "entity_1_idx": [[329, 333]], "entity_1_idx_in_text_with_entity_marker": [333, 337], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p45", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/[E1]extracellular signal regulated protein kinase[/E1] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "extracellular signal regulated protein kinase", "entity_1_idx": [[238, 283]], "entity_1_idx_in_text_with_entity_marker": [242, 287], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p46", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E1]MAPK[/E1])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MAPK", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p47", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E1]AP-1[/E1] and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AP-1", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p48", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E1]p38[/E1] MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p38", "entity_1_idx": [[325, 328]], "entity_1_idx_in_text_with_entity_marker": [329, 332], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p49", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E1]mitogen-activated protein kinase[/E1] (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[198, 230]], "entity_1_idx_in_text_with_entity_marker": [202, 234], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p70", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/[E1]extracellular signal regulated protein kinase[/E1] and c-Jun N-terminal kinase, but not via [E2]p38[/E2] MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "extracellular signal regulated protein kinase", "entity_1_idx": [[238, 283]], "entity_1_idx_in_text_with_entity_marker": [242, 287], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p38", "entity_2_idx": [[325, 328]], "entity_2_idx_in_text_with_entity_marker": [338, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p71", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E1]mitogen-activated protein kinase[/E1] (MAPK)/[E2]extracellular signal regulated protein kinase[/E2] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[198, 230]], "entity_1_idx_in_text_with_entity_marker": [202, 234], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "extracellular signal regulated protein kinase", "entity_2_idx": [[238, 283]], "entity_2_idx_in_text_with_entity_marker": [251, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p72", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E1]AP-1[/E1] and pathways via mitogen-activated protein kinase ([E2]MAPK[/E2])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AP-1", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[232, 236]], "entity_2_idx_in_text_with_entity_marker": [245, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p73", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E1]MAPK[/E1])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E2]p38[/E2] MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAPK", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p38", "entity_2_idx": [[325, 328]], "entity_2_idx_in_text_with_entity_marker": [338, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p74", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E1]mitogen-activated protein kinase[/E1] ([E2]MAPK[/E2])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[198, 230]], "entity_1_idx_in_text_with_entity_marker": [202, 234], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAPK", "entity_2_idx": [[232, 236]], "entity_2_idx_in_text_with_entity_marker": [245, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p75", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E1]AP-1[/E1] and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E2]p38[/E2] MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AP-1", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p38", "entity_2_idx": [[325, 328]], "entity_2_idx_in_text_with_entity_marker": [338, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p76", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E1]AP-1[/E1] and pathways via [E2]mitogen-activated protein kinase[/E2] (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AP-1", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[198, 230]], "entity_2_idx_in_text_with_entity_marker": [211, 243], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p77", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E1]mitogen-activated protein kinase[/E1] (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E2]p38[/E2] MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[198, 230]], "entity_1_idx_in_text_with_entity_marker": [202, 234], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p38", "entity_2_idx": [[325, 328]], "entity_2_idx_in_text_with_entity_marker": [338, 341], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p30", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two [E2]actin[/E2]-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p31", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on [E2]profilin[/E2], consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[94, 102]], "entity_2_idx_in_text_with_entity_marker": [107, 115], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p32", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, [E2]p19[/E2], p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p19", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p33", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, [E2]Arp2[/E2] and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p34", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and [E1]Arp3[/E1]; and five apparently novel proteins, p40, [E2]p35[/E2], p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp3", "entity_1_idx": [[173, 177]], "entity_1_idx_in_text_with_entity_marker": [177, 181], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p35", "entity_2_idx": [[220, 223]], "entity_2_idx_in_text_with_entity_marker": [233, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p35", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, [E1]p40[/E1], [E2]p35[/E2], p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p40", "entity_1_idx": [[215, 218]], "entity_1_idx_in_text_with_entity_marker": [219, 222], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p35", "entity_2_idx": [[220, 223]], "entity_2_idx_in_text_with_entity_marker": [233, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p36", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two [E1]actin[/E1]-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, [E2]p35[/E2], p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p35", "entity_2_idx": [[220, 223]], "entity_2_idx_in_text_with_entity_marker": [233, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p37", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on [E1]profilin[/E1], consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, [E2]p35[/E2], p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p35", "entity_2_idx": [[220, 223]], "entity_2_idx_in_text_with_entity_marker": [233, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p38", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, [E1]p35[/E1], [E2]p19[/E2], p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p35", "entity_1_idx": [[220, 223]], "entity_1_idx_in_text_with_entity_marker": [224, 227], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p19", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p39", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, [E1]Arp2[/E1] and Arp3; and five apparently novel proteins, p40, [E2]p35[/E2], p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[164, 168]], "entity_1_idx_in_text_with_entity_marker": [168, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p35", "entity_2_idx": [[220, 223]], "entity_2_idx_in_text_with_entity_marker": [233, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p110", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p111", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E1]smooth muscle actin[/E1], smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle actin", "entity_1_idx": [[165, 184]], "entity_1_idx_in_text_with_entity_marker": [169, 188], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p112", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins ([E1]CKs[/E1]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKs", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p113", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p114", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p115", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p116", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p117", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E1]CD34[/E1], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p118", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins ([E1]CKs[/E1]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKs", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p119", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p50", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p51", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein ([E1]P[/E1]), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p52", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p53", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion ([E1]F[/E1]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[86, 87]], "entity_1_idx_in_text_with_entity_marker": [90, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p54", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p55", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p56", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p57", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p58", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p59", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E1]N[/E1]: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[245, 246]], "entity_1_idx_in_text_with_entity_marker": [249, 250], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p90", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), [E2]matrix[/E2] (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "matrix", "entity_2_idx": [[66, 72], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [79, 85], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p91", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), [E2]phosphoprotein[/E2] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "phosphoprotein", "entity_2_idx": [[46, 60], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [59, 73], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p92", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion (F), and [E2]large protein[/E2] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "large protein", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p93", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix ([E2]M[/E2]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[74, 75]], "entity_2_idx_in_text_with_entity_marker": [87, 88], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p94", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p95", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), [E2]matrix[/E2] (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "matrix", "entity_2_idx": [[66, 72], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [79, 85], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p96", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion (F), and [E2]large protein[/E2] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "large protein", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p97", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] ([E2]M[/E2]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[74, 75]], "entity_2_idx_in_text_with_entity_marker": [87, 88], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p98", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p99", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and [E2]large protein[/E2] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "large protein", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p20", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p21", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 ([E1]Cx43[/E1]), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cx43", "entity_1_idx": [[168, 172]], "entity_1_idx_in_text_with_entity_marker": [172, 176], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p22", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I ([E1]TnI[/E1]) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TnI", "entity_1_idx": [[140, 143]], "entity_1_idx_in_text_with_entity_marker": [144, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p23", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p24", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] (TnI) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p25", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I (TnI) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p26", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 ([E1]Cx43[/E1]), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cx43", "entity_1_idx": [[168, 172]], "entity_1_idx_in_text_with_entity_marker": [172, 176], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p27", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I (TnI) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p28", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, [E1]connexin 43[/E1] (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "connexin 43", "entity_1_idx": [[155, 166]], "entity_1_idx_in_text_with_entity_marker": [159, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p29", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I ([E1]TnI[/E1]) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TnI", "entity_1_idx": [[140, 143]], "entity_1_idx_in_text_with_entity_marker": [144, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p50", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), [E2]myosin light chain[/E2] (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin light chain", "entity_2_idx": [[102, 120]], "entity_2_idx_in_text_with_entity_marker": [115, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p51", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p52", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), [E2]troponin I[/E2] (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "troponin I", "entity_2_idx": [[128, 138]], "entity_2_idx_in_text_with_entity_marker": [141, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p53", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] (TnI) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p54", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p10", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p11", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p12", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p13", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and [E2]phosphoprotein[/E2] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[184, 198]], "entity_2_idx_in_text_with_entity_marker": [197, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p14", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] ([E2]NP[/E2]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[176, 178]], "entity_2_idx_in_text_with_entity_marker": [189, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p15", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p16", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p17", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein ([E2]P[/E2]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[200, 201]], "entity_2_idx_in_text_with_entity_marker": [213, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p18", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and [E2]membrane protein[/E2] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "membrane protein", "entity_2_idx": [[234, 250]], "entity_2_idx_in_text_with_entity_marker": [247, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p19", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s0_BioInfer.d519.s0.p0", "text": "Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.", "text_with_entity_marker": "Requirement of the yeast MSH3 and [E1]MSH6[/E1] genes for [E2]MSH2[/E2]-dependent genomic stability.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH6", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s0_BioInfer.d519.s0.p1", "text": "Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.", "text_with_entity_marker": "Requirement of the yeast [E1]MSH3[/E1] and MSH6 genes for [E2]MSH2[/E2]-dependent genomic stability.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s0_BioInfer.d519.s0.p2", "text": "Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.", "text_with_entity_marker": "Requirement of the yeast [E1]MSH3[/E1] and [E2]MSH6[/E2] genes for MSH2-dependent genomic stability.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p0", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that [E1]MSH2[/E1] functions in mismatch repair in conjunction with MSH3 or [E2]MSH6[/E2] and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[108, 112]], "entity_2_idx_in_text_with_entity_marker": [121, 125], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p1", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or [E1]MSH6[/E1] and that MSH3 and [E2]MSH6[/E2] constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[108, 112]], "entity_1_idx_in_text_with_entity_marker": [112, 116], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p2", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with [E1]MSH3[/E1] or [E2]MSH6[/E2] and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[108, 112]], "entity_2_idx_in_text_with_entity_marker": [121, 125], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p3", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or [E1]MSH6[/E1] and that MSH3 and MSH6 constitute alternate pathways of [E2]MSH2[/E2]-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[108, 112]], "entity_1_idx_in_text_with_entity_marker": [112, 116], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p4", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or [E1]MSH6[/E1] and that [E2]MSH3[/E2] and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[108, 112]], "entity_1_idx_in_text_with_entity_marker": [112, 116], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p5", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that [E1]MSH2[/E1] functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and [E2]MSH6[/E2] constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p6", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that [E1]MSH2[/E1] functions in mismatch repair in conjunction with [E2]MSH3[/E2] or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[100, 104]], "entity_2_idx_in_text_with_entity_marker": [113, 117], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p7", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that [E1]MSH2[/E1] functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of [E2]MSH2[/E2]-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p8", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that [E1]MSH2[/E1] functions in mismatch repair in conjunction with MSH3 or MSH6 and that [E2]MSH3[/E2] and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p9", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with [E1]MSH3[/E1] or MSH6 and that MSH3 and [E2]MSH6[/E2] constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p10", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and [E1]MSH6[/E1] constitute alternate pathways of [E2]MSH2[/E2]-dependent mismatch repair.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH6", "entity_1_idx": [[131, 135]], "entity_1_idx_in_text_with_entity_marker": [135, 139], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p11", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that [E1]MSH3[/E1] and [E2]MSH6[/E2] constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p12", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with [E1]MSH3[/E1] or MSH6 and that MSH3 and MSH6 constitute alternate pathways of [E2]MSH2[/E2]-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p13", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with [E1]MSH3[/E1] or MSH6 and that [E2]MSH3[/E2] and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d519.s1_BioInfer.d519.s1.p14", "text": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.", "text_with_entity_marker": "Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that [E1]MSH3[/E1] and MSH6 constitute alternate pathways of [E2]MSH2[/E2]-dependent mismatch repair.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p1", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in [E1]EGF[/E1]-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the [E2]actin[/E2] dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p2", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the [E1]actin[/E1] dynamics by measuring the changes in the number of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[237, 242]], "entity_1_idx_in_text_with_entity_marker": [241, 246], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[294, 299]], "entity_2_idx_in_text_with_entity_marker": [307, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p3", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of [E1]cofilin[/E1] relative to free barbed ends and characterized the [E2]actin[/E2] dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p4", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in EGF-stimulated [E1]actin[/E1] polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the [E2]actin[/E2] dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p5", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of [E1]cofilin[/E1] in [E2]EGF[/E2]-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGF", "entity_2_idx": [[38, 41]], "entity_2_idx_in_text_with_entity_marker": [51, 54], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p6", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of [E1]cofilin[/E1] in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[294, 299]], "entity_2_idx_in_text_with_entity_marker": [307, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p7", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of [E1]cofilin[/E1] in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of [E2]cofilin[/E2] relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[178, 185]], "entity_2_idx_in_text_with_entity_marker": [191, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p8", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of [E1]cofilin[/E1] in EGF-stimulated [E2]actin[/E2] polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p9", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in [E1]EGF[/E1]-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[294, 299]], "entity_2_idx_in_text_with_entity_marker": [307, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p10", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of cofilin in [E1]EGF[/E1]-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of [E2]cofilin[/E2] relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[178, 185]], "entity_2_idx_in_text_with_entity_marker": [191, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p10", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and [E1]beta 1 integrins[/E1], pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 1 integrins", "entity_1_idx": [[39, 55]], "entity_1_idx_in_text_with_entity_marker": [43, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p11", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, [E1]talin[/E1], alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p12", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 [E1]focal adhesion kinase[/E1], and alpha-catenin is not affected by the differential [E2]calreticulin[/E2] expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "focal adhesion kinase", "entity_1_idx": [[63, 84]], "entity_1_idx_in_text_with_entity_marker": [67, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[140, 152]], "entity_2_idx_in_text_with_entity_marker": [153, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p13", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of [E1]actin[/E1], talin, [E2]alpha 5[/E2] and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha 5", "entity_2_idx": [[27, 34], [46, 55]], "entity_2_idx_in_text_with_entity_marker": [40, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p14", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of [E1]actin[/E1], talin, alpha 5 and beta 1 integrins, [E2]pp125[/E2] focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pp125", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p15", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of [E1]actin[/E1], talin, alpha 5 and [E2]beta 1 integrins[/E2], pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrins", "entity_2_idx": [[39, 55]], "entity_2_idx_in_text_with_entity_marker": [52, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p16", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of [E1]actin[/E1], [E2]talin[/E2], alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[20, 25]], "entity_2_idx_in_text_with_entity_marker": [33, 38], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p17", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of [E1]actin[/E1], talin, alpha 5 and beta 1 integrins, pp125 [E2]focal adhesion kinase[/E2], and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "focal adhesion kinase", "entity_2_idx": [[63, 84]], "entity_2_idx_in_text_with_entity_marker": [76, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p18", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, [E1]alpha 5[/E1] and beta 1 integrins, [E2]pp125[/E2] focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha 5", "entity_1_idx": [[27, 34], [46, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pp125", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p19", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, [E1]alpha 5[/E1] and [E2]beta 1 integrins[/E2], pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha 5", "entity_1_idx": [[27, 34], [46, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrins", "entity_2_idx": [[39, 55]], "entity_2_idx_in_text_with_entity_marker": [52, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p2", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and [E1]H2a[/E1] mRNA, whereas the [E2]histone[/E2] H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[98, 105]], "entity_2_idx_in_text_with_entity_marker": [111, 118], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p3", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and [E1]H2a[/E1] mRNA, whereas the histone [E2]H4[/E2] and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[106, 108]], "entity_2_idx_in_text_with_entity_marker": [119, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p4", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone [E1]H3[/E1] and H2a genes encode approximately 40% of the total H3 and [E2]H2a[/E2] mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[14, 16]], "entity_1_idx_in_text_with_entity_marker": [18, 20], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2a", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p5", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and [E1]H2a[/E1] genes encode approximately 40% of the total H3 and [E2]H2a[/E2] mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H2a", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2a", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p6", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and [E1]H2a[/E1] mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total [E2]H4[/E2] and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[157, 159]], "entity_2_idx_in_text_with_entity_marker": [170, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p7", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] H3 and H2a genes encode approximately 40% of the total H3 and [E2]H2a[/E2] mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2a", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p8", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total [E1]H3[/E1] and [E2]H2a[/E2] mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[69, 71]], "entity_1_idx_in_text_with_entity_marker": [73, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2a", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p9", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and [E1]H2a[/E1] mRNA, whereas the histone H4 and [E2]histone[/E2] H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2a", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[113, 120]], "entity_2_idx_in_text_with_entity_marker": [126, 133], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p10", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone [E1]H2b[/E1] genes encode < 10% of the total H4 and [E2]H2b[/E2] mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "H2b", "entity_1_idx": [[121, 124]], "entity_1_idx_in_text_with_entity_marker": [125, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2b", "entity_2_idx": [[164, 167]], "entity_2_idx_in_text_with_entity_marker": [177, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p11", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the [E1]histone[/E1] H4 and histone H2b genes encode < 10% of the total H4 and [E2]H2b[/E2] mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2b", "entity_2_idx": [[164, 167]], "entity_2_idx_in_text_with_entity_marker": [177, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p10", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E1]histone[/E1] [E2]H4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[330, 337]], "entity_1_idx_in_text_with_entity_marker": [334, 341], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[338, 340]], "entity_2_idx_in_text_with_entity_marker": [351, 353], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p11", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E1]histone[/E1] H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[242, 249]], "entity_1_idx_in_text_with_entity_marker": [246, 253], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p12", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p13", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p14", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p15", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p16", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone [E1]H2A.Z[/E1], histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.Z", "entity_1_idx": [[280, 285]], "entity_1_idx_in_text_with_entity_marker": [284, 289], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p17", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone [E1]H2A.X[/E1], histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.X", "entity_1_idx": [[265, 270]], "entity_1_idx_in_text_with_entity_marker": [269, 274], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p18", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E1]H2A.2[/E1], histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[250, 255]], "entity_1_idx_in_text_with_entity_marker": [254, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p19", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E1]H2A.2[/E1], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p10", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-[E1]AH[/E1]-[E2]nucleosome[/E2] complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AH", "entity_1_idx": [[57, 59]], "entity_1_idx_in_text_with_entity_marker": [61, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleosome", "entity_2_idx": [[60, 70]], "entity_2_idx_in_text_with_entity_marker": [73, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p11", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-[E1]nucleosome[/E1] complexes demonstrated the predominant presence of acetylated [E2]histone[/E2] H4 relative to acetylated histone H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleosome", "entity_1_idx": [[60, 70]], "entity_1_idx_in_text_with_entity_marker": [64, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p12", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified [E1]USF[/E1]-nucleosome and GAL4-AH-[E2]nucleosome[/E2] complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "USF", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleosome", "entity_2_idx": [[60, 70]], "entity_2_idx_in_text_with_entity_marker": [73, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p13", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and [E1]GAL4[/E1]-AH-[E2]nucleosome[/E2] complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GAL4", "entity_1_idx": [[52, 56]], "entity_1_idx_in_text_with_entity_marker": [56, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleosome", "entity_2_idx": [[60, 70]], "entity_2_idx_in_text_with_entity_marker": [73, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p14", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-[E1]nucleosome[/E1] complexes demonstrated the predominant presence of acetylated histone [E2]H4[/E2] relative to acetylated histone H3.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleosome", "entity_1_idx": [[60, 70]], "entity_1_idx_in_text_with_entity_marker": [64, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[141, 143]], "entity_2_idx_in_text_with_entity_marker": [154, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p15", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-[E1]nucleosome[/E1] and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated [E2]histone[/E2] H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleosome", "entity_1_idx": [[37, 47]], "entity_1_idx_in_text_with_entity_marker": [41, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[167, 174]], "entity_2_idx_in_text_with_entity_marker": [180, 187], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p16", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-[E1]AH[/E1]-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated [E2]histone[/E2] H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AH", "entity_1_idx": [[57, 59]], "entity_1_idx_in_text_with_entity_marker": [61, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[167, 174]], "entity_2_idx_in_text_with_entity_marker": [180, 187], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p17", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated [E1]histone[/E1] H4 relative to acetylated [E2]histone[/E2] H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[133, 140]], "entity_1_idx_in_text_with_entity_marker": [137, 144], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[167, 174]], "entity_2_idx_in_text_with_entity_marker": [180, 187], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p18", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified [E1]USF[/E1]-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated [E2]histone[/E2] H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "USF", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[167, 174]], "entity_2_idx_in_text_with_entity_marker": [180, 187], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p19", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and [E1]GAL4[/E1]-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated [E2]histone[/E2] H3.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GAL4", "entity_1_idx": [[52, 56]], "entity_1_idx_in_text_with_entity_marker": [56, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[167, 174]], "entity_2_idx_in_text_with_entity_marker": [180, 187], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d478.s0_BioInfer.d478.s0.p0", "text": "Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells.", "text_with_entity_marker": "Overexpression of cyclin E and [E1]cyclin-dependent kinase inhibitor[/E1] ([E2]p27Kip1[/E2]): effect on cell cycle regulation in HeLa cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[31, 64]], "entity_1_idx_in_text_with_entity_marker": [35, 68], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27Kip1", "entity_2_idx": [[66, 73]], "entity_2_idx_in_text_with_entity_marker": [79, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d478.s0_BioInfer.d478.s0.p1", "text": "Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells.", "text_with_entity_marker": "Overexpression of [E1]cyclin E[/E1] and [E2]cyclin-dependent kinase inhibitor[/E2] (p27Kip1): effect on cell cycle regulation in HeLa cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[18, 26]], "entity_1_idx_in_text_with_entity_marker": [22, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[31, 64]], "entity_2_idx_in_text_with_entity_marker": [44, 77], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d478.s0_BioInfer.d478.s0.p2", "text": "Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1): effect on cell cycle regulation in HeLa cells.", "text_with_entity_marker": "Overexpression of [E1]cyclin E[/E1] and cyclin-dependent kinase inhibitor ([E2]p27Kip1[/E2]): effect on cell cycle regulation in HeLa cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[18, 26]], "entity_1_idx_in_text_with_entity_marker": [22, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27Kip1", "entity_2_idx": [[66, 73]], "entity_2_idx_in_text_with_entity_marker": [79, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d311.s0_BioInfer.d311.s0.p0", "text": "In addition to their role in mismatch repair (MMR), the MSH2 and MSH3 gene products are required to remove 3' nonhomologous DNA tails during genetic recombination.", "text_with_entity_marker": "In addition to their role in mismatch repair (MMR), the [E1]MSH2[/E1] and [E2]MSH3[/E2] gene products are required to remove 3' nonhomologous DNA tails during genetic recombination.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[65, 69]], "entity_2_idx_in_text_with_entity_marker": [78, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p0", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, [E1]major DNA-binding protein[/E1], [E2]DNA polymerase[/E2], UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "major DNA-binding protein", "entity_1_idx": [[238, 263]], "entity_1_idx_in_text_with_entity_marker": [242, 267], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNA polymerase", "entity_2_idx": [[265, 279]], "entity_2_idx_in_text_with_entity_marker": [278, 292], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p1", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, [E1]UL8[/E1], major DNA-binding protein, [E2]DNA polymerase[/E2], UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNA polymerase", "entity_2_idx": [[265, 279]], "entity_2_idx_in_text_with_entity_marker": [278, 292], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p2", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], UL8, major DNA-binding protein, [E2]DNA polymerase[/E2], UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNA polymerase", "entity_2_idx": [[265, 279]], "entity_2_idx_in_text_with_entity_marker": [278, 292], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p3", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, [E1]DNA polymerase[/E1], UL42, and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNA polymerase", "entity_1_idx": [[265, 279]], "entity_1_idx_in_text_with_entity_marker": [269, 283], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p4", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, [E1]DNA polymerase[/E1], [E2]UL42[/E2], and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNA polymerase", "entity_1_idx": [[265, 279]], "entity_1_idx_in_text_with_entity_marker": [269, 283], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p5", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, [E1]UL8[/E1], [E2]major DNA-binding protein[/E2], DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "major DNA-binding protein", "entity_2_idx": [[238, 263]], "entity_2_idx_in_text_with_entity_marker": [251, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p6", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], UL8, [E2]major DNA-binding protein[/E2], DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "major DNA-binding protein", "entity_2_idx": [[238, 263]], "entity_2_idx_in_text_with_entity_marker": [251, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p7", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, [E1]major DNA-binding protein[/E1], DNA polymerase, UL42, and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "major DNA-binding protein", "entity_1_idx": [[238, 263]], "entity_1_idx_in_text_with_entity_marker": [242, 267], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p8", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, [E1]major DNA-binding protein[/E1], DNA polymerase, [E2]UL42[/E2], and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "major DNA-binding protein", "entity_1_idx": [[238, 263]], "entity_1_idx_in_text_with_entity_marker": [242, 267], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p9", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], [E2]UL8[/E2], major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p10", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, [E1]UL8[/E1], major DNA-binding protein, DNA polymerase, UL42, and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p11", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, [E1]UL8[/E1], major DNA-binding protein, DNA polymerase, [E2]UL42[/E2], and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p12", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], UL8, major DNA-binding protein, DNA polymerase, UL42, and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p13", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], UL8, major DNA-binding protein, DNA polymerase, [E2]UL42[/E2], and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p14", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, [E1]UL42[/E1], and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL42", "entity_1_idx": [[281, 285]], "entity_1_idx_in_text_with_entity_marker": [285, 289], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p40", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the [E1]SAGA[/E1] complex, was critical in complexing with E2A in up-regulation of p21/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SAGA", "entity_1_idx": [[202, 206]], "entity_1_idx_in_text_with_entity_marker": [206, 210], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p41", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the [E1]SAGA[/E1] complex, was critical in complexing with E2A in up-regulation of [E2]p21[/E2]/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SAGA", "entity_1_idx": [[202, 206]], "entity_1_idx_in_text_with_entity_marker": [206, 210], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "p21", "entity_2_idx": [[272, 275]], "entity_2_idx_in_text_with_entity_marker": [285, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p42", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not [E1]histone[/E1] H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the [E2]SAGA[/E2] complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "SAGA", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p43", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the [E1]SAGA[/E1] complex, was critical in complexing with [E2]E2A[/E2] in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SAGA", "entity_1_idx": [[202, 206]], "entity_1_idx_in_text_with_entity_marker": [206, 210], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "E2A", "entity_2_idx": [[248, 251]], "entity_2_idx_in_text_with_entity_marker": [261, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p44", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the [E2]SAGA[/E2] complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "SAGA", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p45", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/[E1]waf1[/E1] promoter in vivo, implying that CBP/[E2]p300[/E2], and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "waf1", "entity_1_idx": [[143, 147]], "entity_1_idx_in_text_with_entity_marker": [147, 151], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "p300", "entity_2_idx": [[184, 188]], "entity_2_idx_in_text_with_entity_marker": [197, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p46", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/[E1]p300[/E1], and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[184, 188]], "entity_1_idx_in_text_with_entity_marker": [188, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p47", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/[E1]p300[/E1], and not the SAGA complex, was critical in complexing with E2A in up-regulation of [E2]p21[/E2]/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[184, 188]], "entity_1_idx_in_text_with_entity_marker": [188, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[272, 275]], "entity_2_idx_in_text_with_entity_marker": [285, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p48", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not [E1]histone[/E1] H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/[E2]p300[/E2], and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p300", "entity_2_idx": [[184, 188]], "entity_2_idx_in_text_with_entity_marker": [197, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p49", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/[E1]p300[/E1], and not the SAGA complex, was critical in complexing with [E2]E2A[/E2] in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p300", "entity_1_idx": [[184, 188]], "entity_1_idx_in_text_with_entity_marker": [188, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E2A", "entity_2_idx": [[248, 251]], "entity_2_idx_in_text_with_entity_marker": [261, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p60", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not [E1]histone[/E1] H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of [E2]p21[/E2]/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[272, 275]], "entity_2_idx_in_text_with_entity_marker": [285, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p61", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with [E1]E2A[/E1] in up-regulation of [E2]p21[/E2]/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E2A", "entity_1_idx": [[248, 251]], "entity_1_idx_in_text_with_entity_marker": [252, 255], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[272, 275]], "entity_2_idx_in_text_with_entity_marker": [285, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p62", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of [E2]p21[/E2]/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[272, 275]], "entity_2_idx_in_text_with_entity_marker": [285, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p63", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not [E1]histone[/E1] H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with [E2]E2A[/E2] in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "E2A", "entity_2_idx": [[248, 251]], "entity_2_idx_in_text_with_entity_marker": [261, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p64", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] H4, and not [E2]histone[/E2] H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[92, 99]], "entity_2_idx_in_text_with_entity_marker": [105, 112], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p65", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with [E2]E2A[/E2] in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "E2A", "entity_2_idx": [[248, 251]], "entity_2_idx_in_text_with_entity_marker": [261, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s0_BioInfer.d38.s0.p0", "text": "All these results suggest that cofilin is a new type of actin-associated protein.", "text_with_entity_marker": "All these results suggest that [E1]cofilin[/E1] is a new type of [E2]actin[/E2]-associated protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[31, 38]], "entity_1_idx_in_text_with_entity_marker": [35, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[56, 61]], "entity_2_idx_in_text_with_entity_marker": [69, 74], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p0", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the [E1]DNase I[/E1] inhibition assay demonstrate that [E2]cofilin[/E2] binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNase I", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[75, 82]], "entity_2_idx_in_text_with_entity_marker": [88, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p1", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the [E1]DNase I[/E1] inhibition assay demonstrate that cofilin binds to [E2]actin[/E2] filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNase I", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p2", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the [E1]DNase I[/E1] inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that [E2]cofilin[/E2] increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNase I", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[182, 189]], "entity_2_idx_in_text_with_entity_marker": [195, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p3", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the [E1]DNase I[/E1] inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric [E2]actin[/E2] to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNase I", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[214, 219]], "entity_2_idx_in_text_with_entity_marker": [227, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p4", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the [E1]DNase I[/E1] inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to [E2]actin[/E2] monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNase I", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p5", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the [E1]DNase I[/E1] inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of [E2]cofilin[/E2] to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNase I", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[132, 139]], "entity_2_idx_in_text_with_entity_marker": [145, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p6", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that [E1]cofilin[/E1] binds to [E2]actin[/E2] filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[75, 82]], "entity_1_idx_in_text_with_entity_marker": [79, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p7", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that [E1]cofilin[/E1] binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that [E2]cofilin[/E2] increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[75, 82]], "entity_1_idx_in_text_with_entity_marker": [79, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[182, 189]], "entity_2_idx_in_text_with_entity_marker": [195, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d38.s1_BioInfer.d38.s1.p8", "text": "The centrifugation assay and the DNase I inhibition assay demonstrate that cofilin binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric actin to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "text_with_entity_marker": "The centrifugation assay and the DNase I inhibition assay demonstrate that [E1]cofilin[/E1] binds to actin filaments in a 1:1 molar ratio of cofilin to actin monomer in the filament and that cofilin increases the monomeric [E2]actin[/E2] to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[75, 82]], "entity_1_idx_in_text_with_entity_marker": [79, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[214, 219]], "entity_2_idx_in_text_with_entity_marker": [227, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d147.s0_BioInfer.d147.s0.p0", "text": "Cofilin was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.", "text_with_entity_marker": "[E1]Cofilin[/E1] was identified by peptide sequencing, and [E2]cofilin[/E2] recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cofilin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[50, 57]], "entity_2_idx_in_text_with_entity_marker": [63, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d147.s0_BioInfer.d147.s0.p1", "text": "Cofilin was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.", "text_with_entity_marker": "[E1]Cofilin[/E1] was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing [E2]actin[/E2] filament turnover.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cofilin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[184, 189]], "entity_2_idx_in_text_with_entity_marker": [197, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d147.s0_BioInfer.d147.s0.p2", "text": "Cofilin was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.", "text_with_entity_marker": "Cofilin was identified by peptide sequencing, and [E1]cofilin[/E1] recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing [E2]actin[/E2] filament turnover.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[184, 189]], "entity_2_idx_in_text_with_entity_marker": [197, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d673.s0_BioInfer.d673.s0.p0", "text": "The protein profilin binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.", "text_with_entity_marker": "The protein [E1]profilin[/E1] binds to both [E2]actin[/E2] and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[35, 40]], "entity_2_idx_in_text_with_entity_marker": [48, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d673.s0_BioInfer.d673.s0.p1", "text": "The protein profilin binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.", "text_with_entity_marker": "The protein profilin binds to both [E1]actin[/E1] and the head groups of poly)phosphoinositide)s and may regulate both [E2]actin[/E2] assembly and the phosphoinositide signaling pathway.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[110, 115]], "entity_2_idx_in_text_with_entity_marker": [123, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d673.s0_BioInfer.d673.s0.p2", "text": "The protein profilin binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.", "text_with_entity_marker": "The protein [E1]profilin[/E1] binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both [E2]actin[/E2] assembly and the phosphoinositide signaling pathway.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[110, 115]], "entity_2_idx_in_text_with_entity_marker": [123, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d183.s0_BioInfer.d183.s0.p0", "text": "Dynamic actin structures stabilized by profilin.", "text_with_entity_marker": "Dynamic [E1]actin[/E1] structures stabilized by [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[8, 13]], "entity_1_idx_in_text_with_entity_marker": [12, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d183.s1_BioInfer.d183.s1.p0", "text": "The distribution of actin filaments is altered by profilin overexpression.", "text_with_entity_marker": "The distribution of [E1]actin[/E1] filaments is altered by [E2]profilin[/E2] overexpression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[50, 58]], "entity_2_idx_in_text_with_entity_marker": [63, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d183.s2_BioInfer.d183.s2.p0", "text": "While parallel actin bundles crossing the cells are virtually absent in cells overexpressing profilin, the submembranous actin network of these cells is denser than in control cells.", "text_with_entity_marker": "While parallel [E1]actin[/E1] bundles crossing the cells are virtually absent in cells overexpressing profilin, the submembranous [E2]actin[/E2] network of these cells is denser than in control cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[15, 20]], "entity_1_idx_in_text_with_entity_marker": [19, 24], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d183.s2_BioInfer.d183.s2.p1", "text": "While parallel actin bundles crossing the cells are virtually absent in cells overexpressing profilin, the submembranous actin network of these cells is denser than in control cells.", "text_with_entity_marker": "While parallel actin bundles crossing the cells are virtually absent in cells overexpressing [E1]profilin[/E1], the submembranous [E2]actin[/E2] network of these cells is denser than in control cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[93, 101]], "entity_1_idx_in_text_with_entity_marker": [97, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d183.s2_BioInfer.d183.s2.p2", "text": "While parallel actin bundles crossing the cells are virtually absent in cells overexpressing profilin, the submembranous actin network of these cells is denser than in control cells.", "text_with_entity_marker": "While parallel [E1]actin[/E1] bundles crossing the cells are virtually absent in cells overexpressing [E2]profilin[/E2], the submembranous actin network of these cells is denser than in control cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[15, 20]], "entity_1_idx_in_text_with_entity_marker": [19, 24], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[93, 101]], "entity_2_idx_in_text_with_entity_marker": [106, 114], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p0", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an [E1]E-cadherin[/E1] mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[300, 312]], "entity_2_idx_in_text_with_entity_marker": [313, 325], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p1", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an [E1]E-cadherin[/E1] mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate [E2]alpha-catenin[/E2], although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p2", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an [E1]E-cadherin[/E1] mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both [E2]alpha-[/E2] and beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-", "entity_2_idx": [[289, 295], [305, 312]], "entity_2_idx_in_text_with_entity_marker": [302, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p3", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an [E1]E-cadherin[/E1] mAb, which is known to co-precipitate the [E2]catenins[/E2], demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenins", "entity_2_idx": [[81, 89]], "entity_2_idx_in_text_with_entity_marker": [94, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p4", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an [E1]E-cadherin[/E1] mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing [E2]E-cadherin[/E2] did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[163, 173]], "entity_2_idx_in_text_with_entity_marker": [176, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p5", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate [E1]alpha-catenin[/E1], although all of the moderately-well differentiated cell lines expressed both alpha- and [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[197, 210]], "entity_1_idx_in_text_with_entity_marker": [201, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[300, 312]], "entity_2_idx_in_text_with_entity_marker": [313, 325], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p6", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both [E1]alpha-[/E1] and [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-", "entity_1_idx": [[289, 295], [305, 312]], "entity_1_idx_in_text_with_entity_marker": [293, 299], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[300, 312]], "entity_2_idx_in_text_with_entity_marker": [313, 325], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p7", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the [E1]catenins[/E1], demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "catenins", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[300, 312]], "entity_2_idx_in_text_with_entity_marker": [313, 325], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p8", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing [E1]E-cadherin[/E1] did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[163, 173]], "entity_1_idx_in_text_with_entity_marker": [167, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[300, 312]], "entity_2_idx_in_text_with_entity_marker": [313, 325], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p9", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate [E1]alpha-catenin[/E1], although all of the moderately-well differentiated cell lines expressed both [E2]alpha-[/E2] and beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[197, 210]], "entity_1_idx_in_text_with_entity_marker": [201, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-", "entity_2_idx": [[289, 295], [305, 312]], "entity_2_idx_in_text_with_entity_marker": [302, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p10", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the [E1]catenins[/E1], demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate [E2]alpha-catenin[/E2], although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "catenins", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p11", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing [E1]E-cadherin[/E1] did not co-precipitate [E2]alpha-catenin[/E2], although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[163, 173]], "entity_1_idx_in_text_with_entity_marker": [167, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p12", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the [E1]catenins[/E1], demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both [E2]alpha-[/E2] and beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "catenins", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-", "entity_2_idx": [[289, 295], [305, 312]], "entity_2_idx_in_text_with_entity_marker": [302, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p13", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing [E1]E-cadherin[/E1] did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both [E2]alpha-[/E2] and beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[163, 173]], "entity_1_idx_in_text_with_entity_marker": [167, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-", "entity_2_idx": [[289, 295], [305, 312]], "entity_2_idx_in_text_with_entity_marker": [302, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p14", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the [E1]catenins[/E1], demonstrated that the three poorly differentiated cell lines expressing [E2]E-cadherin[/E2] did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "catenins", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[163, 173]], "entity_2_idx_in_text_with_entity_marker": [176, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s1_BioInfer.d113.s1.p5", "text": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by [E1]EGFR[/E1] upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[192, 202]], "entity_2_idx_in_text_with_entity_marker": [205, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p0", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor ([E1]EGFR[/E1]) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[273, 283]], "entity_2_idx_in_text_with_entity_marker": [286, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p1", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of [E1]beta-catenin[/E1] with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[87, 99]], "entity_1_idx_in_text_with_entity_marker": [91, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[273, 283]], "entity_2_idx_in_text_with_entity_marker": [286, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p2", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of [E1]beta-catenin[/E1] was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[28, 40]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[273, 283]], "entity_2_idx_in_text_with_entity_marker": [286, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p3", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with [E1]EGF receptor[/E1] (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF receptor", "entity_1_idx": [[105, 117]], "entity_1_idx_in_text_with_entity_marker": [109, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[273, 283]], "entity_2_idx_in_text_with_entity_marker": [286, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p4", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of [E1]alpha-catenin[/E1] from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[254, 267]], "entity_1_idx_in_text_with_entity_marker": [258, 271], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[273, 283]], "entity_2_idx_in_text_with_entity_marker": [286, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p5", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of [E1]beta-catenin[/E1] with EGF receptor ([E2]EGFR[/E2]) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[87, 99]], "entity_1_idx_in_text_with_entity_marker": [91, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[119, 123]], "entity_2_idx_in_text_with_entity_marker": [132, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p6", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of [E1]beta-catenin[/E1] was concomitantly induced with association of beta-catenin with EGF receptor ([E2]EGFR[/E2]) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[28, 40]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[119, 123]], "entity_2_idx_in_text_with_entity_marker": [132, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p7", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with [E1]EGF receptor[/E1] ([E2]EGFR[/E2]) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF receptor", "entity_1_idx": [[105, 117]], "entity_1_idx_in_text_with_entity_marker": [109, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[119, 123]], "entity_2_idx_in_text_with_entity_marker": [132, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s2_BioInfer.d113.s2.p8", "text": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor ([E1]EGFR[/E1]) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of [E2]alpha-catenin[/E2] from E-cadherin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[254, 267]], "entity_2_idx_in_text_with_entity_marker": [267, 280], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d619.s0_BioInfer.d619.s0.p0", "text": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the [E1]UL52[/E1] but not the [E2]ICP8[/E2] or POL replication proteins in virus-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL52", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d619.s0_BioInfer.d619.s0.p1", "text": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the [E1]ICP8[/E1] or [E2]POL[/E2] replication proteins in virus-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ICP8", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "POL", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d619.s0_BioInfer.d619.s0.p2", "text": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 [E1]UL8[/E1] protein influences the intracellular localization of the UL52 but not the [E2]ICP8[/E2] or POL replication proteins in virus-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d619.s0_BioInfer.d619.s0.p3", "text": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the [E1]UL52[/E1] but not the ICP8 or [E2]POL[/E2] replication proteins in virus-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL52", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "POL", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d619.s0_BioInfer.d619.s0.p4", "text": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 [E1]UL8[/E1] protein influences the intracellular localization of the [E2]UL52[/E2] but not the ICP8 or POL replication proteins in virus-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d619.s0_BioInfer.d619.s0.p5", "text": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 [E1]UL8[/E1] protein influences the intracellular localization of the UL52 but not the ICP8 or [E2]POL[/E2] replication proteins in virus-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "POL", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d241.s0_BioInfer.d241.s0.p0", "text": "Here, we describe proline-rich proteins involved in regulating actin polymerization and classify them according to their role in recruiting profilin to the membrane.", "text_with_entity_marker": "Here, we describe proline-rich proteins involved in regulating [E1]actin[/E1] polymerization and classify them according to their role in recruiting [E2]profilin[/E2] to the membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[140, 148]], "entity_2_idx_in_text_with_entity_marker": [153, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d339.s0_BioInfer.d339.s0.p0", "text": "Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).", "text_with_entity_marker": "Inhibition of [E1]actin[/E1] polymerization in KCl was stronger than that of the parental [E2]profilin[/E2], and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[81, 89]], "entity_2_idx_in_text_with_entity_marker": [94, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d339.s0_BioInfer.d339.s0.p1", "text": "Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).", "text_with_entity_marker": "Inhibition of actin polymerization in KCl was stronger than that of the parental [E1]profilin[/E1], and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine [E2]profilin[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[285, 293]], "entity_2_idx_in_text_with_entity_marker": [298, 306], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d339.s0_BioInfer.d339.s0.p2", "text": "Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).", "text_with_entity_marker": "Inhibition of actin polymerization in KCl was stronger than that of the parental [E1]profilin[/E1], and the Kd value of its interaction with rabbit [E2]skeletal muscle actin[/E2], as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[139, 160]], "entity_2_idx_in_text_with_entity_marker": [152, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d339.s0_BioInfer.d339.s0.p3", "text": "Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).", "text_with_entity_marker": "Inhibition of [E1]actin[/E1] polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine [E2]profilin[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[285, 293]], "entity_2_idx_in_text_with_entity_marker": [298, 306], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d339.s0_BioInfer.d339.s0.p4", "text": "Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).", "text_with_entity_marker": "Inhibition of [E1]actin[/E1] polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit [E2]skeletal muscle actin[/E2], as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[139, 160]], "entity_2_idx_in_text_with_entity_marker": [152, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d339.s0_BioInfer.d339.s0.p5", "text": "Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).", "text_with_entity_marker": "Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit [E1]skeletal muscle actin[/E1], as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine [E2]profilin[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "skeletal muscle actin", "entity_1_idx": [[139, 160]], "entity_1_idx_in_text_with_entity_marker": [143, 164], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[285, 293]], "entity_2_idx_in_text_with_entity_marker": [298, 306], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p2", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, UL5, UL8 [E1]UL52[/E1], and UL9, are necessary for the localization of [E2]ICP8[/E2] (UL29) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL52", "entity_1_idx": [[53, 57]], "entity_1_idx_in_text_with_entity_marker": [57, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[106, 110]], "entity_2_idx_in_text_with_entity_marker": [119, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p3", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, UL5, [E1]UL8[/E1] UL52, and UL9, are necessary for the localization of [E2]ICP8[/E2] (UL29) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[106, 110]], "entity_2_idx_in_text_with_entity_marker": [119, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p4", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, [E1]UL5[/E1], UL8 UL52, and UL9, are necessary for the localization of [E2]ICP8[/E2] (UL29) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[106, 110]], "entity_2_idx_in_text_with_entity_marker": [119, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p5", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, UL5, UL8 UL52, and [E1]UL9[/E1], are necessary for the localization of ICP8 ([E2]UL29[/E2]) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL9", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL29", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p6", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, UL5, UL8 [E1]UL52[/E1], and UL9, are necessary for the localization of ICP8 ([E2]UL29[/E2]) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL52", "entity_1_idx": [[53, 57]], "entity_1_idx_in_text_with_entity_marker": [57, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL29", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p7", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, UL5, [E1]UL8[/E1] UL52, and UL9, are necessary for the localization of ICP8 ([E2]UL29[/E2]) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL29", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p8", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, [E1]UL5[/E1], UL8 UL52, and UL9, are necessary for the localization of ICP8 ([E2]UL29[/E2]) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL29", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p9", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, UL5, UL8 [E1]UL52[/E1], and [E2]UL9[/E2], are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL52", "entity_1_idx": [[53, 57]], "entity_1_idx_in_text_with_entity_marker": [57, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL9", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p10", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, UL5, [E1]UL8[/E1] UL52, and [E2]UL9[/E2], are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL8", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL9", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s1_BioInfer.d465.s1.p11", "text": "We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "text_with_entity_marker": "We observed that four replication proteins, [E1]UL5[/E1], UL8 UL52, and [E2]UL9[/E2], are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL9", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p30", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases[/E1]-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "caspases", "entity_1_idx": [[102, 110], [117, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p31", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases-8[/E1] and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "caspases-8", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p32", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E1]TRAIL receptors[/E1] 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL receptors", "entity_1_idx": [[166, 181], [188, 189]], "entity_1_idx_in_text_with_entity_marker": [170, 185], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p33", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E1]TRAIL receptors 1[/E1] and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL receptors 1", "entity_1_idx": [[166, 183]], "entity_1_idx_in_text_with_entity_marker": [170, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p34", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E1]TRAIL-R1[/E1] and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL-R1", "entity_1_idx": [[191, 199]], "entity_1_idx_in_text_with_entity_marker": [195, 203], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p35", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1-E2]caspases[/E1]-8[/E2] and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "caspases", "entity_1_idx": [[102, 110], [117, 120]], "entity_1_idx_in_text_with_entity_marker": [109, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspases[/E1]-8", "entity_2_idx": [[102, 112]], "entity_2_idx_in_text_with_entity_marker": [109, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p36", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases[/E1]-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors[/E2] 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "caspases", "entity_1_idx": [[102, 110], [117, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors", "entity_2_idx": [[166, 181], [188, 189]], "entity_2_idx_in_text_with_entity_marker": [179, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p37", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases[/E1]-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "caspases", "entity_1_idx": [[102, 110], [117, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [179, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p38", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases[/E1]-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "caspases", "entity_1_idx": [[102, 110], [117, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p39", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating [E1]caspases-8[/E1] and -10 in death signaling by the two death-inducing [E2]TRAIL receptors[/E2] 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "caspases-8", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors", "entity_2_idx": [[166, 181], [188, 189]], "entity_2_idx_in_text_with_entity_marker": [179, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p0", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, [E1]RAD52[/E1], RAD54 and BRCA1 and [E2]BRCA2[/E2] loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p1", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, RAD52, [E1]RAD54[/E1] and BRCA1 and [E2]BRCA2[/E2] loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p2", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at [E1]RAD51[/E1], RAD52, RAD54 and BRCA1 and [E2]BRCA2[/E2] loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p3", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and [E1]BRCA1[/E1] and [E2]BRCA2[/E2] loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BRCA1", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p4", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, [E1]RAD52[/E1], [E2]RAD54[/E2] and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p5", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at [E1]RAD51[/E1], [E2]RAD52[/E2], RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p6", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, [E1]RAD52[/E1], RAD54 and [E2]BRCA1[/E2] and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA1", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p7", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at [E1]RAD51[/E1], RAD52, [E2]RAD54[/E2] and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p8", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at RAD51, RAD52, [E1]RAD54[/E1] and [E2]BRCA1[/E2] and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA1", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s0_BioInfer.d171.s0.p9", "text": "Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.", "text_with_entity_marker": "Detection of loss of heterozygosity at [E1]RAD51[/E1], RAD52, RAD54 and [E2]BRCA1[/E2] and BRCA2 loci in breast cancer: pathological correlations.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA1", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d86.s0_BioInfer.d86.s0.p0", "text": "At least one element of the actin-binding region of human profilin is an alpha-helix.", "text_with_entity_marker": "At least one element of the [E1]actin[/E1]-binding region of human [E2]profilin[/E2] is an alpha-helix.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[58, 66]], "entity_2_idx_in_text_with_entity_marker": [71, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p0", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed [E1]nuclear basic proteins[/E1]: the 14 kd is the histone H4, the 19 kd is the [E2]histone[/E2] H3, and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nuclear basic proteins", "entity_1_idx": [[45, 67]], "entity_1_idx_in_text_with_entity_marker": [49, 71], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p1", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed [E1]nuclear basic proteins[/E1]: the 14 kd is the [E2]histone[/E2] H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nuclear basic proteins", "entity_1_idx": [[45, 67]], "entity_1_idx_in_text_with_entity_marker": [49, 71], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[86, 93]], "entity_2_idx_in_text_with_entity_marker": [99, 106], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p2", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed [E1]nuclear basic proteins[/E1]: the 14 kd is the histone [E2]H4[/E2], the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nuclear basic proteins", "entity_1_idx": [[45, 67]], "entity_1_idx_in_text_with_entity_marker": [49, 71], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[94, 96]], "entity_2_idx_in_text_with_entity_marker": [107, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p3", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed [E1]nuclear basic proteins[/E1]: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein [E2]SP2[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nuclear basic proteins", "entity_1_idx": [[45, 67]], "entity_1_idx_in_text_with_entity_marker": [49, 71], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "SP2", "entity_2_idx": [[171, 174]], "entity_2_idx_in_text_with_entity_marker": [184, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p4", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed [E1]nuclear basic proteins[/E1]: the 14 kd is the histone H4, the 19 kd is the histone [E2]H3[/E2], and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nuclear basic proteins", "entity_1_idx": [[45, 67]], "entity_1_idx_in_text_with_entity_marker": [49, 71], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[123, 125]], "entity_2_idx_in_text_with_entity_marker": [136, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p5", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the [E1]histone[/E1] H4, the 19 kd is the [E2]histone[/E2] H3, and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[86, 93]], "entity_1_idx_in_text_with_entity_marker": [90, 97], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p6", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone [E1]H4[/E1], the 19 kd is the [E2]histone[/E2] H3, and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[94, 96]], "entity_1_idx_in_text_with_entity_marker": [98, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p7", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the [E1]histone[/E1] H3, and the 25 kd is the sperm-specific protein [E2]SP2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[115, 122]], "entity_1_idx_in_text_with_entity_marker": [119, 126], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "SP2", "entity_2_idx": [[171, 174]], "entity_2_idx_in_text_with_entity_marker": [184, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p8", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the [E1]histone[/E1] [E2]H3[/E2], and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[115, 122]], "entity_1_idx_in_text_with_entity_marker": [119, 126], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[123, 125]], "entity_2_idx_in_text_with_entity_marker": [136, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p9", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the [E1]histone[/E1] [E2]H4[/E2], the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[86, 93]], "entity_1_idx_in_text_with_entity_marker": [90, 97], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[94, 96]], "entity_2_idx_in_text_with_entity_marker": [107, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p10", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the [E1]histone[/E1] H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein [E2]SP2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[86, 93]], "entity_1_idx_in_text_with_entity_marker": [90, 97], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "SP2", "entity_2_idx": [[171, 174]], "entity_2_idx_in_text_with_entity_marker": [184, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p11", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the [E1]histone[/E1] H4, the 19 kd is the histone [E2]H3[/E2], and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[86, 93]], "entity_1_idx_in_text_with_entity_marker": [90, 97], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[123, 125]], "entity_2_idx_in_text_with_entity_marker": [136, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p12", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone [E1]H4[/E1], the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein [E2]SP2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[94, 96]], "entity_1_idx_in_text_with_entity_marker": [98, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SP2", "entity_2_idx": [[171, 174]], "entity_2_idx_in_text_with_entity_marker": [184, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p13", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone [E1]H4[/E1], the 19 kd is the histone [E2]H3[/E2], and the 25 kd is the sperm-specific protein SP2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[94, 96]], "entity_1_idx_in_text_with_entity_marker": [98, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[123, 125]], "entity_2_idx_in_text_with_entity_marker": [136, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d815.s0_BioInfer.d815.s0.p14", "text": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.", "text_with_entity_marker": "We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone [E1]H3[/E1], and the 25 kd is the sperm-specific protein [E2]SP2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[123, 125]], "entity_1_idx_in_text_with_entity_marker": [127, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SP2", "entity_2_idx": [[171, 174]], "entity_2_idx_in_text_with_entity_marker": [184, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p0", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of [E1]histone[/E1] [E2]H3[/E2] and only inefficiently competed with DNA for binding of histone H1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[124, 131]], "entity_1_idx_in_text_with_entity_marker": [128, 135], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[132, 134]], "entity_2_idx_in_text_with_entity_marker": [145, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p1", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of [E1]histone[/E1] H3 and only inefficiently competed with DNA for binding of [E2]histone[/E2] H1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[124, 131]], "entity_1_idx_in_text_with_entity_marker": [128, 135], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p2", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of [E1]histone[/E1] H4, it equally competed with DNA for binding of [E2]histone[/E2] H3 and only inefficiently competed with DNA for binding of histone H1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[124, 131]], "entity_2_idx_in_text_with_entity_marker": [137, 144], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p3", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone [E1]H4[/E1], it equally competed with DNA for binding of [E2]histone[/E2] H3 and only inefficiently competed with DNA for binding of histone H1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[76, 78]], "entity_1_idx_in_text_with_entity_marker": [80, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[124, 131]], "entity_2_idx_in_text_with_entity_marker": [137, 144], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p4", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of [E1]histone[/E1] H3 and only inefficiently competed with DNA for binding of histone [E2]H1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[124, 131]], "entity_1_idx_in_text_with_entity_marker": [128, 135], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1", "entity_2_idx": [[199, 201]], "entity_2_idx_in_text_with_entity_marker": [212, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p5", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone [E1]H3[/E1] and only inefficiently competed with DNA for binding of [E2]histone[/E2] H1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[132, 134]], "entity_1_idx_in_text_with_entity_marker": [136, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p6", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of [E1]histone[/E1] H4, it equally competed with DNA for binding of histone [E2]H3[/E2] and only inefficiently competed with DNA for binding of histone H1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[132, 134]], "entity_2_idx_in_text_with_entity_marker": [145, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p7", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone [E1]H4[/E1], it equally competed with DNA for binding of histone [E2]H3[/E2] and only inefficiently competed with DNA for binding of histone H1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[76, 78]], "entity_1_idx_in_text_with_entity_marker": [80, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[132, 134]], "entity_2_idx_in_text_with_entity_marker": [145, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p8", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone [E1]H3[/E1] and only inefficiently competed with DNA for binding of histone [E2]H1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[132, 134]], "entity_1_idx_in_text_with_entity_marker": [136, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[199, 201]], "entity_2_idx_in_text_with_entity_marker": [212, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p9", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of [E1]histone[/E1] H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of [E2]histone[/E2] H1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p10", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone [E1]H4[/E1], it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of [E2]histone[/E2] H1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[76, 78]], "entity_1_idx_in_text_with_entity_marker": [80, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p11", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of [E1]histone[/E1] [E2]H1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[191, 198]], "entity_1_idx_in_text_with_entity_marker": [195, 202], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1", "entity_2_idx": [[199, 201]], "entity_2_idx_in_text_with_entity_marker": [212, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p12", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of [E1]histone[/E1] [E2]H4[/E2], it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[76, 78]], "entity_2_idx_in_text_with_entity_marker": [89, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p13", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of [E1]histone[/E1] H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone [E2]H1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[68, 75]], "entity_1_idx_in_text_with_entity_marker": [72, 79], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1", "entity_2_idx": [[199, 201]], "entity_2_idx_in_text_with_entity_marker": [212, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d832.s0_BioInfer.d832.s0.p14", "text": "While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.", "text_with_entity_marker": "While poly(ADP-ribose) effectively competed with DNA for binding of histone [E1]H4[/E1], it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone [E2]H1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[76, 78]], "entity_1_idx_in_text_with_entity_marker": [80, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[199, 201]], "entity_2_idx_in_text_with_entity_marker": [212, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s0_BioInfer.d61.s0.p0", "text": "Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and plakoglobin.", "text_with_entity_marker": "Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[119, 131]], "entity_1_idx_in_text_with_entity_marker": [123, 135], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s0_BioInfer.d61.s0.p1", "text": "Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and plakoglobin.", "text_with_entity_marker": "Analysis of various truncated [E1]alpha-catenin[/E1] molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[30, 43]], "entity_1_idx_in_text_with_entity_marker": [34, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s0_BioInfer.d61.s0.p2", "text": "Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and plakoglobin.", "text_with_entity_marker": "Analysis of various truncated [E1]alpha-catenin[/E1] molecules revealed that amino-terminal residues 48-163 are able to bind to [E2]beta-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[30, 43]], "entity_1_idx_in_text_with_entity_marker": [34, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[119, 131]], "entity_2_idx_in_text_with_entity_marker": [132, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p0", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of [E1]alpha-catenin[/E1], beta-catenin competed with the binding of plakoglobin to [E2]alpha-catenin[/E2] and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[93, 106]], "entity_1_idx_in_text_with_entity_marker": [97, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[165, 178]], "entity_2_idx_in_text_with_entity_marker": [178, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p1", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2] competed with the binding of plakoglobin to alpha-catenin and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[93, 106]], "entity_1_idx_in_text_with_entity_marker": [97, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[108, 120]], "entity_2_idx_in_text_with_entity_marker": [121, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p2", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of [E1]alpha-catenin[/E1], beta-catenin competed with the binding of [E2]plakoglobin[/E2] to alpha-catenin and vice versa.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[93, 106]], "entity_1_idx_in_text_with_entity_marker": [97, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[150, 161]], "entity_2_idx_in_text_with_entity_marker": [163, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p3", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and [E1]plakoglobin[/E1] bind to the same region of [E2]alpha-catenin[/E2], beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[54, 65]], "entity_1_idx_in_text_with_entity_marker": [58, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[93, 106]], "entity_2_idx_in_text_with_entity_marker": [106, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p4", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that [E1]beta-catenin[/E1] and plakoglobin bind to the same region of [E2]alpha-catenin[/E2], beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[37, 49]], "entity_1_idx_in_text_with_entity_marker": [41, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[93, 106]], "entity_2_idx_in_text_with_entity_marker": [106, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p5", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, [E1]beta-catenin[/E1] competed with the binding of plakoglobin to [E2]alpha-catenin[/E2] and vice versa.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[108, 120]], "entity_1_idx_in_text_with_entity_marker": [112, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[165, 178]], "entity_2_idx_in_text_with_entity_marker": [178, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p6", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of [E1]plakoglobin[/E1] to [E2]alpha-catenin[/E2] and vice versa.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[150, 161]], "entity_1_idx_in_text_with_entity_marker": [154, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[165, 178]], "entity_2_idx_in_text_with_entity_marker": [178, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p0", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa [E1]soluble NRP1[/E1] (sNRP1) isoform containing just the a/[E2]CUB[/E2] and b/coagulation factor homology extracellular domains of NRP1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "soluble NRP1", "entity_1_idx": [[62, 74]], "entity_1_idx_in_text_with_entity_marker": [66, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CUB", "entity_2_idx": [[113, 116]], "entity_2_idx_in_text_with_entity_marker": [126, 129], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p1", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa [E1]soluble NRP1[/E1] ([E2]sNRP1[/E2]) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "soluble NRP1", "entity_1_idx": [[62, 74]], "entity_1_idx_in_text_with_entity_marker": [66, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "sNRP1", "entity_2_idx": [[76, 81]], "entity_2_idx_in_text_with_entity_marker": [89, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p2", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa [E1]soluble NRP1[/E1] (sNRP1) isoform containing just the a/CUB and b/[E2]coagulation factor[/E2] homology extracellular domains of NRP1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "soluble NRP1", "entity_1_idx": [[62, 74]], "entity_1_idx_in_text_with_entity_marker": [66, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "coagulation factor", "entity_2_idx": [[123, 141]], "entity_2_idx_in_text_with_entity_marker": [136, 154], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p3", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa [E1]soluble NRP1[/E1] (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "soluble NRP1", "entity_1_idx": [[62, 74]], "entity_1_idx_in_text_with_entity_marker": [66, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p4", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated [E1]NRP1[/E1] cDNA was cloned that encodes a 644-aa [E2]soluble NRP1[/E2] (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NRP1", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "soluble NRP1", "entity_2_idx": [[62, 74]], "entity_2_idx_in_text_with_entity_marker": [75, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p5", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa [E1]soluble NRP1[/E1] (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "soluble NRP1", "entity_1_idx": [[62, 74]], "entity_1_idx_in_text_with_entity_marker": [66, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p6", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 ([E1]sNRP1[/E1]) isoform containing just the a/[E2]CUB[/E2] and b/coagulation factor homology extracellular domains of NRP1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sNRP1", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CUB", "entity_2_idx": [[113, 116]], "entity_2_idx_in_text_with_entity_marker": [126, 129], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p7", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/[E1]CUB[/E1] and b/[E2]coagulation factor[/E2] homology extracellular domains of NRP1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CUB", "entity_1_idx": [[113, 116]], "entity_1_idx_in_text_with_entity_marker": [117, 120], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "coagulation factor", "entity_2_idx": [[123, 141]], "entity_2_idx_in_text_with_entity_marker": [136, 154], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p8", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/[E1]CUB[/E1] and b/coagulation factor homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CUB", "entity_1_idx": [[113, 116]], "entity_1_idx_in_text_with_entity_marker": [117, 120], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p9", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated [E1]NRP1[/E1] cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/[E2]CUB[/E2] and b/coagulation factor homology extracellular domains of NRP1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NRP1", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CUB", "entity_2_idx": [[113, 116]], "entity_2_idx_in_text_with_entity_marker": [126, 129], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d605.s0_BioInfer.d605.s0.p0", "text": "The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the actin/poly-proline binding protein, profilin, and the GAF/PAS family of regulatory modules.", "text_with_entity_marker": "The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the [E1]actin[/E1]/poly-proline binding protein, profilin, and the [E2]GAF/PAS[/E2] family of regulatory modules.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[106, 111]], "entity_1_idx_in_text_with_entity_marker": [110, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GAF/PAS", "entity_2_idx": [[160, 167]], "entity_2_idx_in_text_with_entity_marker": [173, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d605.s0_BioInfer.d605.s0.p1", "text": "The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the actin/poly-proline binding protein, profilin, and the GAF/PAS family of regulatory modules.", "text_with_entity_marker": "The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the [E1]actin[/E1]/poly-proline binding protein, [E2]profilin[/E2], and the GAF/PAS family of regulatory modules.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[106, 111]], "entity_1_idx_in_text_with_entity_marker": [110, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[142, 150]], "entity_2_idx_in_text_with_entity_marker": [155, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d605.s0_BioInfer.d605.s0.p2", "text": "The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the actin/poly-proline binding protein, profilin, and the GAF/PAS family of regulatory modules.", "text_with_entity_marker": "The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the actin/poly-proline binding protein, [E1]profilin[/E1], and the [E2]GAF/PAS[/E2] family of regulatory modules.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[142, 150]], "entity_1_idx_in_text_with_entity_marker": [146, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GAF/PAS", "entity_2_idx": [[160, 167]], "entity_2_idx_in_text_with_entity_marker": [173, 180], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p0", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral [E1]E1A[/E1]-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and [E2]K03H1.10[/E2] (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E1A", "entity_1_idx": [[121, 124]], "entity_1_idx_in_text_with_entity_marker": [125, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "K03H1.10", "entity_2_idx": [[246, 254]], "entity_2_idx_in_text_with_entity_marker": [259, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p1", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral [E1]E1A[/E1]-associated cellular protein [E2]p300[/E2] (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E1A", "entity_1_idx": [[121, 124]], "entity_1_idx_in_text_with_entity_marker": [125, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p2", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral [E1]E1A[/E1]-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, [E2]R10E11.1[/E2] and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E1A", "entity_1_idx": [[121, 124]], "entity_1_idx_in_text_with_entity_marker": [125, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "R10E11.1", "entity_2_idx": [[233, 241]], "entity_2_idx_in_text_with_entity_marker": [246, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p3", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in [E1]CREB[/E1] binding and transcriptional activation are highly related to the adenoviral [E2]E1A[/E2]-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E1A", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p4", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in [E1]CBP[/E1] that are involved in CREB binding and transcriptional activation are highly related to the adenoviral [E2]E1A[/E2]-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E1A", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p5", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein [E1]p300[/E1] (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and [E2]K03H1.10[/E2] (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[153, 157]], "entity_1_idx_in_text_with_entity_marker": [157, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "K03H1.10", "entity_2_idx": [[246, 254]], "entity_2_idx_in_text_with_entity_marker": [259, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p6", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, [E1]R10E11.1[/E1] and [E2]K03H1.10[/E2] (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "R10E11.1", "entity_1_idx": [[233, 241]], "entity_1_idx_in_text_with_entity_marker": [237, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "K03H1.10", "entity_2_idx": [[246, 254]], "entity_2_idx_in_text_with_entity_marker": [259, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p7", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in [E1]CREB[/E1] binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and [E2]K03H1.10[/E2] (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "K03H1.10", "entity_2_idx": [[246, 254]], "entity_2_idx_in_text_with_entity_marker": [259, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p8", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in [E1]CBP[/E1] that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and [E2]K03H1.10[/E2] (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "K03H1.10", "entity_2_idx": [[246, 254]], "entity_2_idx_in_text_with_entity_marker": [259, 267], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p9", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein [E1]p300[/E1] (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, [E2]R10E11.1[/E2] and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[153, 157]], "entity_1_idx_in_text_with_entity_marker": [157, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "R10E11.1", "entity_2_idx": [[233, 241]], "entity_2_idx_in_text_with_entity_marker": [246, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p10", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in [E1]CREB[/E1] binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein [E2]p300[/E2] (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p11", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in [E1]CBP[/E1] that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein [E2]p300[/E2] (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p300", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p12", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in CBP that are involved in [E1]CREB[/E1] binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, [E2]R10E11.1[/E2] and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "R10E11.1", "entity_2_idx": [[233, 241]], "entity_2_idx_in_text_with_entity_marker": [246, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p13", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in [E1]CBP[/E1] that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, [E2]R10E11.1[/E2] and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "R10E11.1", "entity_2_idx": [[233, 241]], "entity_2_idx_in_text_with_entity_marker": [246, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d606.s0_BioInfer.d606.s0.p14", "text": "The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "text_with_entity_marker": "The domains in [E1]CBP[/E1] that are involved in [E2]CREB[/E2] binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[40, 44]], "entity_2_idx_in_text_with_entity_marker": [53, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d544.s0_BioInfer.d544.s0.p0", "text": "Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles.", "text_with_entity_marker": "[E1-E2]Smooth muscle[/E1] alpha actin[/E2] and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Smooth muscle", "entity_1_idx": [[0, 13], [30, 48]], "entity_1_idx_in_text_with_entity_marker": [7, 20], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Smooth muscle[/E1] alpha actin", "entity_2_idx": [[0, 25]], "entity_2_idx_in_text_with_entity_marker": [7, 37], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d94.s0_BioInfer.d94.s0.p0", "text": "Because both proteins exchange rapidly between actin molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.", "text_with_entity_marker": "Because both proteins exchange rapidly between actin molecules, low concentrations of [E1]profilin[/E1] can overcome the inhibitory effects of high concentrations of [E2]thymosin beta 4[/E2] on the nucleotide exchange.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[86, 94]], "entity_1_idx_in_text_with_entity_marker": [90, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta 4", "entity_2_idx": [[157, 172]], "entity_2_idx_in_text_with_entity_marker": [170, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d94.s0_BioInfer.d94.s0.p1", "text": "Because both proteins exchange rapidly between actin molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.", "text_with_entity_marker": "Because both proteins exchange rapidly between [E1]actin[/E1] molecules, low concentrations of [E2]profilin[/E2] can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[86, 94]], "entity_2_idx_in_text_with_entity_marker": [99, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d94.s0_BioInfer.d94.s0.p2", "text": "Because both proteins exchange rapidly between actin molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.", "text_with_entity_marker": "Because both proteins exchange rapidly between [E1]actin[/E1] molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of [E2]thymosin beta 4[/E2] on the nucleotide exchange.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta 4", "entity_2_idx": [[157, 172]], "entity_2_idx_in_text_with_entity_marker": [170, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d399.s0_BioInfer.d399.s0.p0", "text": "Kinetic studies on the effect of yeast cofilin on yeast actin polymerization.", "text_with_entity_marker": "Kinetic studies on the effect of yeast [E1]cofilin[/E1] on yeast [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[39, 46]], "entity_1_idx_in_text_with_entity_marker": [43, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[56, 61]], "entity_2_idx_in_text_with_entity_marker": [69, 74], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d399.s1_BioInfer.d399.s1.p0", "text": "The results suggest some cooperativity with respect to cofilin binding to filamentous actin which may be pH dependent.", "text_with_entity_marker": "The results suggest some cooperativity with respect to [E1]cofilin[/E1] binding to filamentous [E2]actin[/E2] which may be pH dependent.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[55, 62]], "entity_1_idx_in_text_with_entity_marker": [59, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[86, 91]], "entity_2_idx_in_text_with_entity_marker": [99, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p40", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones [E2]H2A[/E2], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[42, 45]], "entity_2_idx_in_text_with_entity_marker": [55, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p41", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, [E2]H3[/E2], and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[52, 54]], "entity_2_idx_in_text_with_entity_marker": [65, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p42", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, [E2]H2B[/E2], H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[47, 50]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p43", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones [E2]H2A[/E2] and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[396, 399]], "entity_2_idx_in_text_with_entity_marker": [409, 412], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p44", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone [E2]H3[/E2]; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[383, 385]], "entity_2_idx_in_text_with_entity_marker": [396, 398], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p45", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p46", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E1]histone[/E1] H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[375, 382]], "entity_1_idx_in_text_with_entity_marker": [379, 386], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p47", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E1]histone[/E1] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[245, 252]], "entity_1_idx_in_text_with_entity_marker": [249, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p48", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, [E1]histones[/E1] H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p49", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone [E1]H4[/E1] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p70", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E1]histone[/E1] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[245, 252]], "entity_1_idx_in_text_with_entity_marker": [249, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p71", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, [E1]histones[/E1] H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p72", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone [E1]H4[/E1] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p73", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and [E1]H4[/E1], are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[60, 62]], "entity_1_idx_in_text_with_entity_marker": [64, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p74", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone [E1]H3[/E1] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[253, 255]], "entity_1_idx_in_text_with_entity_marker": [257, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p75", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E1]H4[/E1] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[180, 182]], "entity_1_idx_in_text_with_entity_marker": [184, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p76", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p77", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, [E1]H3[/E1], and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p78", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, [E1]H2B[/E1], H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p79", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones [E1]H2A[/E1] and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[396, 399]], "entity_1_idx_in_text_with_entity_marker": [400, 403], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d125.s0_BioInfer.d125.s0.p0", "text": "Calculated solution molecular masses are 213 kDa for alpha-catenin, 73 kDa for beta-catenin, and 186 kDa for both.", "text_with_entity_marker": "Calculated solution molecular masses are 213 kDa for [E1]alpha-catenin[/E1], 73 kDa for [E2]beta-catenin[/E2], and 186 kDa for both.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[53, 66]], "entity_1_idx_in_text_with_entity_marker": [57, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[79, 91]], "entity_2_idx_in_text_with_entity_marker": [92, 104], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d757.s0_BioInfer.d757.s0.p0", "text": "Thus, the actin-binding dodecapeptide sequence of cofilin may constitute a multifunctional domain in cofilin.", "text_with_entity_marker": "Thus, the [E1]actin[/E1]-binding dodecapeptide sequence of [E2]cofilin[/E2] may constitute a multifunctional domain in cofilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[50, 57]], "entity_2_idx_in_text_with_entity_marker": [63, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d757.s0_BioInfer.d757.s0.p1", "text": "Thus, the actin-binding dodecapeptide sequence of cofilin may constitute a multifunctional domain in cofilin.", "text_with_entity_marker": "Thus, the [E1]actin[/E1]-binding dodecapeptide sequence of cofilin may constitute a multifunctional domain in [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[101, 108]], "entity_2_idx_in_text_with_entity_marker": [114, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d757.s0_BioInfer.d757.s0.p2", "text": "Thus, the actin-binding dodecapeptide sequence of cofilin may constitute a multifunctional domain in cofilin.", "text_with_entity_marker": "Thus, the actin-binding dodecapeptide sequence of [E1]cofilin[/E1] may constitute a multifunctional domain in [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[101, 108]], "entity_2_idx_in_text_with_entity_marker": [114, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d757.s1_BioInfer.d757.s1.p0", "text": "We have previously shown that the synthetic dodecapeptide corresponding to Trp104-Met115 of cofilin is a potent inhibitor of actin polymerization (Yonezawa, N., Nishida, E., Iida, K., Kumagai, H., Yahara, I., and Sakai, H. (1991) J. Biol. Chem. 266, 10485-10489).", "text_with_entity_marker": "We have previously shown that the synthetic dodecapeptide corresponding to Trp104-Met115 of [E1]cofilin[/E1] is a potent inhibitor of [E2]actin[/E2] polymerization (Yonezawa, N., Nishida, E., Iida, K., Kumagai, H., Yahara, I., and Sakai, H. (1991) J. Biol. Chem. 266, 10485-10489).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p0", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that [E1]cdc12p[/E1] is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe [E2]fus1[/E2], which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdc12p", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fus1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p1", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that [E1]cdc12p[/E1] is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other [E2]actin[/E2]-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdc12p", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p2", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that [E1]cdc12p[/E1] is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae [E2]BNI1[/E2], and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdc12p", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "BNI1", "entity_2_idx": [[119, 123]], "entity_2_idx_in_text_with_entity_marker": [132, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p3", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that [E1]cdc12p[/E1] is a member of a family of proteins including Drosophila [E2]diaphanous[/E2], Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdc12p", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "diaphanous", "entity_2_idx": [[82, 92]], "entity_2_idx_in_text_with_entity_marker": [95, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p4", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe [E1]fus1[/E1], which are involved in cytokinesis or other [E2]actin[/E2]-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fus1", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p5", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae [E1]BNI1[/E1], and S. pombe [E2]fus1[/E2], which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BNI1", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fus1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p6", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila [E1]diaphanous[/E1], Saccharomyces cerevisiae BNI1, and S. pombe [E2]fus1[/E2], which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "diaphanous", "entity_1_idx": [[82, 92]], "entity_1_idx_in_text_with_entity_marker": [86, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fus1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p7", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae [E1]BNI1[/E1], and S. pombe fus1, which are involved in cytokinesis or other [E2]actin[/E2]-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BNI1", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p8", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila [E1]diaphanous[/E1], Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other [E2]actin[/E2]-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "diaphanous", "entity_1_idx": [[82, 92]], "entity_1_idx_in_text_with_entity_marker": [86, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p9", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila [E1]diaphanous[/E1], Saccharomyces cerevisiae [E2]BNI1[/E2], and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "diaphanous", "entity_1_idx": [[82, 92]], "entity_1_idx_in_text_with_entity_marker": [86, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "BNI1", "entity_2_idx": [[119, 123]], "entity_2_idx_in_text_with_entity_marker": [132, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p0", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo ([E1]Arm[/E1]) repeat 10 to the COOH terminus of beta-catenin is involved in binding to [E2]CBP[/E2], whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arm", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[89, 92]], "entity_2_idx_in_text_with_entity_marker": [102, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p1", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to [E1]CBP[/E1], whereas [E2]beta-catenin[/E2] interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[89, 92]], "entity_1_idx_in_text_with_entity_marker": [93, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[102, 114]], "entity_2_idx_in_text_with_entity_marker": [115, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p2", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to [E1]CBP[/E1], whereas beta-catenin interacts directly with the [E2]CREB[/E2]-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[89, 92]], "entity_1_idx_in_text_with_entity_marker": [93, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p3", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "[E1]Armadillo[/E1] (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to [E2]CBP[/E2], whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Armadillo", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[89, 92]], "entity_2_idx_in_text_with_entity_marker": [102, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p4", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to [E1]CBP[/E1], whereas beta-catenin interacts directly with the CREB-binding domain of [E2]CBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[89, 92]], "entity_1_idx_in_text_with_entity_marker": [93, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[166, 169]], "entity_2_idx_in_text_with_entity_marker": [179, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p5", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of [E1]beta-catenin[/E1] is involved in binding to [E2]CBP[/E2], whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[50, 62]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[89, 92]], "entity_2_idx_in_text_with_entity_marker": [102, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p6", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo ([E1]Arm[/E1]) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas [E2]beta-catenin[/E2] interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arm", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[102, 114]], "entity_2_idx_in_text_with_entity_marker": [115, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p7", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo ([E1]Arm[/E1]) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the [E2]CREB[/E2]-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arm", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p8", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "[E1]Armadillo[/E1] ([E2]Arm[/E2]) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arm", "entity_2_idx": [[11, 14]], "entity_2_idx_in_text_with_entity_marker": [24, 27], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p9", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo ([E1]Arm[/E1]) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of [E2]CBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arm", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[166, 169]], "entity_2_idx_in_text_with_entity_marker": [179, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p10", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo ([E1]Arm[/E1]) repeat 10 to the COOH terminus of [E2]beta-catenin[/E2] is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arm", "entity_1_idx": [[11, 14]], "entity_1_idx_in_text_with_entity_marker": [15, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[50, 62]], "entity_2_idx_in_text_with_entity_marker": [63, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p11", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas [E1]beta-catenin[/E1] interacts directly with the [E2]CREB[/E2]-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[102, 114]], "entity_1_idx_in_text_with_entity_marker": [106, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p12", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "[E1]Armadillo[/E1] (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas [E2]beta-catenin[/E2] interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[102, 114]], "entity_2_idx_in_text_with_entity_marker": [115, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p13", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas [E1]beta-catenin[/E1] interacts directly with the CREB-binding domain of [E2]CBP[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[102, 114]], "entity_1_idx_in_text_with_entity_marker": [106, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[166, 169]], "entity_2_idx_in_text_with_entity_marker": [179, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p14", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of [E1]beta-catenin[/E1] is involved in binding to CBP, whereas [E2]beta-catenin[/E2] interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[50, 62]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[102, 114]], "entity_2_idx_in_text_with_entity_marker": [115, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p15", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "[E1]Armadillo[/E1] (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the [E2]CREB[/E2]-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p16", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the [E1]CREB[/E1]-binding domain of [E2]CBP[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[143, 147]], "entity_1_idx_in_text_with_entity_marker": [147, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[166, 169]], "entity_2_idx_in_text_with_entity_marker": [179, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p17", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of [E1]beta-catenin[/E1] is involved in binding to CBP, whereas beta-catenin interacts directly with the [E2]CREB[/E2]-binding domain of CBP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[50, 62]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p18", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "[E1]Armadillo[/E1] (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of [E2]CBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[166, 169]], "entity_2_idx_in_text_with_entity_marker": [179, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p19", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "[E1]Armadillo[/E1] (Arm) repeat 10 to the COOH terminus of [E2]beta-catenin[/E2] is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Armadillo", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[50, 62]], "entity_2_idx_in_text_with_entity_marker": [63, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d76.s0_BioInfer.d76.s0.p20", "text": "Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.", "text_with_entity_marker": "Armadillo (Arm) repeat 10 to the COOH terminus of [E1]beta-catenin[/E1] is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of [E2]CBP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[50, 62]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[166, 169]], "entity_2_idx_in_text_with_entity_marker": [179, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p60", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, [E1]STE12[/E1], TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "STE12", "entity_1_idx": [[212, 217]], "entity_1_idx_in_text_with_entity_marker": [216, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p61", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, [E1]STE12[/E1], TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, [E2]DFG9[/E2], DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "STE12", "entity_1_idx": [[212, 217]], "entity_1_idx_in_text_with_entity_marker": [216, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG9", "entity_2_idx": [[280, 284]], "entity_2_idx_in_text_with_entity_marker": [293, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p62", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, [E1]STE12[/E1], TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, [E2]SPA2[/E2], BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "STE12", "entity_1_idx": [[212, 217]], "entity_1_idx_in_text_with_entity_marker": [216, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SPA2", "entity_2_idx": [[262, 266]], "entity_2_idx_in_text_with_entity_marker": [275, 279], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p63", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, [E1]STE12[/E1], TEC1, WHI3, NAB1, DBR1, CDC55, [E2]SRV2[/E2], TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "STE12", "entity_1_idx": [[212, 217]], "entity_1_idx_in_text_with_entity_marker": [216, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SRV2", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p64", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, [E1]STE12[/E1], TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, [E2]DFG5[/E2], DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "STE12", "entity_1_idx": [[212, 217]], "entity_1_idx_in_text_with_entity_marker": [216, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG5", "entity_2_idx": [[274, 278]], "entity_2_idx_in_text_with_entity_marker": [287, 291], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p65", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, [E1]WHI3[/E1], NAB1, DBR1, [E2]CDC55[/E2], SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WHI3", "entity_1_idx": [[225, 229]], "entity_1_idx_in_text_with_entity_marker": [229, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CDC55", "entity_2_idx": [[243, 248]], "entity_2_idx_in_text_with_entity_marker": [256, 261], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p66", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, [E1]CDC55[/E1], SRV2, [E2]TPM1[/E2], SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC55", "entity_1_idx": [[243, 248]], "entity_1_idx_in_text_with_entity_marker": [247, 252], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TPM1", "entity_2_idx": [[256, 260]], "entity_2_idx_in_text_with_entity_marker": [269, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p67", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, [E1]DBR1[/E1], [E2]CDC55[/E2], SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DBR1", "entity_1_idx": [[237, 241]], "entity_1_idx_in_text_with_entity_marker": [241, 245], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CDC55", "entity_2_idx": [[243, 248]], "entity_2_idx_in_text_with_entity_marker": [256, 261], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p68", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, [E1]CDC55[/E1], SRV2, TPM1, SPA2, [E2]BNI1[/E2], DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC55", "entity_1_idx": [[243, 248]], "entity_1_idx_in_text_with_entity_marker": [247, 252], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BNI1", "entity_2_idx": [[268, 272]], "entity_2_idx_in_text_with_entity_marker": [281, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p69", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, [E1]CDC55[/E1], SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC55", "entity_1_idx": [[243, 248]], "entity_1_idx_in_text_with_entity_marker": [247, 252], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p1", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using cofilin and [E1]actin[/E1] mutants identified residues necessary for the interaction of [E2]actin[/E2], cofilin, and Aip1p in an apparent ternary complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p2", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using cofilin and [E1]actin[/E1] mutants identified residues necessary for the interaction of actin, [E2]cofilin[/E2], and Aip1p in an apparent ternary complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[120, 127]], "entity_2_idx_in_text_with_entity_marker": [133, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p3", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using cofilin and [E1]actin[/E1] mutants identified residues necessary for the interaction of actin, cofilin, and [E2]Aip1p[/E2] in an apparent ternary complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Aip1p", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p4", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using [E1]cofilin[/E1] and actin mutants identified residues necessary for the interaction of [E2]actin[/E2], cofilin, and Aip1p in an apparent ternary complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p5", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using [E1]cofilin[/E1] and actin mutants identified residues necessary for the interaction of actin, [E2]cofilin[/E2], and Aip1p in an apparent ternary complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[120, 127]], "entity_2_idx_in_text_with_entity_marker": [133, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p6", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using [E1]cofilin[/E1] and actin mutants identified residues necessary for the interaction of actin, cofilin, and [E2]Aip1p[/E2] in an apparent ternary complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Aip1p", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p7", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of [E1]actin[/E1], [E2]cofilin[/E2], and Aip1p in an apparent ternary complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[113, 118]], "entity_1_idx_in_text_with_entity_marker": [117, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[120, 127]], "entity_2_idx_in_text_with_entity_marker": [133, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p8", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of [E1]actin[/E1], cofilin, and [E2]Aip1p[/E2] in an apparent ternary complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[113, 118]], "entity_1_idx_in_text_with_entity_marker": [117, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Aip1p", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p9", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, [E1]cofilin[/E1], and [E2]Aip1p[/E2] in an apparent ternary complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[120, 127]], "entity_1_idx_in_text_with_entity_marker": [124, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Aip1p", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s3_BioInfer.d35.s3.p0", "text": "Here, we report that Aip1p also interacts with the ubiquitous actin depolymerizing factor cofilin.", "text_with_entity_marker": "Here, we report that Aip1p also interacts with the ubiquitous [E1]actin depolymerizing factor[/E1] [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[62, 89]], "entity_1_idx_in_text_with_entity_marker": [66, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p0", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, [E1]MORT1[/E1] (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/[E2]APO1[/E2]; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT1", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p1", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, [E1]TRADD[/E1], binds to the p55 TNF receptor but not to Fas/[E2]APO1[/E2]; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p2", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to [E1]p55-R[/E1]; another, TRADD, binds to the p55 TNF receptor but not to Fas/[E2]APO1[/E2]; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55-R", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p3", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called [E1]FADD[/E1]), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/[E2]APO1[/E2]; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p4", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/[E1]APO1[/E1] but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/[E2]APO1[/E2]; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APO1", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p5", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to [E1]Fas[/E1]/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/[E2]APO1[/E2]; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p6", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 [E1]TNF receptor[/E1] but not to Fas/[E2]APO1[/E2]; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF receptor", "entity_1_idx": [[100, 112]], "entity_1_idx_in_text_with_entity_marker": [104, 116], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "APO1", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p7", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/[E1]APO1[/E1]; and the third, [E2]RIP[/E2], binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APO1", "entity_1_idx": [[128, 132]], "entity_1_idx_in_text_with_entity_marker": [132, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p8", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to [E1]Fas[/E1]/[E2]APO1[/E2]; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[124, 127]], "entity_1_idx_in_text_with_entity_marker": [128, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p9", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the [E1]p55[/E1] TNF receptor but not to Fas/[E2]APO1[/E2]; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d195.s0_BioInfer.d195.s0.p0", "text": "Evidence for a conformational change in actin induced by fimbrin (N375) binding.", "text_with_entity_marker": "Evidence for a conformational change in actin induced by [E1]fimbrin[/E1] ([E2]N375[/E2]) binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[57, 64]], "entity_1_idx_in_text_with_entity_marker": [61, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N375", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d195.s0_BioInfer.d195.s0.p1", "text": "Evidence for a conformational change in actin induced by fimbrin (N375) binding.", "text_with_entity_marker": "Evidence for a conformational change in [E1]actin[/E1] induced by [E2]fimbrin[/E2] (N375) binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[57, 64]], "entity_2_idx_in_text_with_entity_marker": [70, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d195.s0_BioInfer.d195.s0.p2", "text": "Evidence for a conformational change in actin induced by fimbrin (N375) binding.", "text_with_entity_marker": "Evidence for a conformational change in [E1]actin[/E1] induced by fimbrin ([E2]N375[/E2]) binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N375", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d477.s0_BioInfer.d477.s0.p0", "text": "Overexpression of cofilin stimulates bundling of actin filaments, membrane ruffling, and cell movement in Dictyostelium.", "text_with_entity_marker": "Overexpression of [E1]cofilin[/E1] stimulates bundling of [E2]actin[/E2] filaments, membrane ruffling, and cell movement in Dictyostelium.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[18, 25]], "entity_1_idx_in_text_with_entity_marker": [22, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d181.s0_BioInfer.d181.s0.p0", "text": "During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.", "text_with_entity_marker": "During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors [E1]p21[/E1] and [E2]p27[/E2] increased, whereas expression of cyclin D1 decreased.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[97, 100]], "entity_1_idx_in_text_with_entity_marker": [101, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[105, 108]], "entity_2_idx_in_text_with_entity_marker": [118, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d181.s0_BioInfer.d181.s0.p1", "text": "During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.", "text_with_entity_marker": "During apoptotic process induced by the agents, expression of [E1]cyclin-dependent kinase inhibitors[/E1] [E2]p21[/E2] and p27 increased, whereas expression of cyclin D1 decreased.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitors", "entity_1_idx": [[62, 96]], "entity_1_idx_in_text_with_entity_marker": [66, 100], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[97, 100]], "entity_2_idx_in_text_with_entity_marker": [110, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d181.s0_BioInfer.d181.s0.p2", "text": "During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.", "text_with_entity_marker": "During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors [E1]p21[/E1] and p27 increased, whereas expression of [E2]cyclin D1[/E2] decreased.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[97, 100]], "entity_1_idx_in_text_with_entity_marker": [101, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[142, 151]], "entity_2_idx_in_text_with_entity_marker": [155, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d181.s0_BioInfer.d181.s0.p3", "text": "During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.", "text_with_entity_marker": "During apoptotic process induced by the agents, expression of [E1]cyclin-dependent kinase inhibitors[/E1] p21 and [E2]p27[/E2] increased, whereas expression of cyclin D1 decreased.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitors", "entity_1_idx": [[62, 96]], "entity_1_idx_in_text_with_entity_marker": [66, 100], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[105, 108]], "entity_2_idx_in_text_with_entity_marker": [118, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d181.s0_BioInfer.d181.s0.p4", "text": "During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.", "text_with_entity_marker": "During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and [E1]p27[/E1] increased, whereas expression of [E2]cyclin D1[/E2] decreased.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[105, 108]], "entity_1_idx_in_text_with_entity_marker": [109, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[142, 151]], "entity_2_idx_in_text_with_entity_marker": [155, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d181.s0_BioInfer.d181.s0.p5", "text": "During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.", "text_with_entity_marker": "During apoptotic process induced by the agents, expression of [E1]cyclin-dependent kinase inhibitors[/E1] p21 and p27 increased, whereas expression of [E2]cyclin D1[/E2] decreased.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitors", "entity_1_idx": [[62, 96]], "entity_1_idx_in_text_with_entity_marker": [66, 100], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin D1", "entity_2_idx": [[142, 151]], "entity_2_idx_in_text_with_entity_marker": [155, 164], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d556.s0_BioInfer.d556.s0.p0", "text": "Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.", "text_with_entity_marker": "Suppression of cell transformation by the cyclin-dependent kinase inhibitor [E1]p57KIP2[/E1] requires binding to [E2]proliferating cell nuclear antigen[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p57KIP2", "entity_1_idx": [[76, 83]], "entity_1_idx_in_text_with_entity_marker": [80, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[104, 138]], "entity_2_idx_in_text_with_entity_marker": [117, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d556.s0_BioInfer.d556.s0.p1", "text": "Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.", "text_with_entity_marker": "Suppression of cell transformation by the [E1]cyclin-dependent kinase inhibitor[/E1] p57KIP2 requires binding to [E2]proliferating cell nuclear antigen[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[42, 75]], "entity_1_idx_in_text_with_entity_marker": [46, 79], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[104, 138]], "entity_2_idx_in_text_with_entity_marker": [117, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d556.s0_BioInfer.d556.s0.p2", "text": "Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.", "text_with_entity_marker": "Suppression of cell transformation by the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p57KIP2[/E2] requires binding to proliferating cell nuclear antigen.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[42, 75]], "entity_1_idx_in_text_with_entity_marker": [46, 79], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p57KIP2", "entity_2_idx": [[76, 83]], "entity_2_idx_in_text_with_entity_marker": [89, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d671.s0_BioInfer.d671.s0.p0", "text": "The prominent 125 A transverse stripping pattern characteristic of the actin cross-bridges in a bundle is also absent in hair borders suggesting fimbrin as the component that gives rise to the transverse stripes.", "text_with_entity_marker": "The prominent 125 A transverse stripping pattern characteristic of the [E1]actin[/E1] cross-bridges in a bundle is also absent in hair borders suggesting [E2]fimbrin[/E2] as the component that gives rise to the transverse stripes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[145, 152]], "entity_2_idx_in_text_with_entity_marker": [158, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d820.s0_BioInfer.d820.s0.p0", "text": "We show here that the phenotype of ts cut2-364 is highly similar to that of cut1 and that the functions of the gene products of cut1+ and cut2+ are closely interrelated.", "text_with_entity_marker": "We show here that the phenotype of ts [E1]cut2-364[/E1] is highly similar to that of [E2]cut1[/E2] and that the functions of the gene products of cut1+ and cut2+ are closely interrelated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cut2-364", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cut1", "entity_2_idx": [[76, 80]], "entity_2_idx_in_text_with_entity_marker": [89, 93], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d820.s0_BioInfer.d820.s0.p1", "text": "We show here that the phenotype of ts cut2-364 is highly similar to that of cut1 and that the functions of the gene products of cut1+ and cut2+ are closely interrelated.", "text_with_entity_marker": "We show here that the phenotype of ts [E1]cut2-364[/E1] is highly similar to that of cut1 and that the functions of the gene products of [E2]cut1+[/E2] and cut2+ are closely interrelated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cut2-364", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cut1+", "entity_2_idx": [[128, 133]], "entity_2_idx_in_text_with_entity_marker": [141, 146], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d820.s0_BioInfer.d820.s0.p2", "text": "We show here that the phenotype of ts cut2-364 is highly similar to that of cut1 and that the functions of the gene products of cut1+ and cut2+ are closely interrelated.", "text_with_entity_marker": "We show here that the phenotype of ts [E1]cut2-364[/E1] is highly similar to that of cut1 and that the functions of the gene products of cut1+ and [E2]cut2+[/E2] are closely interrelated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cut2-364", "entity_1_idx": [[38, 46]], "entity_1_idx_in_text_with_entity_marker": [42, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cut2+", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d820.s0_BioInfer.d820.s0.p3", "text": "We show here that the phenotype of ts cut2-364 is highly similar to that of cut1 and that the functions of the gene products of cut1+ and cut2+ are closely interrelated.", "text_with_entity_marker": "We show here that the phenotype of ts cut2-364 is highly similar to that of [E1]cut1[/E1] and that the functions of the gene products of [E2]cut1+[/E2] and cut2+ are closely interrelated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cut1", "entity_1_idx": [[76, 80]], "entity_1_idx_in_text_with_entity_marker": [80, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cut1+", "entity_2_idx": [[128, 133]], "entity_2_idx_in_text_with_entity_marker": [141, 146], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d820.s0_BioInfer.d820.s0.p4", "text": "We show here that the phenotype of ts cut2-364 is highly similar to that of cut1 and that the functions of the gene products of cut1+ and cut2+ are closely interrelated.", "text_with_entity_marker": "We show here that the phenotype of ts cut2-364 is highly similar to that of [E1]cut1[/E1] and that the functions of the gene products of cut1+ and [E2]cut2+[/E2] are closely interrelated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cut1", "entity_1_idx": [[76, 80]], "entity_1_idx_in_text_with_entity_marker": [80, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cut2+", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d820.s0_BioInfer.d820.s0.p5", "text": "We show here that the phenotype of ts cut2-364 is highly similar to that of cut1 and that the functions of the gene products of cut1+ and cut2+ are closely interrelated.", "text_with_entity_marker": "We show here that the phenotype of ts cut2-364 is highly similar to that of cut1 and that the functions of the gene products of [E1]cut1+[/E1] and [E2]cut2+[/E2] are closely interrelated.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cut1+", "entity_1_idx": [[128, 133]], "entity_1_idx_in_text_with_entity_marker": [132, 137], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "cut2+", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s1_BioInfer.d33.s1.p4", "text": "Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "text_with_entity_marker": "Loss of normal surface [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[23, 33]], "entity_1_idx_in_text_with_entity_marker": [27, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[35, 48]], "entity_2_idx_in_text_with_entity_marker": [48, 61], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s1_BioInfer.d33.s1.p5", "text": "Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "text_with_entity_marker": "Loss of normal surface E-cadherin, [E1]alpha-catenin[/E1], beta-catenin and [E2]gamma-catenin[/E2] expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[35, 48]], "entity_1_idx_in_text_with_entity_marker": [39, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[67, 80]], "entity_2_idx_in_text_with_entity_marker": [80, 93], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p0", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an [E1]avidin[/E1]-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, [E2]beta-catenin[/E2], gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "avidin", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[130, 142]], "entity_2_idx_in_text_with_entity_marker": [143, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p1", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an [E1]avidin[/E1]-biotin immunoperoxidase technique to examine the cellular localization of [E2]alpha-catenin[/E2], beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "avidin", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[115, 128]], "entity_2_idx_in_text_with_entity_marker": [128, 141], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p2", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an [E1]avidin[/E1]-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and [E2]E-cadherin[/E2] in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "avidin", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[162, 172]], "entity_2_idx_in_text_with_entity_marker": [175, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p3", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an [E1]avidin[/E1]-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, [E2]gamma-catenin[/E2] and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "avidin", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[144, 157]], "entity_2_idx_in_text_with_entity_marker": [157, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p4", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[115, 128]], "entity_1_idx_in_text_with_entity_marker": [119, 132], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[130, 142]], "entity_2_idx_in_text_with_entity_marker": [143, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p5", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, [E1]beta-catenin[/E1], gamma-catenin and [E2]E-cadherin[/E2] in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[130, 142]], "entity_1_idx_in_text_with_entity_marker": [134, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[162, 172]], "entity_2_idx_in_text_with_entity_marker": [175, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p6", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, [E1]beta-catenin[/E1], [E2]gamma-catenin[/E2] and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[130, 142]], "entity_1_idx_in_text_with_entity_marker": [134, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[144, 157]], "entity_2_idx_in_text_with_entity_marker": [157, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p7", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of [E1]alpha-catenin[/E1], beta-catenin, gamma-catenin and [E2]E-cadherin[/E2] in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[115, 128]], "entity_1_idx_in_text_with_entity_marker": [119, 132], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[162, 172]], "entity_2_idx_in_text_with_entity_marker": [175, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p0", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for [E1]alpha-smooth muscle actin[/E1] and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for [E2]desmin[/E2] and nonmuscle myosin heavy chain II-B.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[77, 102]], "entity_1_idx_in_text_with_entity_marker": [81, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p1", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for [E1]desmin[/E1] and [E2]nonmuscle myosin heavy chain II-B[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[206, 212]], "entity_1_idx_in_text_with_entity_marker": [210, 216], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nonmuscle myosin heavy chain II-B", "entity_2_idx": [[217, 250]], "entity_2_idx_in_text_with_entity_marker": [230, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p2", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and [E1]smooth muscle myosin heavy chain[/E1] and a weak to moderate reactivity of a lesser number of cells for [E2]desmin[/E2] and nonmuscle myosin heavy chain II-B.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[107, 139]], "entity_1_idx_in_text_with_entity_marker": [111, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p3", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for [E1]alpha-smooth muscle actin[/E1] and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and [E2]nonmuscle myosin heavy chain II-B[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[77, 102]], "entity_1_idx_in_text_with_entity_marker": [81, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nonmuscle myosin heavy chain II-B", "entity_2_idx": [[217, 250]], "entity_2_idx_in_text_with_entity_marker": [230, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p4", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for [E1]alpha-smooth muscle actin[/E1] and [E2]smooth muscle myosin heavy chain[/E2] and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[77, 102]], "entity_1_idx_in_text_with_entity_marker": [81, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[107, 139]], "entity_2_idx_in_text_with_entity_marker": [120, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p5", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and [E1]smooth muscle myosin heavy chain[/E1] and a weak to moderate reactivity of a lesser number of cells for desmin and [E2]nonmuscle myosin heavy chain II-B[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[107, 139]], "entity_1_idx_in_text_with_entity_marker": [111, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nonmuscle myosin heavy chain II-B", "entity_2_idx": [[217, 250]], "entity_2_idx_in_text_with_entity_marker": [230, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p10", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E2]dystrophin[/E2], utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[217, 227]], "entity_2_idx_in_text_with_entity_marker": [230, 240], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p11", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo [E2]87K[/E2] protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K", "entity_2_idx": [[282, 285]], "entity_2_idx_in_text_with_entity_marker": [295, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p12", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both [E2]beta 2-[/E2] and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 2-", "entity_2_idx": [[121, 128], [141, 151]], "entity_2_idx_in_text_with_entity_marker": [134, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p13", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the [E1]syntrophin[/E1]-binding region of dystrophin, [E2]utrophin[/E2]/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "syntrophin", "entity_1_idx": [[188, 198]], "entity_1_idx_in_text_with_entity_marker": [192, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[229, 237]], "entity_2_idx_in_text_with_entity_marker": [242, 250], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p14", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, [E1]utrophin[/E1]/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[229, 237]], "entity_1_idx_in_text_with_entity_marker": [233, 241], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p15", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E1]dystrophin[/E1], [E2]utrophin[/E2]/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[217, 227]], "entity_1_idx_in_text_with_entity_marker": [221, 231], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[229, 237]], "entity_2_idx_in_text_with_entity_marker": [242, 250], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p16", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, [E1]utrophin[/E1]/dystrophin related protein, and the Torpedo [E2]87K[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[229, 237]], "entity_1_idx_in_text_with_entity_marker": [233, 241], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K", "entity_2_idx": [[282, 285]], "entity_2_idx_in_text_with_entity_marker": [295, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p17", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both [E1]beta 2-[/E1] and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, [E2]utrophin[/E2]/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta 2-", "entity_1_idx": [[121, 128], [141, 151]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[229, 237]], "entity_2_idx_in_text_with_entity_marker": [242, 250], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p18", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the [E1]syntrophin[/E1]-binding region of dystrophin, utrophin/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "syntrophin", "entity_1_idx": [[188, 198]], "entity_1_idx_in_text_with_entity_marker": [192, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p19", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the [E1]syntrophin[/E1]-binding region of [E2]dystrophin[/E2], utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "syntrophin", "entity_1_idx": [[188, 198]], "entity_1_idx_in_text_with_entity_marker": [192, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[217, 227]], "entity_2_idx_in_text_with_entity_marker": [230, 240], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p20", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p21", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion ([E2]F[/E2]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[65, 66]], "entity_2_idx_in_text_with_entity_marker": [78, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p22", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p23", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p24", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p25", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p26", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), [E2]fusion[/E2] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[57, 63], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p27", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), [E2]nucleocapsid protein[/E2] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p28", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p29", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p50", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p51", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, [E2]troponin I[/E2], myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin I", "entity_2_idx": [[54, 64]], "entity_2_idx_in_text_with_entity_marker": [67, 77], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p52", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p53", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, [E2]calponin[/E2], calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p54", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p55", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p56", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p57", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, [E2]calponin[/E2], calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p58", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p59", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p0", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of nonmuscle myosin heavy chain IIB ([E1]MHC-IIB[/E1]) are generated by alternative splicing; [E2]MHC-IIB(B2)[/E2] differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC-IIB", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC-IIB(B2)", "entity_2_idx": [[98, 109]], "entity_2_idx_in_text_with_entity_marker": [111, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p1", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of [E1]nonmuscle myosin heavy chain IIB[/E1] (MHC-IIB) are generated by alternative splicing; [E2]MHC-IIB(B2)[/E2] differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nonmuscle myosin heavy chain IIB", "entity_1_idx": [[16, 48]], "entity_1_idx_in_text_with_entity_marker": [20, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC-IIB(B2)", "entity_2_idx": [[98, 109]], "entity_2_idx_in_text_with_entity_marker": [111, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p2", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; [E1]MHC-IIB(B2)[/E1] differs from [E2]MHC-IIB(DeltaB2)[/E2] by the insertion of B2 exon cassette near the actin binding region.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MHC-IIB(B2)", "entity_1_idx": [[98, 109]], "entity_1_idx_in_text_with_entity_marker": [102, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC-IIB(DeltaB2)", "entity_2_idx": [[123, 139]], "entity_2_idx_in_text_with_entity_marker": [136, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p3", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; [E1]MHC-IIB(B2)[/E1] differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the [E2]actin[/E2] binding region.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MHC-IIB(B2)", "entity_1_idx": [[98, 109]], "entity_1_idx_in_text_with_entity_marker": [102, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[186, 191]], "entity_2_idx_in_text_with_entity_marker": [199, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p4", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of [E1]nonmuscle myosin heavy chain IIB[/E1] ([E2]MHC-IIB[/E2]) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nonmuscle myosin heavy chain IIB", "entity_1_idx": [[16, 48]], "entity_1_idx_in_text_with_entity_marker": [20, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC-IIB", "entity_2_idx": [[50, 57]], "entity_2_idx_in_text_with_entity_marker": [63, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p5", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of nonmuscle myosin heavy chain IIB ([E1]MHC-IIB[/E1]) are generated by alternative splicing; MHC-IIB(B2) differs from [E2]MHC-IIB(DeltaB2)[/E2] by the insertion of B2 exon cassette near the actin binding region.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC-IIB", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC-IIB(DeltaB2)", "entity_2_idx": [[123, 139]], "entity_2_idx_in_text_with_entity_marker": [136, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p6", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of nonmuscle myosin heavy chain IIB ([E1]MHC-IIB[/E1]) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the [E2]actin[/E2] binding region.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC-IIB", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[186, 191]], "entity_2_idx_in_text_with_entity_marker": [199, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p7", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of [E1]nonmuscle myosin heavy chain IIB[/E1] (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from [E2]MHC-IIB(DeltaB2)[/E2] by the insertion of B2 exon cassette near the actin binding region.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nonmuscle myosin heavy chain IIB", "entity_1_idx": [[16, 48]], "entity_1_idx_in_text_with_entity_marker": [20, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC-IIB(DeltaB2)", "entity_2_idx": [[123, 139]], "entity_2_idx_in_text_with_entity_marker": [136, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p8", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of [E1]nonmuscle myosin heavy chain IIB[/E1] (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the [E2]actin[/E2] binding region.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nonmuscle myosin heavy chain IIB", "entity_1_idx": [[16, 48]], "entity_1_idx_in_text_with_entity_marker": [20, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[186, 191]], "entity_2_idx_in_text_with_entity_marker": [199, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p9", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from [E1]MHC-IIB(DeltaB2)[/E1] by the insertion of B2 exon cassette near the [E2]actin[/E2] binding region.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MHC-IIB(DeltaB2)", "entity_1_idx": [[123, 139]], "entity_1_idx_in_text_with_entity_marker": [127, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[186, 191]], "entity_2_idx_in_text_with_entity_marker": [199, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p20", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p21", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, [E1]nestin[/E1], myosin heavy chain, sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nestin", "entity_1_idx": [[128, 134]], "entity_1_idx_in_text_with_entity_marker": [132, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p22", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, [E1]myosin heavy chain[/E1], sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[136, 154]], "entity_1_idx_in_text_with_entity_marker": [140, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p23", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p24", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], nestin, myosin heavy chain, sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p25", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p26", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, [E1]nestin[/E1], [E2]myosin heavy chain[/E2], sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nestin", "entity_1_idx": [[128, 134]], "entity_1_idx_in_text_with_entity_marker": [132, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p27", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, [E2]nestin[/E2], myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nestin", "entity_2_idx": [[128, 134]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p28", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], [E2]nestin[/E2], myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nestin", "entity_2_idx": [[128, 134]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p29", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, [E2]nestin[/E2], myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nestin", "entity_2_idx": [[128, 134]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p30", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, nestin, [E2]myosin heavy chain[/E2], sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p31", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], nestin, [E2]myosin heavy chain[/E2], sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p32", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, nestin, [E2]myosin heavy chain[/E2], sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p33", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with [E2]desmin[/E2], nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[120, 126]], "entity_2_idx_in_text_with_entity_marker": [133, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p34", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and [E2]MyoD[/E2] mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p35", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with [E2]desmin[/E2], nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[120, 126]], "entity_2_idx_in_text_with_entity_marker": [133, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d726.s0_BioInfer.d726.s0.p0", "text": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "text_with_entity_marker": "The Tetrahymena [E1]fimbrin[/E1] has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links [E2]actin[/E2] filaments in a Ca(2+)- insensitive manner during cytokinesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d726.s0_BioInfer.d726.s0.p1", "text": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "text_with_entity_marker": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena [E1]fimbrin[/E1] probably cross-links [E2]actin[/E2] filaments in a Ca(2+)- insensitive manner during cytokinesis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[127, 134]], "entity_1_idx_in_text_with_entity_marker": [131, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d726.s0_BioInfer.d726.s0.p2", "text": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "text_with_entity_marker": "The Tetrahymena fimbrin has two [E1]actin[/E1]-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links [E2]actin[/E2] filaments in a Ca(2+)- insensitive manner during cytokinesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d726.s0_BioInfer.d726.s0.p3", "text": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "text_with_entity_marker": "The Tetrahymena [E1]fimbrin[/E1] has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena [E2]fimbrin[/E2] probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[127, 134]], "entity_2_idx_in_text_with_entity_marker": [140, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d726.s0_BioInfer.d726.s0.p4", "text": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "text_with_entity_marker": "The Tetrahymena [E1]fimbrin[/E1] has two [E2]actin[/E2]-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d726.s0_BioInfer.d726.s0.p5", "text": "The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "text_with_entity_marker": "The Tetrahymena fimbrin has two [E1]actin[/E1]-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena [E2]fimbrin[/E2] probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[127, 134]], "entity_2_idx_in_text_with_entity_marker": [140, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p0", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios actin mRNA:18S RNA and [E1]fast myosin heavy chain[/E1] mRNA:[E2]18S RNA[/E2] were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fast myosin heavy chain", "entity_1_idx": [[34, 57]], "entity_1_idx_in_text_with_entity_marker": [38, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S RNA", "entity_2_idx": [[63, 70]], "entity_2_idx_in_text_with_entity_marker": [76, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p1", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios [E1]actin[/E1] mRNA:18S RNA and [E2]fast myosin heavy chain[/E2] mRNA:18S RNA were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[11, 16]], "entity_1_idx_in_text_with_entity_marker": [15, 20], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fast myosin heavy chain", "entity_2_idx": [[34, 57]], "entity_2_idx_in_text_with_entity_marker": [47, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p2", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios actin mRNA:[E1]18S RNA[/E1] and [E2]fast myosin heavy chain[/E2] mRNA:18S RNA were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S RNA", "entity_1_idx": [[22, 29]], "entity_1_idx_in_text_with_entity_marker": [26, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fast myosin heavy chain", "entity_2_idx": [[34, 57]], "entity_2_idx_in_text_with_entity_marker": [47, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p3", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios [E1]actin[/E1] mRNA:18S RNA and fast myosin heavy chain mRNA:[E2]18S RNA[/E2] were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[11, 16]], "entity_1_idx_in_text_with_entity_marker": [15, 20], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S RNA", "entity_2_idx": [[63, 70]], "entity_2_idx_in_text_with_entity_marker": [76, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p4", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios actin mRNA:[E1]18S RNA[/E1] and fast myosin heavy chain mRNA:[E2]18S RNA[/E2] were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "18S RNA", "entity_1_idx": [[22, 29]], "entity_1_idx_in_text_with_entity_marker": [26, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S RNA", "entity_2_idx": [[63, 70]], "entity_2_idx_in_text_with_entity_marker": [76, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p5", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios [E1]actin[/E1] mRNA:[E2]18S RNA[/E2] and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[11, 16]], "entity_1_idx_in_text_with_entity_marker": [15, 20], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S RNA", "entity_2_idx": [[22, 29]], "entity_2_idx_in_text_with_entity_marker": [35, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d132.s0_BioInfer.d132.s0.p0", "text": "Cells lacking talin, a protein which in many mammalian cell types is a constituent of focal complexes that link the actin cytoskeleton to the plasma membrane, are strongly impaired in adhesion to external surfaces.", "text_with_entity_marker": "Cells lacking [E1]talin[/E1], a protein which in many mammalian cell types is a constituent of focal complexes that link the [E2]actin[/E2] cytoskeleton to the plasma membrane, are strongly impaired in adhesion to external surfaces.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[116, 121]], "entity_2_idx_in_text_with_entity_marker": [129, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d152.s0_BioInfer.d152.s0.p0", "text": "CONCLUSION: The results show that Munc-18-2 and syntaxin 3 form a complex in vivo and suggest that they participate in epithelial cell differentiation and targeted vesicle transport processes in the developing kidney.", "text_with_entity_marker": "CONCLUSION: The results show that [E1]Munc-18-2[/E1] and [E2]syntaxin 3[/E2] form a complex in vivo and suggest that they participate in epithelial cell differentiation and targeted vesicle transport processes in the developing kidney.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc-18-2", "entity_1_idx": [[34, 43]], "entity_1_idx_in_text_with_entity_marker": [38, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[48, 58]], "entity_2_idx_in_text_with_entity_marker": [61, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p0", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a [E1]profilin[/E1]-like fashion, and [E2]Arp2[/E2]/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[105, 109]], "entity_2_idx_in_text_with_entity_marker": [118, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p1", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a [E1]profilin[/E1]-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by [E2]Arp2[/E2]/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[224, 228]], "entity_2_idx_in_text_with_entity_marker": [237, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p2", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one [E1]actin[/E1] monomer, in a [E2]profilin[/E2]-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[78, 86]], "entity_2_idx_in_text_with_entity_marker": [91, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p3", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a [E1]profilin[/E1]-like fashion, and [E2]Arp[/E2]2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[105, 108], [110, 111]], "entity_2_idx_in_text_with_entity_marker": [118, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p4", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a [E1]profilin[/E1]-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by [E2]Arp[/E2]2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[224, 227], [229, 230]], "entity_2_idx_in_text_with_entity_marker": [237, 240], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p5", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a [E1]profilin[/E1]-like fashion, and Arp2/3 complex and mimics the C-terminal domain of [E2]WASp[/E2] family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[156, 160]], "entity_2_idx_in_text_with_entity_marker": [169, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p6", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of [E1]ActA[/E1] binds one actin monomer, in a [E2]profilin[/E2]-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[78, 86]], "entity_2_idx_in_text_with_entity_marker": [91, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p7", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and [E1]Arp2[/E1]/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by [E2]Arp2[/E2]/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[105, 109]], "entity_1_idx_in_text_with_entity_marker": [109, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[224, 228]], "entity_2_idx_in_text_with_entity_marker": [237, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p8", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one [E1]actin[/E1] monomer, in a profilin-like fashion, and [E2]Arp2[/E2]/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[105, 109]], "entity_2_idx_in_text_with_entity_marker": [118, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p9", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and [E1-E2]Arp[/E1]2[/E2]/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[105, 108], [110, 111]], "entity_1_idx_in_text_with_entity_marker": [112, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[105, 109]], "entity_2_idx_in_text_with_entity_marker": [112, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d588.s0_BioInfer.d588.s0.p0", "text": "The C374S mutation had the most pronounced effect; it reduced the polymerizability of the actin, abolished its binding to profilin, and filaments containing this mutation moved at reduced rates in the in vitro 'motility assay'.", "text_with_entity_marker": "The C374S mutation had the most pronounced effect; it reduced the polymerizability of the [E1]actin[/E1], abolished its binding to [E2]profilin[/E2], and filaments containing this mutation moved at reduced rates in the in vitro 'motility assay'.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[122, 130]], "entity_2_idx_in_text_with_entity_marker": [135, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d416.s0_BioInfer.d416.s0.p0", "text": "Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.", "text_with_entity_marker": "Mechanism of inhibition of [E1]proliferating cell nuclear antigen[/E1]-dependent DNA synthesis by the cyclin-dependent kinase inhibitor [E2]p21[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[27, 61]], "entity_1_idx_in_text_with_entity_marker": [31, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[127, 130]], "entity_2_idx_in_text_with_entity_marker": [140, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d416.s0_BioInfer.d416.s0.p1", "text": "Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.", "text_with_entity_marker": "Mechanism of inhibition of [E1]proliferating cell nuclear antigen[/E1]-dependent DNA synthesis by the [E2]cyclin-dependent kinase inhibitor[/E2] p21.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[27, 61]], "entity_1_idx_in_text_with_entity_marker": [31, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[93, 126]], "entity_2_idx_in_text_with_entity_marker": [106, 139], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d416.s0_BioInfer.d416.s0.p2", "text": "Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.", "text_with_entity_marker": "Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[93, 126]], "entity_1_idx_in_text_with_entity_marker": [97, 130], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[127, 130]], "entity_2_idx_in_text_with_entity_marker": [140, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p10", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that [E1]histone[/E1] [E2]H3[/E2] is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[159, 161]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p11", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and [E1]H4[/E1] and the transcription factor p53, and have determined that histone [E2]H3[/E2] is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[89, 91]], "entity_1_idx_in_text_with_entity_marker": [93, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[159, 161]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p12", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone [E2]H3[/E2] is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[159, 161]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p13", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones [E1]H3[/E1] and H4 and the transcription factor p53, and have determined that histone [E2]H3[/E2] is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[82, 84]], "entity_1_idx_in_text_with_entity_marker": [86, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[159, 161]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p14", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, [E1]histones[/E1] H3 and H4 and the transcription factor p53, and have determined that histone [E2]H3[/E2] is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[159, 161]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p15", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone [E1]H3[/E1] is significantly preferred over the [E2]histone[/E2] H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[159, 161]], "entity_1_idx_in_text_with_entity_marker": [163, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[198, 205]], "entity_2_idx_in_text_with_entity_marker": [211, 218], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p16", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone [E1]H3[/E1] is significantly preferred over the histone H4 and [E2]p53[/E2] substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[159, 161]], "entity_1_idx_in_text_with_entity_marker": [163, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p17", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that [E1]histone[/E1] H3 is significantly preferred over the histone [E2]H4[/E2] and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[206, 208]], "entity_2_idx_in_text_with_entity_marker": [219, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p18", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and [E1]H4[/E1] and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone [E2]H4[/E2] and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[89, 91]], "entity_1_idx_in_text_with_entity_marker": [93, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[206, 208]], "entity_2_idx_in_text_with_entity_marker": [219, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p19", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone [E2]H4[/E2] and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[206, 208]], "entity_2_idx_in_text_with_entity_marker": [219, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p0", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with [E1]vinculin[/E1], [E2]talin[/E2], and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[159, 167]], "entity_1_idx_in_text_with_entity_marker": [163, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[169, 174]], "entity_2_idx_in_text_with_entity_marker": [182, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p1", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, [E1]talin[/E1], and the ends of [E2]actin[/E2] filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[169, 174]], "entity_1_idx_in_text_with_entity_marker": [173, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[192, 197]], "entity_2_idx_in_text_with_entity_marker": [205, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p2", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a [E1]alpha v beta 3[/E1] can be detected in focal contacts, colocalizing with vinculin, [E2]talin[/E2], and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha v beta 3", "entity_1_idx": [[91, 105]], "entity_1_idx_in_text_with_entity_marker": [95, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[169, 174]], "entity_2_idx_in_text_with_entity_marker": [182, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p3", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, [E1]talin[/E1], and the ends of actin filaments, while [E2]alpha v beta 5[/E2] shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[169, 174]], "entity_1_idx_in_text_with_entity_marker": [173, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha v beta 5", "entity_2_idx": [[215, 229]], "entity_2_idx_in_text_with_entity_marker": [228, 242], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p4", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to [E1]vitronectin[/E1], only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, [E2]talin[/E2], and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vitronectin", "entity_1_idx": [[71, 82]], "entity_1_idx_in_text_with_entity_marker": [75, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[169, 174]], "entity_2_idx_in_text_with_entity_marker": [182, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p5", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with [E1]vinculin[/E1], talin, and the ends of [E2]actin[/E2] filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[159, 167]], "entity_1_idx_in_text_with_entity_marker": [163, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[192, 197]], "entity_2_idx_in_text_with_entity_marker": [205, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p6", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a [E1]alpha v beta 3[/E1] can be detected in focal contacts, colocalizing with [E2]vinculin[/E2], talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha v beta 3", "entity_1_idx": [[91, 105]], "entity_1_idx_in_text_with_entity_marker": [95, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p7", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with [E1]vinculin[/E1], talin, and the ends of actin filaments, while [E2]alpha v beta 5[/E2] shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[159, 167]], "entity_1_idx_in_text_with_entity_marker": [163, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha v beta 5", "entity_2_idx": [[215, 229]], "entity_2_idx_in_text_with_entity_marker": [228, 242], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p8", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to [E1]vitronectin[/E1], only a alpha v beta 3 can be detected in focal contacts, colocalizing with [E2]vinculin[/E2], talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vitronectin", "entity_1_idx": [[71, 82]], "entity_1_idx_in_text_with_entity_marker": [75, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[159, 167]], "entity_2_idx_in_text_with_entity_marker": [172, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p9", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a [E1]alpha v beta 3[/E1] can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of [E2]actin[/E2] filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha v beta 3", "entity_1_idx": [[91, 105]], "entity_1_idx_in_text_with_entity_marker": [95, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[192, 197]], "entity_2_idx_in_text_with_entity_marker": [205, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p10", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of [E1]actin[/E1] filaments, while [E2]alpha v beta 5[/E2] shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[192, 197]], "entity_1_idx_in_text_with_entity_marker": [196, 201], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha v beta 5", "entity_2_idx": [[215, 229]], "entity_2_idx_in_text_with_entity_marker": [228, 242], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p11", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to [E1]vitronectin[/E1], only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of [E2]actin[/E2] filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vitronectin", "entity_1_idx": [[71, 82]], "entity_1_idx_in_text_with_entity_marker": [75, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[192, 197]], "entity_2_idx_in_text_with_entity_marker": [205, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p12", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a [E1]alpha v beta 3[/E1] can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while [E2]alpha v beta 5[/E2] shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha v beta 3", "entity_1_idx": [[91, 105]], "entity_1_idx_in_text_with_entity_marker": [95, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha v beta 5", "entity_2_idx": [[215, 229]], "entity_2_idx_in_text_with_entity_marker": [228, 242], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p13", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to [E1]vitronectin[/E1], only a [E2]alpha v beta 3[/E2] can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vitronectin", "entity_1_idx": [[71, 82]], "entity_1_idx_in_text_with_entity_marker": [75, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha v beta 3", "entity_2_idx": [[91, 105]], "entity_2_idx_in_text_with_entity_marker": [104, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d40.s0_BioInfer.d40.s0.p14", "text": "Although both receptors are involved in M21 and H2981 cell adhesion to vitronectin, only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while alpha v beta 5 shows a distinct, nonfocal contact, distribution on the cell surface.", "text_with_entity_marker": "Although both receptors are involved in M21 and H2981 cell adhesion to [E1]vitronectin[/E1], only a alpha v beta 3 can be detected in focal contacts, colocalizing with vinculin, talin, and the ends of actin filaments, while [E2]alpha v beta 5[/E2] shows a distinct, nonfocal contact, distribution on the cell surface.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vitronectin", "entity_1_idx": [[71, 82]], "entity_1_idx_in_text_with_entity_marker": [75, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha v beta 5", "entity_2_idx": [[215, 229]], "entity_2_idx_in_text_with_entity_marker": [228, 242], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d659.s0_BioInfer.d659.s0.p0", "text": "The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.", "text_with_entity_marker": "The polycystic kidney disease 1 gene product mediates [E1]protein kinase C alpha[/E1]-dependent and [E2]c-Jun N-terminal kinase[/E2]-dependent activation of the transcription factor AP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein kinase C alpha", "entity_1_idx": [[54, 76]], "entity_1_idx_in_text_with_entity_marker": [58, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-Jun N-terminal kinase", "entity_2_idx": [[91, 114]], "entity_2_idx_in_text_with_entity_marker": [104, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d659.s0_BioInfer.d659.s0.p1", "text": "The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.", "text_with_entity_marker": "The [E1]polycystic kidney disease 1[/E1] gene product mediates [E2]protein kinase C alpha[/E2]-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "polycystic kidney disease 1", "entity_1_idx": [[4, 31]], "entity_1_idx_in_text_with_entity_marker": [8, 35], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "protein kinase C alpha", "entity_2_idx": [[54, 76]], "entity_2_idx_in_text_with_entity_marker": [67, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d659.s0_BioInfer.d659.s0.p2", "text": "The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.", "text_with_entity_marker": "The polycystic kidney disease 1 gene product mediates [E1]protein kinase C alpha[/E1]-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor [E2]AP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "protein kinase C alpha", "entity_1_idx": [[54, 76]], "entity_1_idx_in_text_with_entity_marker": [58, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d659.s0_BioInfer.d659.s0.p3", "text": "The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.", "text_with_entity_marker": "The [E1]polycystic kidney disease 1[/E1] gene product mediates protein kinase C alpha-dependent and [E2]c-Jun N-terminal kinase[/E2]-dependent activation of the transcription factor AP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "polycystic kidney disease 1", "entity_1_idx": [[4, 31]], "entity_1_idx_in_text_with_entity_marker": [8, 35], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "c-Jun N-terminal kinase", "entity_2_idx": [[91, 114]], "entity_2_idx_in_text_with_entity_marker": [104, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d659.s0_BioInfer.d659.s0.p4", "text": "The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.", "text_with_entity_marker": "The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and [E1]c-Jun N-terminal kinase[/E1]-dependent activation of the transcription factor [E2]AP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "c-Jun N-terminal kinase", "entity_1_idx": [[91, 114]], "entity_1_idx_in_text_with_entity_marker": [95, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d659.s0_BioInfer.d659.s0.p5", "text": "The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.", "text_with_entity_marker": "The [E1]polycystic kidney disease 1[/E1] gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor [E2]AP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "polycystic kidney disease 1", "entity_1_idx": [[4, 31]], "entity_1_idx_in_text_with_entity_marker": [8, 35], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "AP-1", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p0", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein ([E1]N[/E1]) and phosphoprotein (P/[E2]V[/E2]) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[54, 55]], "entity_1_idx_in_text_with_entity_marker": [58, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[79, 80]], "entity_2_idx_in_text_with_entity_marker": [92, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p1", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein ([E1]N[/E1]) and phosphoprotein (P/V) have been determined and recombinant N and [E2]V[/E2] proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[54, 55]], "entity_1_idx_in_text_with_entity_marker": [58, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[125, 126]], "entity_2_idx_in_text_with_entity_marker": [138, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p2", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein ([E1]N[/E1]) and phosphoprotein ([E2]P[/E2]/V) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[54, 55]], "entity_1_idx_in_text_with_entity_marker": [58, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[77, 78]], "entity_2_idx_in_text_with_entity_marker": [90, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p3", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein ([E1]N[/E1]) and phosphoprotein (P/V) have been determined and recombinant [E2]N[/E2] and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[54, 55]], "entity_1_idx_in_text_with_entity_marker": [58, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[119, 120]], "entity_2_idx_in_text_with_entity_marker": [132, 133], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p4", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein ([E1]N[/E1]) and [E2]phosphoprotein[/E2] (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[54, 55]], "entity_1_idx_in_text_with_entity_marker": [58, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[61, 75]], "entity_2_idx_in_text_with_entity_marker": [74, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p5", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the [E1]nucleocapsid protein[/E1] ([E2]N[/E2]) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[32, 52]], "entity_1_idx_in_text_with_entity_marker": [36, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[54, 55]], "entity_2_idx_in_text_with_entity_marker": [67, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p6", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/[E1]V[/E1]) have been determined and recombinant N and [E2]V[/E2] proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "V", "entity_1_idx": [[79, 80]], "entity_1_idx_in_text_with_entity_marker": [83, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[125, 126]], "entity_2_idx_in_text_with_entity_marker": [138, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p7", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein ([E1]P[/E1]/[E2]V[/E2]) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[79, 80]], "entity_2_idx_in_text_with_entity_marker": [92, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p8", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/[E1]V[/E1]) have been determined and recombinant [E2]N[/E2] and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "V", "entity_1_idx": [[79, 80]], "entity_1_idx_in_text_with_entity_marker": [83, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[119, 120]], "entity_2_idx_in_text_with_entity_marker": [132, 133], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p9", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and [E1]phosphoprotein[/E1] (P/[E2]V[/E2]) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[79, 80]], "entity_2_idx_in_text_with_entity_marker": [92, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p10", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the [E1]nucleocapsid protein[/E1] (N) and phosphoprotein (P/[E2]V[/E2]) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[32, 52]], "entity_1_idx_in_text_with_entity_marker": [36, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[79, 80]], "entity_2_idx_in_text_with_entity_marker": [92, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p11", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein ([E1]P[/E1]/V) have been determined and recombinant N and [E2]V[/E2] proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[125, 126]], "entity_2_idx_in_text_with_entity_marker": [138, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p12", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant [E1]N[/E1] and [E2]V[/E2] proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[119, 120]], "entity_1_idx_in_text_with_entity_marker": [123, 124], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "V", "entity_2_idx": [[125, 126]], "entity_2_idx_in_text_with_entity_marker": [138, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p13", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and [E1]phosphoprotein[/E1] (P/V) have been determined and recombinant N and [E2]V[/E2] proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[125, 126]], "entity_2_idx_in_text_with_entity_marker": [138, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p14", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the [E1]nucleocapsid protein[/E1] (N) and phosphoprotein (P/V) have been determined and recombinant N and [E2]V[/E2] proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[32, 52]], "entity_1_idx_in_text_with_entity_marker": [36, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[125, 126]], "entity_2_idx_in_text_with_entity_marker": [138, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p15", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein ([E1]P[/E1]/V) have been determined and recombinant [E2]N[/E2] and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[119, 120]], "entity_2_idx_in_text_with_entity_marker": [132, 133], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p16", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and [E1]phosphoprotein[/E1] ([E2]P[/E2]/V) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[77, 78]], "entity_2_idx_in_text_with_entity_marker": [90, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p17", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the [E1]nucleocapsid protein[/E1] (N) and phosphoprotein ([E2]P[/E2]/V) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[32, 52]], "entity_1_idx_in_text_with_entity_marker": [36, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[77, 78]], "entity_2_idx_in_text_with_entity_marker": [90, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p18", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the nucleocapsid protein (N) and [E1]phosphoprotein[/E1] (P/V) have been determined and recombinant [E2]N[/E2] and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[119, 120]], "entity_2_idx_in_text_with_entity_marker": [132, 133], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p19", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the [E1]nucleocapsid protein[/E1] (N) and phosphoprotein (P/V) have been determined and recombinant [E2]N[/E2] and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[32, 52]], "entity_1_idx_in_text_with_entity_marker": [36, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[119, 120]], "entity_2_idx_in_text_with_entity_marker": [132, 133], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d149.s0_BioInfer.d149.s0.p20", "text": "Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "text_with_entity_marker": "Complete gene sequences for the [E1]nucleocapsid protein[/E1] (N) and [E2]phosphoprotein[/E2] (P/V) have been determined and recombinant N and V proteins produced in baculovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[32, 52]], "entity_1_idx_in_text_with_entity_marker": [36, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[61, 75]], "entity_2_idx_in_text_with_entity_marker": [74, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p0", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the [E1]Ras[/E1]-Raf-mitogen-activated protein kinase ([E2]MAP kinase[/E2]) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAP kinase", "entity_2_idx": [[91, 101]], "entity_2_idx_in_text_with_entity_marker": [104, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p1", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, [E1]HBx[/E1] was shown to stimulate the [E2]Ras[/E2]-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HBx", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[49, 52]], "entity_2_idx_in_text_with_entity_marker": [62, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p2", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the [E1]Ras[/E1]-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor [E2]AP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p3", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the [E1]Ras[/E1]-Raf-[E2]mitogen-activated protein kinase[/E2] (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[57, 89]], "entity_2_idx_in_text_with_entity_marker": [70, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p4", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the [E1]Ras[/E1]-[E2]Raf[/E2]-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ras", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Raf", "entity_2_idx": [[53, 56]], "entity_2_idx_in_text_with_entity_marker": [66, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p5", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, [E1]HBx[/E1] was shown to stimulate the Ras-Raf-mitogen-activated protein kinase ([E2]MAP kinase[/E2]) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HBx", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAP kinase", "entity_2_idx": [[91, 101]], "entity_2_idx_in_text_with_entity_marker": [104, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p6", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase ([E1]MAP kinase[/E1]) cascade, which is essential for activation of transcription factor [E2]AP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MAP kinase", "entity_1_idx": [[91, 101]], "entity_1_idx_in_text_with_entity_marker": [95, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p7", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-[E1]mitogen-activated protein kinase[/E1] ([E2]MAP kinase[/E2]) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[57, 89]], "entity_1_idx_in_text_with_entity_marker": [61, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAP kinase", "entity_2_idx": [[91, 101]], "entity_2_idx_in_text_with_entity_marker": [104, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p8", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the Ras-[E1]Raf[/E1]-mitogen-activated protein kinase ([E2]MAP kinase[/E2]) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Raf", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MAP kinase", "entity_2_idx": [[91, 101]], "entity_2_idx_in_text_with_entity_marker": [104, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p9", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, [E1]HBx[/E1] was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor [E2]AP-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HBx", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p10", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, [E1]HBx[/E1] was shown to stimulate the Ras-Raf-[E2]mitogen-activated protein kinase[/E2] (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HBx", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[57, 89]], "entity_2_idx_in_text_with_entity_marker": [70, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p11", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, [E1]HBx[/E1] was shown to stimulate the Ras-[E2]Raf[/E2]-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HBx", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Raf", "entity_2_idx": [[53, 56]], "entity_2_idx_in_text_with_entity_marker": [66, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p12", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-[E1]mitogen-activated protein kinase[/E1] (MAP kinase) cascade, which is essential for activation of transcription factor [E2]AP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[57, 89]], "entity_1_idx_in_text_with_entity_marker": [61, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p13", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the Ras-[E1]Raf[/E1]-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor [E2]AP-1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Raf", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d367.s0_BioInfer.d367.s0.p14", "text": "In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "text_with_entity_marker": "In the cytoplasm, HBx was shown to stimulate the Ras-[E1]Raf[/E1]-[E2]mitogen-activated protein kinase[/E2] (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Raf", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[57, 89]], "entity_2_idx_in_text_with_entity_marker": [70, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p0", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast [E1]profilin[/E1] for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human [E2]platelet profilin[/E2] for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "platelet profilin", "entity_2_idx": [[120, 137]], "entity_2_idx_in_text_with_entity_marker": [133, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p1", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast [E1]profilin[/E1] for rabbit [E2]actin[/E2] (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p2", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast [E1]profilin[/E1] for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit [E2]actin[/E2] (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p3", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast [E1]profilin[/E1] for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two [E2]profilins[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[296, 305]], "entity_2_idx_in_text_with_entity_marker": [309, 318], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p4", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast profilin for rabbit [E1]actin[/E1] (2.9 microM) is approximately 30-fold weaker than the affinity of human [E2]platelet profilin[/E2] for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "platelet profilin", "entity_2_idx": [[120, 137]], "entity_2_idx_in_text_with_entity_marker": [133, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p5", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human [E1]platelet profilin[/E1] for rabbit [E2]actin[/E2] (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "platelet profilin", "entity_1_idx": [[120, 137]], "entity_1_idx_in_text_with_entity_marker": [124, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p6", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human [E1]platelet profilin[/E1] for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two [E2]profilins[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "platelet profilin", "entity_1_idx": [[120, 137]], "entity_1_idx_in_text_with_entity_marker": [124, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[296, 305]], "entity_2_idx_in_text_with_entity_marker": [309, 318], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p7", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast profilin for rabbit [E1]actin[/E1] (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit [E2]actin[/E2] (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p8", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast profilin for rabbit [E1]actin[/E1] (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two [E2]profilins[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[296, 305]], "entity_2_idx_in_text_with_entity_marker": [309, 318], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p9", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit [E1]actin[/E1] (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two [E2]profilins[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[149, 154]], "entity_1_idx_in_text_with_entity_marker": [153, 158], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[296, 305]], "entity_2_idx_in_text_with_entity_marker": [309, 318], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p0", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that [E1]TNF-alpha[/E1] can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, [E2]TRADD[/E2], FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF-alpha", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p1", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, [E1]TRADD[/E1], FADD, and [E2]FLICE[/E2], and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[122, 127]], "entity_1_idx_in_text_with_entity_marker": [126, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p2", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, [E1]TRADD[/E1], [E2]FADD[/E2], and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[122, 127]], "entity_1_idx_in_text_with_entity_marker": [126, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p3", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, [E1]TRADD[/E1], FADD, and FLICE, and [E2]TNF[/E2]-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[122, 127]], "entity_1_idx_in_text_with_entity_marker": [126, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p4", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through [E1]TNFR1[/E1]-linked apoptotic factors, [E2]TRADD[/E2], FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p5", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that [E1]TNF-alpha[/E1] can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and [E2]FLICE[/E2], and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF-alpha", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p6", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that [E1]TNF-alpha[/E1] can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, [E2]FADD[/E2], and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF-alpha", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p7", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that [E1]TNF-alpha[/E1] can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and [E2]TNF[/E2]-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-alpha", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p8", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that [E1]TNF-alpha[/E1] can cause apoptosis in pancreatic beta cells through [E2]TNFR1[/E2]-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-alpha", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFR1", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p9", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, [E1]FADD[/E1], and [E2]FLICE[/E2], and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[129, 133]], "entity_1_idx_in_text_with_entity_marker": [133, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p10", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and [E1]FLICE[/E1], and [E2]TNF[/E2]-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FLICE", "entity_1_idx": [[139, 144]], "entity_1_idx_in_text_with_entity_marker": [143, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p11", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through [E1]TNFR1[/E1]-linked apoptotic factors, TRADD, FADD, and [E2]FLICE[/E2], and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p12", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, [E1]FADD[/E1], and FLICE, and [E2]TNF[/E2]-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[129, 133]], "entity_1_idx_in_text_with_entity_marker": [133, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p13", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through [E1]TNFR1[/E1]-linked apoptotic factors, TRADD, [E2]FADD[/E2], and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d715.s0_BioInfer.d715.s0.p14", "text": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.", "text_with_entity_marker": "These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through [E1]TNFR1[/E1]-linked apoptotic factors, TRADD, FADD, and FLICE, and [E2]TNF[/E2]-induced ceramide production may be involved in the pathways.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR1", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d327.s0_BioInfer.d327.s0.p0", "text": "In contrast, the RAD51 and RAD52 genes are essential for homothallic mating-type switching.", "text_with_entity_marker": "In contrast, the [E1]RAD51[/E1] and [E2]RAD52[/E2] genes are essential for homothallic mating-type switching.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d697.s0_BioInfer.d697.s0.p0", "text": "These findings reveal striking differences between S. cerevisiae and vertebrates in the functions of RAD51 and RAD52.", "text_with_entity_marker": "These findings reveal striking differences between S. cerevisiae and vertebrates in the functions of [E1]RAD51[/E1] and [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[101, 106]], "entity_1_idx_in_text_with_entity_marker": [105, 110], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d547.s0_BioInfer.d547.s0.p0", "text": "Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "text_with_entity_marker": "Specific interaction between the nucleocapsid protein (N) and the [E1]phosphoprotein[/E1] ([E2]P[/E2]) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[66, 80]], "entity_1_idx_in_text_with_entity_marker": [70, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[82, 83]], "entity_2_idx_in_text_with_entity_marker": [95, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d547.s0_BioInfer.d547.s0.p1", "text": "Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "text_with_entity_marker": "Specific interaction between the [E1]nucleocapsid protein[/E1] (N) and the phosphoprotein ([E2]P[/E2]) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleocapsid protein", "entity_1_idx": [[33, 53]], "entity_1_idx_in_text_with_entity_marker": [37, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[82, 83]], "entity_2_idx_in_text_with_entity_marker": [95, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d547.s0_BioInfer.d547.s0.p2", "text": "Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "text_with_entity_marker": "Specific interaction between the nucleocapsid protein ([E1]N[/E1]) and the phosphoprotein ([E2]P[/E2]) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "N", "entity_1_idx": [[55, 56]], "entity_1_idx_in_text_with_entity_marker": [59, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[82, 83]], "entity_2_idx_in_text_with_entity_marker": [95, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d547.s0_BioInfer.d547.s0.p3", "text": "Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "text_with_entity_marker": "Specific interaction between the [E1]nucleocapsid protein[/E1] (N) and the [E2]phosphoprotein[/E2] (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleocapsid protein", "entity_1_idx": [[33, 53]], "entity_1_idx_in_text_with_entity_marker": [37, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[66, 80]], "entity_2_idx_in_text_with_entity_marker": [79, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d547.s0_BioInfer.d547.s0.p4", "text": "Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "text_with_entity_marker": "Specific interaction between the nucleocapsid protein ([E1]N[/E1]) and the [E2]phosphoprotein[/E2] (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "N", "entity_1_idx": [[55, 56]], "entity_1_idx_in_text_with_entity_marker": [59, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[66, 80]], "entity_2_idx_in_text_with_entity_marker": [79, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d547.s0_BioInfer.d547.s0.p5", "text": "Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "text_with_entity_marker": "Specific interaction between the [E1]nucleocapsid protein[/E1] ([E2]N[/E2]) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[33, 53]], "entity_1_idx_in_text_with_entity_marker": [37, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[55, 56]], "entity_2_idx_in_text_with_entity_marker": [68, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d57.s0_BioInfer.d57.s0.p0", "text": "Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the spleen actin (beta, gamma) which appears to regulate the interaction with profilin.", "text_with_entity_marker": "Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the [E1]spleen actin[/E1] (beta, gamma) which appears to regulate the interaction with [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "spleen actin", "entity_1_idx": [[201, 213], [221, 226]], "entity_1_idx_in_text_with_entity_marker": [205, 217], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[275, 283]], "entity_2_idx_in_text_with_entity_marker": [288, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d57.s0_BioInfer.d57.s0.p1", "text": "Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the spleen actin (beta, gamma) which appears to regulate the interaction with profilin.", "text_with_entity_marker": "Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the [E1]spleen actin[/E1] (beta, gamma) which appears to regulate the interaction with [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "spleen actin", "entity_1_idx": [[201, 213], [215, 219]], "entity_1_idx_in_text_with_entity_marker": [205, 217], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[275, 283]], "entity_2_idx_in_text_with_entity_marker": [288, 296], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d57.s0_BioInfer.d57.s0.p2", "text": "Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the spleen actin (beta, gamma) which appears to regulate the interaction with profilin.", "text_with_entity_marker": "Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the [E1-E2]spleen actin[/E1-E2] (beta, gamma) which appears to regulate the interaction with profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "spleen actin", "entity_1_idx": [[201, 213], [215, 219]], "entity_1_idx_in_text_with_entity_marker": [208, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "spleen actin", "entity_2_idx": [[201, 213], [221, 226]], "entity_2_idx_in_text_with_entity_marker": [208, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d57.s1_BioInfer.d57.s1.p0", "text": "The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.", "text_with_entity_marker": "The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the [E1]actin[/E1], and in the case of [E2]profilin[/E2], the C-terminus is of great importance for the physiochemical behaviour of the protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[113, 118]], "entity_1_idx_in_text_with_entity_marker": [117, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d57.s1_BioInfer.d57.s1.p1", "text": "The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.", "text_with_entity_marker": "The interaction between calf [E1]spleen[/E1] profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of [E2]profilin[/E2], the C-terminus is of great importance for the physiochemical behaviour of the protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "spleen", "entity_1_idx": [[29, 35], [49, 54]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d57.s1_BioInfer.d57.s1.p2", "text": "The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.", "text_with_entity_marker": "The interaction between calf [E1]spleen profilin[/E1] and actin depends critically on the status of the C-terminus of the actin, and in the case of [E2]profilin[/E2], the C-terminus is of great importance for the physiochemical behaviour of the protein.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "spleen profilin", "entity_1_idx": [[29, 44]], "entity_1_idx_in_text_with_entity_marker": [33, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d57.s1_BioInfer.d57.s1.p3", "text": "The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.", "text_with_entity_marker": "The interaction between calf [E1]spleen[/E1] profilin and actin depends critically on the status of the C-terminus of the [E2]actin[/E2], and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "spleen", "entity_1_idx": [[29, 35], [49, 54]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d57.s1_BioInfer.d57.s1.p4", "text": "The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.", "text_with_entity_marker": "The interaction between calf [E1]spleen profilin[/E1] and actin depends critically on the status of the C-terminus of the [E2]actin[/E2], and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "spleen profilin", "entity_1_idx": [[29, 44]], "entity_1_idx_in_text_with_entity_marker": [33, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d57.s1_BioInfer.d57.s1.p5", "text": "The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.", "text_with_entity_marker": "The interaction between calf [E1-E2]spleen[/E1] profilin[/E2] and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "spleen", "entity_1_idx": [[29, 35], [49, 54]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "spleen[/E1] profilin", "entity_2_idx": [[29, 44]], "entity_2_idx_in_text_with_entity_marker": [36, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d410.s0_BioInfer.d410.s0.p0", "text": "Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.", "text_with_entity_marker": "Loss of memberanous expression of [E1]E-cadherin[/E1], alpha-catenin and [E2]beta-catenin[/E2] was demonstrated in 52%, 85% and 40% of tumours respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[64, 76]], "entity_2_idx_in_text_with_entity_marker": [77, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d410.s0_BioInfer.d410.s0.p1", "text": "Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.", "text_with_entity_marker": "Loss of memberanous expression of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2] and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[46, 59]], "entity_2_idx_in_text_with_entity_marker": [59, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d410.s0_BioInfer.d410.s0.p2", "text": "Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.", "text_with_entity_marker": "Loss of memberanous expression of E-cadherin, [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2] was demonstrated in 52%, 85% and 40% of tumours respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[46, 59]], "entity_1_idx_in_text_with_entity_marker": [50, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[64, 76]], "entity_2_idx_in_text_with_entity_marker": [77, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d410.s1_BioInfer.d410.s1.p0", "text": "There was a trend towards an association between advanced tumour stage and loss of membranous expression of alpha-catenin or beta-catenin, although these associations were not statistically significant.", "text_with_entity_marker": "There was a trend towards an association between advanced tumour stage and loss of membranous expression of [E1]alpha-catenin[/E1] or [E2]beta-catenin[/E2], although these associations were not statistically significant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[108, 121]], "entity_1_idx_in_text_with_entity_marker": [112, 125], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[125, 137]], "entity_2_idx_in_text_with_entity_marker": [138, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d212.s0_BioInfer.d212.s0.p0", "text": "First, the C-terminal verprolin-cofilin-acidic domain was shown to be essential for the regulation of actin cytoskeleton.", "text_with_entity_marker": "First, the C-terminal [E1]verprolin[/E1]-[E2]cofilin[/E2]-acidic domain was shown to be essential for the regulation of actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[32, 39]], "entity_2_idx_in_text_with_entity_marker": [45, 52], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d212.s0_BioInfer.d212.s0.p1", "text": "First, the C-terminal verprolin-cofilin-acidic domain was shown to be essential for the regulation of actin cytoskeleton.", "text_with_entity_marker": "First, the C-terminal verprolin-[E1]cofilin[/E1]-acidic domain was shown to be essential for the regulation of [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[32, 39]], "entity_1_idx_in_text_with_entity_marker": [36, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d212.s0_BioInfer.d212.s0.p2", "text": "First, the C-terminal verprolin-cofilin-acidic domain was shown to be essential for the regulation of actin cytoskeleton.", "text_with_entity_marker": "First, the C-terminal [E1]verprolin[/E1]-cofilin-acidic domain was shown to be essential for the regulation of [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p0", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "[E1]Profilin[/E1] is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and [E2]actin[/E2] raised the possibility that profilin might also regulate lipid metabolism.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Profilin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p1", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of [E1]profilin[/E1] and [E2]actin[/E2] raised the possibility that profilin might also regulate lipid metabolism.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[136, 144]], "entity_1_idx_in_text_with_entity_marker": [140, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p2", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "Profilin is generally thought to regulate [E1]actin[/E1] polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and [E2]actin[/E2] raised the possibility that profilin might also regulate lipid metabolism.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p3", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and [E1]actin[/E1] raised the possibility that [E2]profilin[/E2] might also regulate lipid metabolism.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[149, 154]], "entity_1_idx_in_text_with_entity_marker": [153, 158], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[183, 191]], "entity_2_idx_in_text_with_entity_marker": [196, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p4", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "[E1]Profilin[/E1] is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of [E2]profilin[/E2] and actin raised the possibility that profilin might also regulate lipid metabolism.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Profilin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p5", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "[E1]Profilin[/E1] is generally thought to regulate [E2]actin[/E2] polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Profilin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p6", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "[E1]Profilin[/E1] is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that [E2]profilin[/E2] might also regulate lipid metabolism.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Profilin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[183, 191]], "entity_2_idx_in_text_with_entity_marker": [196, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p7", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "Profilin is generally thought to regulate [E1]actin[/E1] polymerization, but the observation that acidic phospholipids dissociate the complex of [E2]profilin[/E2] and actin raised the possibility that profilin might also regulate lipid metabolism.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p8", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of [E1]profilin[/E1] and actin raised the possibility that [E2]profilin[/E2] might also regulate lipid metabolism.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[136, 144]], "entity_1_idx_in_text_with_entity_marker": [140, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[183, 191]], "entity_2_idx_in_text_with_entity_marker": [196, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p9", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "Profilin is generally thought to regulate [E1]actin[/E1] polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that [E2]profilin[/E2] might also regulate lipid metabolism.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[183, 191]], "entity_2_idx_in_text_with_entity_marker": [196, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s1_BioInfer.d497.s1.p0", "text": "The actin-binding protein profilin binds to PIP2 and inhibits its hydrolysis by phospholipase C.", "text_with_entity_marker": "The [E1]actin-binding protein[/E1] [E2]profilin[/E2] binds to PIP2 and inhibits its hydrolysis by phospholipase C.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[4, 25]], "entity_1_idx_in_text_with_entity_marker": [8, 29], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[26, 34]], "entity_2_idx_in_text_with_entity_marker": [39, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s1_BioInfer.d497.s1.p1", "text": "The actin-binding protein profilin binds to PIP2 and inhibits its hydrolysis by phospholipase C.", "text_with_entity_marker": "The [E1]actin-binding protein[/E1] profilin binds to PIP2 and inhibits its hydrolysis by [E2]phospholipase C[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[4, 25]], "entity_1_idx_in_text_with_entity_marker": [8, 29], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "phospholipase C", "entity_2_idx": [[80, 95]], "entity_2_idx_in_text_with_entity_marker": [93, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s1_BioInfer.d497.s1.p2", "text": "The actin-binding protein profilin binds to PIP2 and inhibits its hydrolysis by phospholipase C.", "text_with_entity_marker": "The actin-binding protein [E1]profilin[/E1] binds to PIP2 and inhibits its hydrolysis by [E2]phospholipase C[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[80, 95]], "entity_2_idx_in_text_with_entity_marker": [93, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s2_BioInfer.d497.s2.p0", "text": "The cellular concentrations and binding characteristics of these molecules are consistent with profilin being a negative regulator of the phosphoinositide signaling pathway in addition to its established function as an inhibitor of actin polymerization.", "text_with_entity_marker": "The cellular concentrations and binding characteristics of these molecules are consistent with [E1]profilin[/E1] being a negative regulator of the phosphoinositide signaling pathway in addition to its established function as an inhibitor of [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[95, 103]], "entity_1_idx_in_text_with_entity_marker": [99, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[232, 237]], "entity_2_idx_in_text_with_entity_marker": [245, 250], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s0_BioInfer.d253.s0.p0", "text": "Here we show that the ubiquitin-dependent proteolysis system is involved in the regulation of beta-catenin turnover.", "text_with_entity_marker": "Here we show that the [E1]ubiquitin[/E1]-dependent proteolysis system is involved in the regulation of [E2]beta-catenin[/E2] turnover.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ubiquitin", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[94, 106]], "entity_2_idx_in_text_with_entity_marker": [107, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p0", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not [E1]E-cadherin[/E1], p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[198, 210]], "entity_2_idx_in_text_with_entity_marker": [211, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p1", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, [E1]p120[/E1](cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[198, 210]], "entity_2_idx_in_text_with_entity_marker": [211, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p2", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[198, 210]], "entity_2_idx_in_text_with_entity_marker": [211, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p3", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, p120([E1]cas[/E1]) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cas", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[198, 210]], "entity_2_idx_in_text_with_entity_marker": [211, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p4", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when [E1]proteasome[/E1]-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proteasome", "entity_1_idx": [[86, 96]], "entity_1_idx_in_text_with_entity_marker": [90, 100], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[198, 210]], "entity_2_idx_in_text_with_entity_marker": [211, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p5", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, p120(cas) or [E1]alpha-catenin[/E1], becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[198, 210]], "entity_2_idx_in_text_with_entity_marker": [211, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p6", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not [E1]E-cadherin[/E1], [E2]p120[/E2](cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p7", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not [E2]E-cadherin[/E2], p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[22, 32]], "entity_2_idx_in_text_with_entity_marker": [35, 45], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p8", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not [E1]E-cadherin[/E1], p120([E2]cas[/E2]) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cas", "entity_2_idx": [[39, 42]], "entity_2_idx_in_text_with_entity_marker": [52, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p9", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not [E1]E-cadherin[/E1], p120(cas) or alpha-catenin, becomes stabilized when [E2]proteasome[/E2]-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "proteasome", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p10", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not [E1]E-cadherin[/E1], p120(cas) or [E2]alpha-catenin[/E2], becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p11", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not E-cadherin, [E2]p120[/E2](cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p12", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, [E1]p120[/E1]([E2]cas[/E2]) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cas", "entity_2_idx": [[39, 42]], "entity_2_idx_in_text_with_entity_marker": [52, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p13", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, [E1]p120[/E1](cas) or alpha-catenin, becomes stabilized when [E2]proteasome[/E2]-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proteasome", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p14", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, [E1]p120[/E1](cas) or [E2]alpha-catenin[/E2], becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p15", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not E-cadherin, p120([E2]cas[/E2]) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cas", "entity_2_idx": [[39, 42]], "entity_2_idx_in_text_with_entity_marker": [52, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p16", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when [E2]proteasome[/E2]-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "proteasome", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p17", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not E-cadherin, p120(cas) or [E2]alpha-catenin[/E2], becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p18", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, p120([E1]cas[/E1]) or alpha-catenin, becomes stabilized when [E2]proteasome[/E2]-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cas", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proteasome", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p19", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, p120([E1]cas[/E1]) or [E2]alpha-catenin[/E2], becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cas", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p20", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, p120(cas) or [E1]alpha-catenin[/E1], becomes stabilized when [E2]proteasome[/E2]-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "proteasome", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p30", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, [E2]cadherin[/E2] and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[265, 273]], "entity_2_idx_in_text_with_entity_marker": [278, 286], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p31", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by [E2]beta-catenin[/E2]; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[201, 213]], "entity_2_idx_in_text_with_entity_marker": [214, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p32", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and [E2]beta-catenin[/E2] differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[46, 58]], "entity_2_idx_in_text_with_entity_marker": [59, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p33", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by [E1]beta-catenin[/E1]; and (c) the cytoplasmic partners of beta-catenin, [E2]cadherin[/E2] and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[201, 213]], "entity_1_idx_in_text_with_entity_marker": [205, 217], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[265, 273]], "entity_2_idx_in_text_with_entity_marker": [278, 286], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p34", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and [E1]beta-catenin[/E1] differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, [E2]cadherin[/E2] and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[265, 273]], "entity_2_idx_in_text_with_entity_marker": [278, 286], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p35", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and [E1]beta-catenin[/E1] differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by [E2]beta-catenin[/E2]; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[201, 213]], "entity_2_idx_in_text_with_entity_marker": [214, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p0", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and [E1]BTG[/E1] secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and [E2]myosin[/E2] into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BTG", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[179, 185]], "entity_2_idx_in_text_with_entity_marker": [192, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p1", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in [E1]TXB2[/E1] and [E2]BTG[/E2] secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TXB2", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "BTG", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p2", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and [E1]BTG[/E1] secretion as measured by RIA and an increased incorporation of actin binding protein, [E2]talin[/E2], and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BTG", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p3", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and [E1]BTG[/E1] secretion as measured by RIA and an increased incorporation of [E2]actin binding protein[/E2], talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BTG", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding protein", "entity_2_idx": [[145, 166]], "entity_2_idx_in_text_with_entity_marker": [158, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p4", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with [E1]IL-6[/E1] showed a dose dependent increase in TXB2 and [E2]BTG[/E2] secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IL-6", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "BTG", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p5", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in [E1]TXB2[/E1] and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and [E2]myosin[/E2] into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TXB2", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[179, 185]], "entity_2_idx_in_text_with_entity_marker": [192, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p6", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, [E1]talin[/E1], and [E2]myosin[/E2] into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[168, 173]], "entity_1_idx_in_text_with_entity_marker": [172, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[179, 185]], "entity_2_idx_in_text_with_entity_marker": [192, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p7", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of [E1]actin binding protein[/E1], talin, and [E2]myosin[/E2] into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin binding protein", "entity_1_idx": [[145, 166]], "entity_1_idx_in_text_with_entity_marker": [149, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin", "entity_2_idx": [[179, 185]], "entity_2_idx_in_text_with_entity_marker": [192, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p8", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with [E1]IL-6[/E1] showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and [E2]myosin[/E2] into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-6", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[179, 185]], "entity_2_idx_in_text_with_entity_marker": [192, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p9", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in [E1]TXB2[/E1] and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, [E2]talin[/E2], and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TXB2", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p10", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in [E1]TXB2[/E1] and BTG secretion as measured by RIA and an increased incorporation of [E2]actin binding protein[/E2], talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TXB2", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding protein", "entity_2_idx": [[145, 166]], "entity_2_idx_in_text_with_entity_marker": [158, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p11", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with [E1]IL-6[/E1] showed a dose dependent increase in [E2]TXB2[/E2] and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "IL-6", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TXB2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p12", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of [E1]actin binding protein[/E1], [E2]talin[/E2], and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin binding protein", "entity_1_idx": [[145, 166]], "entity_1_idx_in_text_with_entity_marker": [149, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p13", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with [E1]IL-6[/E1] showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, [E2]talin[/E2], and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-6", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p14", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with [E1]IL-6[/E1] showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of [E2]actin binding protein[/E2], talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "IL-6", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin binding protein", "entity_2_idx": [[145, 166]], "entity_2_idx_in_text_with_entity_marker": [158, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s0_BioInfer.d583.s0.p0", "text": "The binding surfaces for segment 1 and profilin are different, although they peripherally overlap on actin.", "text_with_entity_marker": "The binding surfaces for segment 1 and [E1]profilin[/E1] are different, although they peripherally overlap on [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s1_BioInfer.d583.s1.p0", "text": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.", "text_with_entity_marker": "This review describes three structures of [E1]actin[/E1] complexed with different monomer-binding proteins, namely with [E2]DNase I[/E2], gelsolin segment 1, and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase I", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s1_BioInfer.d583.s1.p1", "text": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.", "text_with_entity_marker": "This review describes three structures of [E1]actin[/E1] complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[144, 152]], "entity_2_idx_in_text_with_entity_marker": [157, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s1_BioInfer.d583.s1.p2", "text": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.", "text_with_entity_marker": "This review describes three structures of [E1]actin[/E1] complexed with different monomer-binding proteins, namely with DNase I, [E2]gelsolin[/E2] segment 1, and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[120, 128]], "entity_2_idx_in_text_with_entity_marker": [133, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s1_BioInfer.d583.s1.p3", "text": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.", "text_with_entity_marker": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with [E1]DNase I[/E1], gelsolin segment 1, and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNase I", "entity_1_idx": [[111, 118]], "entity_1_idx_in_text_with_entity_marker": [115, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[144, 152]], "entity_2_idx_in_text_with_entity_marker": [157, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s1_BioInfer.d583.s1.p4", "text": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.", "text_with_entity_marker": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with [E1]DNase I[/E1], [E2]gelsolin[/E2] segment 1, and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNase I", "entity_1_idx": [[111, 118]], "entity_1_idx_in_text_with_entity_marker": [115, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[120, 128]], "entity_2_idx_in_text_with_entity_marker": [133, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d583.s1_BioInfer.d583.s1.p5", "text": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.", "text_with_entity_marker": "This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, [E1]gelsolin[/E1] segment 1, and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[120, 128]], "entity_1_idx_in_text_with_entity_marker": [124, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[144, 152]], "entity_2_idx_in_text_with_entity_marker": [157, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p0", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "Profilins also bind polyphosphoinositides, which can disrupt the [E1]profilin[/E1]-[E2]actin[/E2] complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[65, 73]], "entity_1_idx_in_text_with_entity_marker": [69, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p1", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-[E1]actin[/E1] complex, and proline-rich ligands which localize profilin to sites requiring extensive [E2]actin[/E2] filament accumulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[167, 172]], "entity_2_idx_in_text_with_entity_marker": [180, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p2", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "[E1]Profilins[/E1] also bind polyphosphoinositides, which can disrupt the profilin-[E2]actin[/E2] complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Profilins", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p3", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-[E1]actin[/E1] complex, and proline-rich ligands which localize [E2]profilin[/E2] to sites requiring extensive actin filament accumulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[129, 137]], "entity_2_idx_in_text_with_entity_marker": [142, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p4", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "Profilins also bind polyphosphoinositides, which can disrupt the [E1]profilin[/E1]-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive [E2]actin[/E2] filament accumulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[65, 73]], "entity_1_idx_in_text_with_entity_marker": [69, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[167, 172]], "entity_2_idx_in_text_with_entity_marker": [180, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p5", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "[E1]Profilins[/E1] also bind polyphosphoinositides, which can disrupt the [E2]profilin[/E2]-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Profilins", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p6", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "Profilins also bind polyphosphoinositides, which can disrupt the [E1]profilin[/E1]-actin complex, and proline-rich ligands which localize [E2]profilin[/E2] to sites requiring extensive actin filament accumulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[65, 73]], "entity_1_idx_in_text_with_entity_marker": [69, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[129, 137]], "entity_2_idx_in_text_with_entity_marker": [142, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p7", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "[E1]Profilins[/E1] also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive [E2]actin[/E2] filament accumulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Profilins", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[167, 172]], "entity_2_idx_in_text_with_entity_marker": [180, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p8", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize [E1]profilin[/E1] to sites requiring extensive [E2]actin[/E2] filament accumulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[129, 137]], "entity_1_idx_in_text_with_entity_marker": [133, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[167, 172]], "entity_2_idx_in_text_with_entity_marker": [180, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p9", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "[E1]Profilins[/E1] also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize [E2]profilin[/E2] to sites requiring extensive actin filament accumulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Profilins", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[129, 137]], "entity_2_idx_in_text_with_entity_marker": [142, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d784.s0_BioInfer.d784.s0.p0", "text": "Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing VASP and profilin.", "text_with_entity_marker": "Unmasking of this site serves as a molecular switch that initiates assembly of an [E1]actin[/E1]-based motility complex containing [E2]VASP[/E2] and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VASP", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d784.s0_BioInfer.d784.s0.p1", "text": "Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing VASP and profilin.", "text_with_entity_marker": "Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing [E1]VASP[/E1] and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "VASP", "entity_1_idx": [[122, 126]], "entity_1_idx_in_text_with_entity_marker": [126, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[131, 139]], "entity_2_idx_in_text_with_entity_marker": [144, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d784.s0_BioInfer.d784.s0.p2", "text": "Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing VASP and profilin.", "text_with_entity_marker": "Unmasking of this site serves as a molecular switch that initiates assembly of an [E1]actin[/E1]-based motility complex containing VASP and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[131, 139]], "entity_2_idx_in_text_with_entity_marker": [144, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p30", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p31", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p32", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p33", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p34", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E1]N[/E1]; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[240, 241]], "entity_1_idx_in_text_with_entity_marker": [244, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p35", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p36", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), [E1]matrix[/E1] (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[301, 307], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [305, 311], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p37", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p38", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p39", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p70", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), [E2]nucleocapsid[/E2] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[226, 238], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [239, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p71", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p72", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p73", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p74", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] ([E2]N[/E2]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[240, 241]], "entity_2_idx_in_text_with_entity_marker": [253, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p75", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p76", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p77", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p78", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p79", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid ([E2]N[/E2]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[240, 241]], "entity_2_idx_in_text_with_entity_marker": [253, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p0", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]RAD14[/E1] was identified in a two-hybrid screen using [E2]MSH2[/E2] as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD14", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p1", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using [E1]MSH2[/E1] as \"bait,\" and pairwise interactions between [E2]MSH2[/E2] and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p2", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using [E1]MSH2[/E1] as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and [E2]RAD25[/E2] subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD25", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p3", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using [E1]MSH2[/E1] as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, [E2]RAD3[/E2], RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD3", "entity_2_idx": [[146, 150]], "entity_2_idx_in_text_with_entity_marker": [159, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p4", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using [E1]MSH2[/E1] as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, [E2]RAD10[/E2], RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD10", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p5", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using [E1]MSH2[/E1] as \"bait,\" and pairwise interactions between MSH2 and [E2]RAD1[/E2], RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD1", "entity_2_idx": [[134, 138]], "entity_2_idx_in_text_with_entity_marker": [147, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p6", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using [E1]MSH2[/E1] as \"bait,\" and pairwise interactions between MSH2 and RAD1, [E2]RAD2[/E2], RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD2", "entity_2_idx": [[140, 144]], "entity_2_idx_in_text_with_entity_marker": [153, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p7", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using [E1]MSH2[/E1] as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, [E2]RAD14[/E2], and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD14", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p8", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]RAD14[/E1] was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between [E2]MSH2[/E2] and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD14", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p9", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]RAD14[/E1] was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and [E2]RAD25[/E2] subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD14", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD25", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p0", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that [E1]SIR2[/E1], but not SIR1, [E2]SIR3[/E2] or SIR4, is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR2", "entity_1_idx": [[53, 57]], "entity_1_idx_in_text_with_entity_marker": [57, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR3", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p1", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that [E1]SIR2[/E1], but not [E2]SIR1[/E2], SIR3 or SIR4, is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR2", "entity_1_idx": [[53, 57]], "entity_1_idx_in_text_with_entity_marker": [57, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR1", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [80, 84], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p2", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that [E1]SIR2[/E1], but not SIR1, SIR3 or [E2]SIR4[/E2], is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR2", "entity_1_idx": [[53, 57]], "entity_1_idx_in_text_with_entity_marker": [57, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p3", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that SIR2, but not [E1]SIR1[/E1], [E2]SIR3[/E2] or SIR4, is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR3", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p4", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, [E1]SIR3[/E1] or [E2]SIR4[/E2], is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR3", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d165.s0_BioInfer.d165.s0.p5", "text": "Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.", "text_with_entity_marker": "Deletion and overexpression studies demonstrate that SIR2, but not [E1]SIR1[/E1], SIR3 or [E2]SIR4[/E2], is required for this rDNA position effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[67, 71]], "entity_1_idx_in_text_with_entity_marker": [71, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s0_BioInfer.d49.s0.p0", "text": "A model is proposed for the function of profilin in actin-based motility.", "text_with_entity_marker": "A model is proposed for the function of [E1]profilin[/E1] in [E2]actin[/E2]-based motility.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p0", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of [E1]profilin[/E1] promote extensive [E2]actin[/E2] assembly off of the pool of actin-T beta 4 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[80, 88]], "entity_1_idx_in_text_with_entity_marker": [84, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p1", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of [E1]profilin[/E1] promote extensive actin assembly off of the pool of [E2]actin[/E2]-T beta 4 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[80, 88]], "entity_1_idx_in_text_with_entity_marker": [84, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p2", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of [E1]thymosin beta 4[/E1] (T beta 4), low amounts of [E2]profilin[/E2] promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta 4", "entity_1_idx": [[37, 52]], "entity_1_idx_in_text_with_entity_marker": [41, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[80, 88]], "entity_2_idx_in_text_with_entity_marker": [93, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p3", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of [E1]profilin[/E1] promote extensive actin assembly off of the pool of actin-[E2]T beta 4[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[80, 88]], "entity_1_idx_in_text_with_entity_marker": [84, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T beta 4", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p4", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 ([E1]T beta 4[/E1]), low amounts of [E2]profilin[/E2] promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "T beta 4", "entity_1_idx": [[54, 62]], "entity_1_idx_in_text_with_entity_marker": [58, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[80, 88]], "entity_2_idx_in_text_with_entity_marker": [93, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p5", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive [E1]actin[/E1] assembly off of the pool of [E2]actin[/E2]-T beta 4 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p6", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of [E1]thymosin beta 4[/E1] (T beta 4), low amounts of profilin promote extensive [E2]actin[/E2] assembly off of the pool of actin-T beta 4 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta 4", "entity_1_idx": [[37, 52]], "entity_1_idx_in_text_with_entity_marker": [41, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p7", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive [E1]actin[/E1] assembly off of the pool of actin-[E2]T beta 4[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T beta 4", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p8", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 ([E1]T beta 4[/E1]), low amounts of profilin promote extensive [E2]actin[/E2] assembly off of the pool of actin-T beta 4 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "T beta 4", "entity_1_idx": [[54, 62]], "entity_1_idx_in_text_with_entity_marker": [58, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p9", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of [E1]thymosin beta 4[/E1] (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of [E2]actin[/E2]-T beta 4 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta 4", "entity_1_idx": [[37, 52]], "entity_1_idx_in_text_with_entity_marker": [41, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p10", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of [E1]actin[/E1]-[E2]T beta 4[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[141, 146]], "entity_1_idx_in_text_with_entity_marker": [145, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T beta 4", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p11", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 ([E1]T beta 4[/E1]), low amounts of profilin promote extensive actin assembly off of the pool of [E2]actin[/E2]-T beta 4 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "T beta 4", "entity_1_idx": [[54, 62]], "entity_1_idx_in_text_with_entity_marker": [58, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[141, 146]], "entity_2_idx_in_text_with_entity_marker": [154, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p12", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of [E1]thymosin beta 4[/E1] (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-[E2]T beta 4[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta 4", "entity_1_idx": [[37, 52]], "entity_1_idx_in_text_with_entity_marker": [41, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T beta 4", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p13", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of [E1]thymosin beta 4[/E1] ([E2]T beta 4[/E2]), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta 4", "entity_1_idx": [[37, 52]], "entity_1_idx_in_text_with_entity_marker": [41, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T beta 4", "entity_2_idx": [[54, 62]], "entity_2_idx_in_text_with_entity_marker": [67, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s1_BioInfer.d49.s1.p14", "text": "As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.", "text_with_entity_marker": "As a consequence, in the presence of thymosin beta 4 ([E1]T beta 4[/E1]), low amounts of profilin promote extensive actin assembly off of the pool of actin-[E2]T beta 4[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "T beta 4", "entity_1_idx": [[54, 62]], "entity_1_idx_in_text_with_entity_marker": [58, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "T beta 4", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s2_BioInfer.d49.s2.p0", "text": "How profilin promotes actin filament assembly in the presence of thymosin beta 4.", "text_with_entity_marker": "How profilin promotes [E1]actin[/E1] filament assembly in the presence of [E2]thymosin beta 4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta 4", "entity_2_idx": [[65, 80]], "entity_2_idx_in_text_with_entity_marker": [78, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s2_BioInfer.d49.s2.p1", "text": "How profilin promotes actin filament assembly in the presence of thymosin beta 4.", "text_with_entity_marker": "How [E1]profilin[/E1] promotes [E2]actin[/E2] filament assembly in the presence of thymosin beta 4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[22, 27]], "entity_2_idx_in_text_with_entity_marker": [35, 40], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s2_BioInfer.d49.s2.p2", "text": "How profilin promotes actin filament assembly in the presence of thymosin beta 4.", "text_with_entity_marker": "How [E1]profilin[/E1] promotes actin filament assembly in the presence of [E2]thymosin beta 4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta 4", "entity_2_idx": [[65, 80]], "entity_2_idx_in_text_with_entity_marker": [78, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s3_BioInfer.d49.s3.p0", "text": "The role of profilin in the regulation of actin assembly has been reexamined.", "text_with_entity_marker": "The role of [E1]profilin[/E1] in the regulation of [E2]actin[/E2] assembly has been reexamined.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d49.s4_BioInfer.d49.s4.p0", "text": "When barbed ends are capped, profilin simply sequesters globular actin.", "text_with_entity_marker": "When barbed ends are capped, [E1]profilin[/E1] simply sequesters globular [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[29, 37]], "entity_1_idx_in_text_with_entity_marker": [33, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d236.s0_BioInfer.d236.s0.p0", "text": "Hence, we conclude that in its dimeric form, which is used in actin and lipid binding, talin is a dumbbell-shaped molecule built of two antiparallel subunits.", "text_with_entity_marker": "Hence, we conclude that in its dimeric form, which is used in [E1]actin[/E1] and lipid binding, [E2]talin[/E2] is a dumbbell-shaped molecule built of two antiparallel subunits.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[87, 92]], "entity_2_idx_in_text_with_entity_marker": [100, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d236.s1_BioInfer.d236.s1.p0", "text": "The talin dimer, which is crucial for actin and lipid binding, is built of a backbone containing the 200 kDa rod portions, at both ends of which a 47 kDa globular domain is attached.", "text_with_entity_marker": "The [E1]talin[/E1] dimer, which is crucial for [E2]actin[/E2] and lipid binding, is built of a backbone containing the 200 kDa rod portions, at both ends of which a 47 kDa globular domain is attached.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[38, 43]], "entity_2_idx_in_text_with_entity_marker": [51, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d337.s0_BioInfer.d337.s0.p0", "text": "Inhibition of 12P-CRE binding was also observed in the presence of an antibody to CREB-binding protein (265-kDa CBP), an integrator and coactivator of cAMP-responsive genes.", "text_with_entity_marker": "Inhibition of 12P-CRE binding was also observed in the presence of an antibody to [E1]CREB-binding protein[/E1] (265-kDa [E2]CBP[/E2]), an integrator and coactivator of cAMP-responsive genes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB-binding protein", "entity_1_idx": [[82, 102]], "entity_1_idx_in_text_with_entity_marker": [86, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[112, 115]], "entity_2_idx_in_text_with_entity_marker": [125, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p20", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of [E1]acid SMase[/E1] ([E2]A-SMase[/E2]) through the p55 TNF receptor-associated proteins TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "acid SMase", "entity_1_idx": [[49, 59]], "entity_1_idx_in_text_with_entity_marker": [53, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-SMase", "entity_2_idx": [[61, 68]], "entity_2_idx_in_text_with_entity_marker": [74, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s1_BioInfer.d242.s1.p0", "text": "TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.", "text_with_entity_marker": "TNF receptor death domain-associated proteins [E1]TRADD[/E1] and FADD signal activation of [E2]acid sphingomyelinase[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acid sphingomyelinase", "entity_2_idx": [[82, 103]], "entity_2_idx_in_text_with_entity_marker": [95, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s1_BioInfer.d242.s1.p1", "text": "TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.", "text_with_entity_marker": "TNF receptor death domain-associated proteins [E1]TRADD[/E1] and [E2]FADD[/E2] signal activation of acid sphingomyelinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[56, 60]], "entity_2_idx_in_text_with_entity_marker": [69, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s1_BioInfer.d242.s1.p2", "text": "TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.", "text_with_entity_marker": "[E1]TNF receptor[/E1] death domain-associated proteins [E2]TRADD[/E2] and FADD signal activation of acid sphingomyelinase.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF receptor", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s1_BioInfer.d242.s1.p3", "text": "TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.", "text_with_entity_marker": "TNF receptor death domain-associated proteins TRADD and [E1]FADD[/E1] signal activation of [E2]acid sphingomyelinase[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acid sphingomyelinase", "entity_2_idx": [[82, 103]], "entity_2_idx_in_text_with_entity_marker": [95, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s1_BioInfer.d242.s1.p4", "text": "TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.", "text_with_entity_marker": "[E1]TNF receptor[/E1] death domain-associated proteins TRADD and FADD signal activation of [E2]acid sphingomyelinase[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF receptor", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acid sphingomyelinase", "entity_2_idx": [[82, 103]], "entity_2_idx_in_text_with_entity_marker": [95, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s1_BioInfer.d242.s1.p5", "text": "TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.", "text_with_entity_marker": "[E1]TNF receptor[/E1] death domain-associated proteins TRADD and [E2]FADD[/E2] signal activation of acid sphingomyelinase.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF receptor", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[56, 60]], "entity_2_idx_in_text_with_entity_marker": [69, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p0", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2] during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[99, 112]], "entity_1_idx_in_text_with_entity_marker": [103, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[132, 143]], "entity_2_idx_in_text_with_entity_marker": [145, 156], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p1", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2] during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[114, 126]], "entity_1_idx_in_text_with_entity_marker": [118, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[132, 143]], "entity_2_idx_in_text_with_entity_marker": [145, 156], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p2", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of [E1]VE-cadherin[/E1], alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2] during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[86, 97]], "entity_1_idx_in_text_with_entity_marker": [90, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[132, 143]], "entity_2_idx_in_text_with_entity_marker": [145, 156], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p3", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[99, 112]], "entity_1_idx_in_text_with_entity_marker": [103, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[114, 126]], "entity_2_idx_in_text_with_entity_marker": [127, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p4", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of [E1]VE-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[86, 97]], "entity_1_idx_in_text_with_entity_marker": [90, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[99, 112]], "entity_2_idx_in_text_with_entity_marker": [112, 125], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d434.s0_BioInfer.d434.s0.p5", "text": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.", "text_with_entity_marker": "Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of [E1]VE-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin during transendothelial migration under physiological flow conditions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[86, 97]], "entity_1_idx_in_text_with_entity_marker": [90, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[114, 126]], "entity_2_idx_in_text_with_entity_marker": [127, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p110", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked [E1]PKC1[/E1] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E2]ROM2[/E2], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "ROM2", "entity_2_idx": [[258, 262]], "entity_2_idx_in_text_with_entity_marker": [271, 275], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p111", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E1]ROM2[/E1], RHO2, HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ROM2", "entity_1_idx": [[258, 262]], "entity_1_idx_in_text_with_entity_marker": [262, 266], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p112", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E2]ROM2[/E2], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "ROM2", "entity_2_idx": [[258, 262]], "entity_2_idx_in_text_with_entity_marker": [271, 275], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p113", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E1]MEK[/E1]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E2]ROM2[/E2], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "ROM2", "entity_2_idx": [[258, 262]], "entity_2_idx_in_text_with_entity_marker": [271, 275], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p114", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E1]MAP kinase[/E1]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as [E2]ROM2[/E2], RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MAP kinase", "entity_1_idx": [[120, 130]], "entity_1_idx_in_text_with_entity_marker": [124, 134], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "ROM2", "entity_2_idx": [[258, 262]], "entity_2_idx_in_text_with_entity_marker": [271, 275], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p115", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E1]glc7-10[/E1] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glc7-10", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p116", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked [E1]PKC1[/E1] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKC1", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p117", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/[E1]SLG1[/E1] and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SLG1", "entity_1_idx": [[281, 285]], "entity_1_idx_in_text_with_entity_marker": [285, 289], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p118", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p119", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 ([E1]MEK[/E1]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[106, 109]], "entity_1_idx_in_text_with_entity_marker": [110, 113], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d335.s0_BioInfer.d335.s0.p0", "text": "In flattened cells under starvation stress, cofilin localized at dramatically reorganizing actin-cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques.", "text_with_entity_marker": "In flattened cells under starvation stress, [E1]cofilin[/E1] localized at dramatically reorganizing actin-cytoskeletons in ruffling membranes of the leading edge, but not at rigid [E2]actin[/E2] meshwork in focal adhesion plaques.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[44, 51]], "entity_1_idx_in_text_with_entity_marker": [48, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[171, 176]], "entity_2_idx_in_text_with_entity_marker": [184, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d335.s0_BioInfer.d335.s0.p1", "text": "In flattened cells under starvation stress, cofilin localized at dramatically reorganizing actin-cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques.", "text_with_entity_marker": "In flattened cells under starvation stress, cofilin localized at dramatically reorganizing [E1]actin[/E1]-cytoskeletons in ruffling membranes of the leading edge, but not at rigid [E2]actin[/E2] meshwork in focal adhesion plaques.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[171, 176]], "entity_2_idx_in_text_with_entity_marker": [184, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d335.s0_BioInfer.d335.s0.p2", "text": "In flattened cells under starvation stress, cofilin localized at dramatically reorganizing actin-cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques.", "text_with_entity_marker": "In flattened cells under starvation stress, [E1]cofilin[/E1] localized at dramatically reorganizing [E2]actin[/E2]-cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[44, 51]], "entity_1_idx_in_text_with_entity_marker": [48, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d335.s1_BioInfer.d335.s1.p0", "text": "These results suggest that cofilin may be involved in dynamic reorganization of membranous actin cytoskeletons.", "text_with_entity_marker": "These results suggest that [E1]cofilin[/E1] may be involved in dynamic reorganization of membranous [E2]actin[/E2] cytoskeletons.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d129.s0_BioInfer.d129.s0.p0", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "[E1]CD26[/E1], a T cell activation Ag, also known as [E2]dipeptidyl peptidase IV[/E2], is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[44, 67]], "entity_2_idx_in_text_with_entity_marker": [57, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d129.s0_BioInfer.d129.s0.p1", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "[E1]CD26[/E1], a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase ([E2]ADA[/E2]) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d129.s0_BioInfer.d129.s0.p2", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "[E1]CD26[/E1], a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with [E2]adenosine deaminase[/E2] (ADA) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[97, 116]], "entity_2_idx_in_text_with_entity_marker": [110, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d129.s0_BioInfer.d129.s0.p3", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "CD26, a T cell activation Ag, also known as [E1]dipeptidyl peptidase IV[/E1], is directly associated with adenosine deaminase ([E2]ADA[/E2]) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[44, 67]], "entity_1_idx_in_text_with_entity_marker": [48, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d129.s0_BioInfer.d129.s0.p4", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "CD26, a T cell activation Ag, also known as [E1]dipeptidyl peptidase IV[/E1], is directly associated with [E2]adenosine deaminase[/E2] (ADA) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[44, 67]], "entity_1_idx_in_text_with_entity_marker": [48, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[97, 116]], "entity_2_idx_in_text_with_entity_marker": [110, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d129.s0_BioInfer.d129.s0.p5", "text": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.", "text_with_entity_marker": "CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with [E1]adenosine deaminase[/E1] ([E2]ADA[/E2]) on the surface of T cells and T cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "adenosine deaminase", "entity_1_idx": [[97, 116]], "entity_1_idx_in_text_with_entity_marker": [101, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s0_BioInfer.d334.s0.p0", "text": "In extracts from mouse brain, profilin I and profilin II can form complexes with regulators of endocytosis, synaptic vesicle recycling and actin assembly.", "text_with_entity_marker": "In extracts from mouse brain, [E1]profilin I[/E1] and profilin II can form complexes with regulators of endocytosis, synaptic vesicle recycling and [E2]actin[/E2] assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[30, 40]], "entity_1_idx_in_text_with_entity_marker": [34, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s0_BioInfer.d334.s0.p1", "text": "In extracts from mouse brain, profilin I and profilin II can form complexes with regulators of endocytosis, synaptic vesicle recycling and actin assembly.", "text_with_entity_marker": "In extracts from mouse brain, profilin I and [E1]profilin II[/E1] can form complexes with regulators of endocytosis, synaptic vesicle recycling and [E2]actin[/E2] assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[45, 56]], "entity_1_idx_in_text_with_entity_marker": [49, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s0_BioInfer.d334.s0.p2", "text": "In extracts from mouse brain, profilin I and profilin II can form complexes with regulators of endocytosis, synaptic vesicle recycling and actin assembly.", "text_with_entity_marker": "In extracts from mouse brain, [E1]profilin I[/E1] and [E2]profilin II[/E2] can form complexes with regulators of endocytosis, synaptic vesicle recycling and actin assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[30, 40]], "entity_1_idx_in_text_with_entity_marker": [34, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[45, 56]], "entity_2_idx_in_text_with_entity_marker": [58, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s1_BioInfer.d334.s1.p0", "text": "In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly.", "text_with_entity_marker": "In mouse brain profilin I and [E1]profilin II[/E1] associate with regulators of the endocytic pathway and [E2]actin[/E2] assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s1_BioInfer.d334.s1.p1", "text": "In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly.", "text_with_entity_marker": "In mouse brain [E1]profilin I[/E1] and [E2]profilin II[/E2] associate with regulators of the endocytic pathway and actin assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[30, 41]], "entity_2_idx_in_text_with_entity_marker": [43, 54], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s1_BioInfer.d334.s1.p2", "text": "In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly.", "text_with_entity_marker": "In mouse brain [E1]profilin I[/E1] and profilin II associate with regulators of the endocytic pathway and [E2]actin[/E2] assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p0", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing [E1]actin[/E1] and [E2]clathrin[/E2] assembly to distinct membrane domains.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[148, 153]], "entity_1_idx_in_text_with_entity_marker": [152, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "clathrin", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p1", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the [E1]actin[/E1] cytoskeleton and endocytic membrane flow, directing [E2]actin[/E2] and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p2", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and [E1]profilin II[/E1] complexes link the actin cytoskeleton and endocytic membrane flow, directing [E2]actin[/E2] and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin II", "entity_1_idx": [[59, 70]], "entity_1_idx_in_text_with_entity_marker": [63, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p3", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain [E1]profilin I[/E1] and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing [E2]actin[/E2] and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin I", "entity_1_idx": [[44, 54]], "entity_1_idx_in_text_with_entity_marker": [48, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p4", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the [E1]actin[/E1] cytoskeleton and endocytic membrane flow, directing actin and [E2]clathrin[/E2] assembly to distinct membrane domains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "clathrin", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p5", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and [E1]profilin II[/E1] complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and [E2]clathrin[/E2] assembly to distinct membrane domains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin II", "entity_1_idx": [[59, 70]], "entity_1_idx_in_text_with_entity_marker": [63, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "clathrin", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p6", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain [E1]profilin I[/E1] and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and [E2]clathrin[/E2] assembly to distinct membrane domains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin I", "entity_1_idx": [[44, 54]], "entity_1_idx_in_text_with_entity_marker": [48, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "clathrin", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p7", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain profilin I and [E1]profilin II[/E1] complexes link the [E2]actin[/E2] cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin II", "entity_1_idx": [[59, 70]], "entity_1_idx_in_text_with_entity_marker": [63, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p8", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain [E1]profilin I[/E1] and profilin II complexes link the [E2]actin[/E2] cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin I", "entity_1_idx": [[44, 54]], "entity_1_idx_in_text_with_entity_marker": [48, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d334.s2_BioInfer.d334.s2.p9", "text": "Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "text_with_entity_marker": "Our findings strongly suggest that in brain [E1]profilin I[/E1] and [E2]profilin II[/E2] complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[44, 54]], "entity_1_idx_in_text_with_entity_marker": [48, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[59, 70]], "entity_2_idx_in_text_with_entity_marker": [72, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p0", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases [E1]ERK1[/E1] and [E2]ERK2[/E2], induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK1", "entity_1_idx": [[92, 96]], "entity_1_idx_in_text_with_entity_marker": [96, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ERK2", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p1", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases [E1]ERK1[/E1] and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor [E2]AP-1[/E2] DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK1", "entity_1_idx": [[92, 96]], "entity_1_idx_in_text_with_entity_marker": [96, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p2", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases [E1]ERK1[/E1] and ERK2, induction of c-fos and [E2]c-jun[/E2] protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK1", "entity_1_idx": [[92, 96]], "entity_1_idx_in_text_with_entity_marker": [96, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-jun", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p3", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases [E1]ERK1[/E1] and ERK2, induction of [E2]c-fos[/E2] and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK1", "entity_1_idx": [[92, 96]], "entity_1_idx_in_text_with_entity_marker": [96, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-fos", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p4", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of [E1]extracellular signal-regulated protein kinases[/E1] [E2]ERK1[/E2] and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "extracellular signal-regulated protein kinases", "entity_1_idx": [[45, 91]], "entity_1_idx_in_text_with_entity_marker": [49, 95], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "ERK1", "entity_2_idx": [[92, 96]], "entity_2_idx_in_text_with_entity_marker": [105, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p5", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and [E1]ERK2[/E1], induction of c-fos and c-jun protein expression, and an increase in transcription factor [E2]AP-1[/E2] DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK2", "entity_1_idx": [[101, 105]], "entity_1_idx_in_text_with_entity_marker": [105, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p6", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and [E1]ERK2[/E1], induction of c-fos and [E2]c-jun[/E2] protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK2", "entity_1_idx": [[101, 105]], "entity_1_idx_in_text_with_entity_marker": [105, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-jun", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p7", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and [E1]ERK2[/E1], induction of [E2]c-fos[/E2] and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK2", "entity_1_idx": [[101, 105]], "entity_1_idx_in_text_with_entity_marker": [105, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-fos", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p8", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of [E1]extracellular signal-regulated protein kinases[/E1] ERK1 and [E2]ERK2[/E2], induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "extracellular signal-regulated protein kinases", "entity_1_idx": [[45, 91]], "entity_1_idx_in_text_with_entity_marker": [49, 95], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "ERK2", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p9", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and [E1]c-jun[/E1] protein expression, and an increase in transcription factor [E2]AP-1[/E2] DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-jun", "entity_1_idx": [[130, 135]], "entity_1_idx_in_text_with_entity_marker": [134, 139], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AP-1", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p10", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of [E1]c-fos[/E1] and c-jun protein expression, and an increase in transcription factor [E2]AP-1[/E2] DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-fos", "entity_1_idx": [[120, 125]], "entity_1_idx_in_text_with_entity_marker": [124, 129], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AP-1", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p11", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of [E1]extracellular signal-regulated protein kinases[/E1] ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor [E2]AP-1[/E2] DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "extracellular signal-regulated protein kinases", "entity_1_idx": [[45, 91]], "entity_1_idx_in_text_with_entity_marker": [49, 95], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "AP-1", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p12", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of [E1]c-fos[/E1] and [E2]c-jun[/E2] protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-fos", "entity_1_idx": [[120, 125]], "entity_1_idx_in_text_with_entity_marker": [124, 129], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "c-jun", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p13", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of [E1]extracellular signal-regulated protein kinases[/E1] ERK1 and ERK2, induction of c-fos and [E2]c-jun[/E2] protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "extracellular signal-regulated protein kinases", "entity_1_idx": [[45, 91]], "entity_1_idx_in_text_with_entity_marker": [49, 95], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "c-jun", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d777.s0_BioInfer.d777.s0.p14", "text": "Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "text_with_entity_marker": "Treatment with HNE resulted in activation of [E1]extracellular signal-regulated protein kinases[/E1] ERK1 and ERK2, induction of [E2]c-fos[/E2] and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "extracellular signal-regulated protein kinases", "entity_1_idx": [[45, 91]], "entity_1_idx_in_text_with_entity_marker": [49, 95], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "c-fos", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s0_BioInfer.d81.s0.p0", "text": "As expected from immunofluorescence experiments, Abp1p, cofilin, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "text_with_entity_marker": "As expected from immunofluorescence experiments, Abp1p, [E1]cofilin[/E1], and [E2]actin[/E2] colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s0_BioInfer.d81.s0.p1", "text": "As expected from immunofluorescence experiments, Abp1p, cofilin, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "text_with_entity_marker": "As expected from immunofluorescence experiments, [E1]Abp1p[/E1], [E2]cofilin[/E2], and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Abp1p", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s0_BioInfer.d81.s0.p2", "text": "As expected from immunofluorescence experiments, Abp1p, cofilin, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "text_with_entity_marker": "As expected from immunofluorescence experiments, [E1]Abp1p[/E1], cofilin, and [E2]actin[/E2] colocalized in immuno-EM to the dense patchlike structures but not to the cables.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Abp1p", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s1_BioInfer.d81.s1.p0", "text": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.", "text_with_entity_marker": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the [E1]actin binding proteins[/E1] Abp1p and [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin binding proteins", "entity_1_idx": [[110, 132]], "entity_1_idx_in_text_with_entity_marker": [114, 136], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[143, 150]], "entity_2_idx_in_text_with_entity_marker": [156, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s1_BioInfer.d81.s1.p1", "text": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.", "text_with_entity_marker": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins [E1]Abp1p[/E1] and [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[133, 138]], "entity_1_idx_in_text_with_entity_marker": [137, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[143, 150]], "entity_2_idx_in_text_with_entity_marker": [156, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s1_BioInfer.d81.s1.p2", "text": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.", "text_with_entity_marker": "Immuno-EM double-labeling experiments were conducted with antibodies to [E1]actin[/E1] together with antibodies to the actin binding proteins Abp1p and [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[143, 150]], "entity_2_idx_in_text_with_entity_marker": [156, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s1_BioInfer.d81.s1.p3", "text": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.", "text_with_entity_marker": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the [E1]actin binding proteins[/E1] [E2]Abp1p[/E2] and cofilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin binding proteins", "entity_1_idx": [[110, 132]], "entity_1_idx_in_text_with_entity_marker": [114, 136], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Abp1p", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s1_BioInfer.d81.s1.p4", "text": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.", "text_with_entity_marker": "Immuno-EM double-labeling experiments were conducted with antibodies to [E1]actin[/E1] together with antibodies to the [E2]actin binding proteins[/E2] Abp1p and cofilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin binding proteins", "entity_2_idx": [[110, 132]], "entity_2_idx_in_text_with_entity_marker": [123, 145], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d81.s1_BioInfer.d81.s1.p5", "text": "Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.", "text_with_entity_marker": "Immuno-EM double-labeling experiments were conducted with antibodies to [E1]actin[/E1] together with antibodies to the actin binding proteins [E2]Abp1p[/E2] and cofilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Abp1p", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p0", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of [E1]profilin[/E1]: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of [E2]profilin[/E2] molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[187, 195]], "entity_2_idx_in_text_with_entity_marker": [200, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p1", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of [E1]profilin[/E1]: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked [E2]actin[/E2] ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p2", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of [E1]profilin[/E1]: [E2]actin[/E2] crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[22, 27]], "entity_2_idx_in_text_with_entity_marker": [35, 40], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p3", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of [E1]profilin[/E1]: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring [E2]actin[/E2] subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p4", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked [E1]actin[/E1] ribbons held in place by columns of [E2]profilin[/E2] molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[145, 150]], "entity_1_idx_in_text_with_entity_marker": [149, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[187, 195]], "entity_2_idx_in_text_with_entity_marker": [200, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p5", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of profilin: [E1]actin[/E1] crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of [E2]profilin[/E2] molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[187, 195]], "entity_2_idx_in_text_with_entity_marker": [200, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p6", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of [E1]profilin[/E1] molecules, wedged in between neighboring [E2]actin[/E2] subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[187, 195]], "entity_1_idx_in_text_with_entity_marker": [191, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p7", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of profilin: [E1]actin[/E1] crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked [E2]actin[/E2] ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p8", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked [E1]actin[/E1] ribbons held in place by columns of profilin molecules, wedged in between neighboring [E2]actin[/E2] subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[145, 150]], "entity_1_idx_in_text_with_entity_marker": [149, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s0_BioInfer.d55.s0.p9", "text": "Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.", "text_with_entity_marker": "Analysis of profilin: [E1]actin[/E1] crystals reveals an extensive intermolecular network, rather than a discrete \"monomeric complex\", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring [E2]actin[/E2] subunits and running perpendicular to the ribbons.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d55.s1_BioInfer.d55.s1.p0", "text": "Molecular packing in profilin: actin crystals and its implications.", "text_with_entity_marker": "Molecular packing in [E1]profilin[/E1]: [E2]actin[/E2] crystals and its implications.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[31, 36]], "entity_2_idx_in_text_with_entity_marker": [44, 49], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p0", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, [E1]RAD51[/E1] on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD 54[/E2], 55 and 57 did not suppress.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD 54", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p1", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, [E1]RAD51[/E1] on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [190, 192]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p2", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, [E1]RAD51[/E1] on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [183, 185]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p3", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the [E1]RAD51[/E1] and RAD52 proteins interact, [E2]RAD51[/E2] on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p4", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and [E1]RAD52[/E1] proteins interact, [E2]RAD51[/E2] on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p5", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, [E1]RAD51[/E1] on a high copy number plasmid was tested and found to suppress the [E2]rad52-20[/E2] allele, but RAD 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "rad52-20", "entity_2_idx": [[154, 162]], "entity_2_idx_in_text_with_entity_marker": [167, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p6", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E1-E2]RAD[/E1] 54[/E2], 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD", "entity_1_idx": [[175, 178], [190, 192]], "entity_1_idx_in_text_with_entity_marker": [182, 185], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD[/E1] 54", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [182, 193], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p7", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E1-E2]RAD[/E1] 54[/E2], 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD", "entity_1_idx": [[175, 178], [183, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 185], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD[/E1] 54", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [182, 193], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p8", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the [E1]RAD51[/E1] and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD 54[/E2], 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD 54", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p9", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and [E1]RAD52[/E1] proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD 54[/E2], 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD 54", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p10", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the [E1]rad52-20[/E1] allele, but [E2]RAD 54[/E2], 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad52-20", "entity_1_idx": [[154, 162]], "entity_1_idx_in_text_with_entity_marker": [158, 166], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD 54", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p11", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E1-E2]RAD[/E1-E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD", "entity_1_idx": [[175, 178], [183, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 185], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [190, 192]], "entity_2_idx_in_text_with_entity_marker": [182, 185], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p12", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the [E1]RAD51[/E1] and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [190, 192]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p13", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and [E1]RAD52[/E1] proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [190, 192]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p14", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the [E1]rad52-20[/E1] allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad52-20", "entity_1_idx": [[154, 162]], "entity_1_idx_in_text_with_entity_marker": [158, 166], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [190, 192]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p15", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the [E1]RAD51[/E1] and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [183, 185]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p16", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and [E1]RAD52[/E1] proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [183, 185]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p17", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the [E1]rad52-20[/E1] allele, but [E2]RAD[/E2] 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad52-20", "entity_1_idx": [[154, 162]], "entity_1_idx_in_text_with_entity_marker": [158, 166], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD", "entity_2_idx": [[175, 178], [183, 185]], "entity_2_idx_in_text_with_entity_marker": [188, 191], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p18", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the [E1]RAD51[/E1] and [E2]RAD52[/E2] proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[56, 61]], "entity_2_idx_in_text_with_entity_marker": [69, 74], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p19", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the [E1]RAD51[/E1] and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the [E2]rad52-20[/E2] allele, but RAD 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "rad52-20", "entity_2_idx": [[154, 162]], "entity_2_idx_in_text_with_entity_marker": [167, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d95.s0_BioInfer.d95.s0.p20", "text": "Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.", "text_with_entity_marker": "Because other researchers have shown that the RAD51 and [E1]RAD52[/E1] proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the [E2]rad52-20[/E2] allele, but RAD 54, 55 and 57 did not suppress.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "rad52-20", "entity_2_idx": [[154, 162]], "entity_2_idx_in_text_with_entity_marker": [167, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d10.s0_BioInfer.d10.s0.p0", "text": "Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).", "text_with_entity_marker": "Acidic domain of the [E1]phosphoprotein[/E1] (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous [E2]nucleocapsid protein[/E2] (N).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[21, 35]], "entity_1_idx_in_text_with_entity_marker": [25, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[128, 148]], "entity_2_idx_in_text_with_entity_marker": [141, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d10.s0_BioInfer.d10.s0.p1", "text": "Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).", "text_with_entity_marker": "Acidic domain of the phosphoprotein ([E1]P[/E1]) of vesicular stomatitis virus differentially interacts with homologous and heterologous [E2]nucleocapsid protein[/E2] (N).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[37, 38]], "entity_1_idx_in_text_with_entity_marker": [41, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[128, 148]], "entity_2_idx_in_text_with_entity_marker": [141, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d10.s0_BioInfer.d10.s0.p2", "text": "Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).", "text_with_entity_marker": "Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous [E1]nucleocapsid protein[/E1] ([E2]N[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[128, 148]], "entity_1_idx_in_text_with_entity_marker": [132, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[150, 151]], "entity_2_idx_in_text_with_entity_marker": [163, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d10.s0_BioInfer.d10.s0.p3", "text": "Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).", "text_with_entity_marker": "Acidic domain of the [E1]phosphoprotein[/E1] ([E2]P[/E2]) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[21, 35]], "entity_1_idx_in_text_with_entity_marker": [25, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[37, 38]], "entity_2_idx_in_text_with_entity_marker": [50, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d10.s0_BioInfer.d10.s0.p4", "text": "Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).", "text_with_entity_marker": "Acidic domain of the [E1]phosphoprotein[/E1] (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein ([E2]N[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[21, 35]], "entity_1_idx_in_text_with_entity_marker": [25, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[150, 151]], "entity_2_idx_in_text_with_entity_marker": [163, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d10.s0_BioInfer.d10.s0.p5", "text": "Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).", "text_with_entity_marker": "Acidic domain of the phosphoprotein ([E1]P[/E1]) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein ([E2]N[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[37, 38]], "entity_1_idx_in_text_with_entity_marker": [41, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[150, 151]], "entity_2_idx_in_text_with_entity_marker": [163, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s0_BioInfer.d516.s0.p0", "text": "Reinvestigation of the inhibition of actin polymerization by profilin.", "text_with_entity_marker": "Reinvestigation of the inhibition of [E1]actin[/E1] polymerization by [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p0", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of [E1]profilin[/E1] and the apparently weak inhibition by [E2]profilin[/E2] of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[174, 182]], "entity_1_idx_in_text_with_entity_marker": [178, 186], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[221, 229]], "entity_2_idx_in_text_with_entity_marker": [234, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p1", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by [E1]profilin[/E1] of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[221, 229]], "entity_1_idx_in_text_with_entity_marker": [225, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p2", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled [E1]actin[/E1] in the presence of profilin and the apparently weak inhibition by [E2]profilin[/E2] of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[149, 154]], "entity_1_idx_in_text_with_entity_marker": [153, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[221, 229]], "entity_2_idx_in_text_with_entity_marker": [234, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p3", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified [E1]actin[/E1] explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by [E2]profilin[/E2] of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[221, 229]], "entity_2_idx_in_text_with_entity_marker": [234, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p4", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of [E1]profilin[/E1] for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by [E2]profilin[/E2] of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[221, 229]], "entity_2_idx_in_text_with_entity_marker": [234, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p5", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of [E1]profilin[/E1] and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[174, 182]], "entity_1_idx_in_text_with_entity_marker": [178, 186], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p6", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled [E1]actin[/E1] in the presence of [E2]profilin[/E2] and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[149, 154]], "entity_1_idx_in_text_with_entity_marker": [153, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[174, 182]], "entity_2_idx_in_text_with_entity_marker": [187, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p7", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified [E1]actin[/E1] explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of [E2]profilin[/E2] and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[174, 182]], "entity_2_idx_in_text_with_entity_marker": [187, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p8", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of [E1]profilin[/E1] for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of [E2]profilin[/E2] and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[174, 182]], "entity_2_idx_in_text_with_entity_marker": [187, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p9", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled [E1]actin[/E1] in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[149, 154]], "entity_1_idx_in_text_with_entity_marker": [153, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p10", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified [E1]actin[/E1] explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p11", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of [E1]profilin[/E1] for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p12", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of profilin for modified [E1]actin[/E1] explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled [E2]actin[/E2] in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p13", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of [E1]profilin[/E1] for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled [E2]actin[/E2] in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p14", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of [E1]profilin[/E1] for modified [E2]actin[/E2] explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p0", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with [E1]myosin[/E1]'s binding to [E2]actin[/E2] was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin", "entity_1_idx": [[103, 109]], "entity_1_idx_in_text_with_entity_marker": [107, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p1", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the [E1]myosin heavy chain[/E1] (Myh) predicted to interfere strongly with [E2]myosin[/E2]'s binding to actin was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chain", "entity_1_idx": [[41, 59]], "entity_1_idx_in_text_with_entity_marker": [45, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[103, 109]], "entity_2_idx_in_text_with_entity_marker": [116, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p2", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the myosin heavy chain ([E1]Myh[/E1]) predicted to interfere strongly with [E2]myosin[/E2]'s binding to actin was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Myh", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[103, 109]], "entity_2_idx_in_text_with_entity_marker": [116, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p3", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the [E1]myosin heavy chain[/E1] (Myh) predicted to interfere strongly with myosin's binding to [E2]actin[/E2] was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chain", "entity_1_idx": [[41, 59]], "entity_1_idx_in_text_with_entity_marker": [45, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p4", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the myosin heavy chain ([E1]Myh[/E1]) predicted to interfere strongly with myosin's binding to [E2]actin[/E2] was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Myh", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p5", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the [E1]myosin heavy chain[/E1] ([E2]Myh[/E2]) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[41, 59]], "entity_1_idx_in_text_with_entity_marker": [45, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Myh", "entity_2_idx": [[61, 64]], "entity_2_idx_in_text_with_entity_marker": [74, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p0", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Testicular protein kinase 1 ([E1]TESK1[/E1]) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TESK1", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[165, 170]], "entity_2_idx_in_text_with_entity_marker": [178, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p1", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "[E1]Testicular protein kinase 1[/E1] (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Testicular protein kinase 1", "entity_1_idx": [[0, 27]], "entity_1_idx_in_text_with_entity_marker": [4, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[165, 170]], "entity_2_idx_in_text_with_entity_marker": [178, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p2", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Testicular protein kinase 1 (TESK1) is a [E1]serine/threonine kinase[/E1] highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "serine/threonine kinase", "entity_1_idx": [[41, 64]], "entity_1_idx_in_text_with_entity_marker": [45, 68], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[165, 170]], "entity_2_idx_in_text_with_entity_marker": [178, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p3", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate [E1]cofilin[/E1] and induce [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[146, 153]], "entity_1_idx_in_text_with_entity_marker": [150, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[165, 170]], "entity_2_idx_in_text_with_entity_marker": [178, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p4", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "[E1]Testicular protein kinase 1[/E1] ([E2]TESK1[/E2]) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Testicular protein kinase 1", "entity_1_idx": [[0, 27]], "entity_1_idx_in_text_with_entity_marker": [4, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TESK1", "entity_2_idx": [[29, 34]], "entity_2_idx_in_text_with_entity_marker": [42, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p5", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Testicular protein kinase 1 ([E1]TESK1[/E1]) is a [E2]serine/threonine kinase[/E2] highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TESK1", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "serine/threonine kinase", "entity_2_idx": [[41, 64]], "entity_2_idx_in_text_with_entity_marker": [54, 77], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p6", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Testicular protein kinase 1 ([E1]TESK1[/E1]) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate [E2]cofilin[/E2] and induce actin cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TESK1", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[146, 153]], "entity_2_idx_in_text_with_entity_marker": [159, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p7", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "[E1]Testicular protein kinase 1[/E1] (TESK1) is a [E2]serine/threonine kinase[/E2] highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Testicular protein kinase 1", "entity_1_idx": [[0, 27]], "entity_1_idx_in_text_with_entity_marker": [4, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "serine/threonine kinase", "entity_2_idx": [[41, 64]], "entity_2_idx_in_text_with_entity_marker": [54, 77], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p8", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "[E1]Testicular protein kinase 1[/E1] (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate [E2]cofilin[/E2] and induce actin cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Testicular protein kinase 1", "entity_1_idx": [[0, 27]], "entity_1_idx_in_text_with_entity_marker": [4, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[146, 153]], "entity_2_idx_in_text_with_entity_marker": [159, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d559.s0_BioInfer.d559.s0.p9", "text": "Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Testicular protein kinase 1 (TESK1) is a [E1]serine/threonine kinase[/E1] highly expressed in testicular germ cells and has the potential to phosphorylate [E2]cofilin[/E2] and induce actin cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "serine/threonine kinase", "entity_1_idx": [[41, 64]], "entity_1_idx_in_text_with_entity_marker": [45, 68], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[146, 153]], "entity_2_idx_in_text_with_entity_marker": [159, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p0", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the [E1]cyclin-dependent kinase inhibitor[/E1] p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in [E2]cyclin E-associated kinase[/E2] activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[136, 169]], "entity_1_idx_in_text_with_entity_marker": [140, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E-associated kinase", "entity_2_idx": [[289, 315]], "entity_2_idx_in_text_with_entity_marker": [302, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p1", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the [E1]cyclin-dependent kinase inhibitor[/E1] p27(KIP1) that is accompanied by an increase in p27([E2]KIP1[/E2]) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[136, 169]], "entity_1_idx_in_text_with_entity_marker": [140, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "KIP1", "entity_2_idx": [[222, 226]], "entity_2_idx_in_text_with_entity_marker": [235, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p2", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p27[/E2](KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[136, 169]], "entity_1_idx_in_text_with_entity_marker": [140, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[170, 173]], "entity_2_idx_in_text_with_entity_marker": [183, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p3", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the [E1]cyclin-dependent kinase inhibitor[/E1] p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to [E2]cyclin E[/E2] and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[136, 169]], "entity_1_idx_in_text_with_entity_marker": [140, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[250, 258]], "entity_2_idx_in_text_with_entity_marker": [263, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p4", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that [E1]pRb[/E1] causes a posttranscriptional accumulation of the [E2]cyclin-dependent kinase inhibitor[/E2] p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pRb", "entity_1_idx": [[83, 86]], "entity_1_idx_in_text_with_entity_marker": [87, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[136, 169]], "entity_2_idx_in_text_with_entity_marker": [149, 182], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p5", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the [E1]cyclin-dependent kinase inhibitor[/E1] p27([E2]KIP1[/E2]) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[136, 169]], "entity_1_idx_in_text_with_entity_marker": [140, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "KIP1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p6", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which [E1]pRb[/E1] induces senescence, we have found that pRb causes a posttranscriptional accumulation of the [E2]cyclin-dependent kinase inhibitor[/E2] p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pRb", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[136, 169]], "entity_2_idx_in_text_with_entity_marker": [149, 182], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p7", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the [E1]cyclin-dependent kinase inhibitor[/E1] p27(KIP1) that is accompanied by an increase in [E2]p27[/E2](KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[136, 169]], "entity_1_idx_in_text_with_entity_marker": [140, 173], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p8", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27([E1]KIP1[/E1]) specifically bound to cyclin E and a concomitant decrease in [E2]cyclin E-associated kinase[/E2] activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "KIP1", "entity_1_idx": [[222, 226]], "entity_1_idx_in_text_with_entity_marker": [226, 230], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E-associated kinase", "entity_2_idx": [[289, 315]], "entity_2_idx_in_text_with_entity_marker": [302, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p9", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor [E1]p27[/E1](KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in [E2]cyclin E-associated kinase[/E2] activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[170, 173]], "entity_1_idx_in_text_with_entity_marker": [174, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E-associated kinase", "entity_2_idx": [[289, 315]], "entity_2_idx_in_text_with_entity_marker": [302, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d801.s0_BioInfer.d801.s0.p0", "text": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain (MHC), actin, and mixed muscle proteins in nonfrail elders and younger women and men.", "text_with_entity_marker": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, [E1]myosin heavy chain[/E1] (MHC), [E2]actin[/E2], and mixed muscle proteins in nonfrail elders and younger women and men.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[121, 139]], "entity_1_idx_in_text_with_entity_marker": [125, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d801.s0_BioInfer.d801.s0.p1", "text": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain (MHC), actin, and mixed muscle proteins in nonfrail elders and younger women and men.", "text_with_entity_marker": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain ([E1]MHC[/E1]), [E2]actin[/E2], and mixed muscle proteins in nonfrail elders and younger women and men.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[141, 144]], "entity_1_idx_in_text_with_entity_marker": [145, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d801.s0_BioInfer.d801.s0.p2", "text": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain (MHC), actin, and mixed muscle proteins in nonfrail elders and younger women and men.", "text_with_entity_marker": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]), actin, and mixed muscle proteins in nonfrail elders and younger women and men.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[121, 139]], "entity_1_idx_in_text_with_entity_marker": [125, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[141, 144]], "entity_2_idx_in_text_with_entity_marker": [154, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p90", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, [E1]histone[/E1] [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[223, 230]], "entity_1_idx_in_text_with_entity_marker": [227, 234], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p91", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E1]H[/E1]2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[213, 214], [219, 221]], "entity_1_idx_in_text_with_entity_marker": [217, 218], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p92", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p93", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p94", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p95", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p96", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E1-E2]H[/E1]2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[213, 214], [219, 221]], "entity_1_idx_in_text_with_entity_marker": [220, 221], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H[/E1]2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [220, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p97", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E1]H1[/E1], histone [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[201, 203]], "entity_1_idx_in_text_with_entity_marker": [205, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p98", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] (PCNA), histone H1, histone [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p99", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E1]H[/E1]2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[213, 214], [219, 221]], "entity_1_idx_in_text_with_entity_marker": [217, 218], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p0", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of gelsolin truncates that inhibit [E1]actin[/E1] depolymerization by severing activity of gelsolin and [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[112, 119]], "entity_2_idx_in_text_with_entity_marker": [125, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p1", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of [E1]gelsolin[/E1] and [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[99, 107]], "entity_1_idx_in_text_with_entity_marker": [103, 111], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[112, 119]], "entity_2_idx_in_text_with_entity_marker": [125, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p2", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of [E1]gelsolin[/E1] truncates that inhibit actin depolymerization by severing activity of gelsolin and [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gelsolin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[112, 119]], "entity_2_idx_in_text_with_entity_marker": [125, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p3", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of gelsolin truncates that inhibit [E1]actin[/E1] depolymerization by severing activity of [E2]gelsolin[/E2] and cofilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[99, 107]], "entity_2_idx_in_text_with_entity_marker": [112, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p4", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of [E1]gelsolin[/E1] truncates that inhibit [E2]actin[/E2] depolymerization by severing activity of gelsolin and cofilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gelsolin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d137.s0_BioInfer.d137.s0.p5", "text": "Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.", "text_with_entity_marker": "Characterization of [E1]gelsolin[/E1] truncates that inhibit actin depolymerization by severing activity of [E2]gelsolin[/E2] and cofilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gelsolin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[99, 107]], "entity_2_idx_in_text_with_entity_marker": [112, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
